Characterization of porcine adipose tissue-derived stem cells by Williams, Kellie J
Louisiana State University
LSU Digital Commons
LSU Doctoral Dissertations Graduate School
2009
Characterization of porcine adipose tissue-derived
stem cells
Kellie J. Williams
Louisiana State University and Agricultural and Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Animal Sciences Commons
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please contactgradetd@lsu.edu.
Recommended Citation
Williams, Kellie J., "Characterization of porcine adipose tissue-derived stem cells" (2009). LSU Doctoral Dissertations. 428.
https://digitalcommons.lsu.edu/gradschool_dissertations/428
 CHARACTERIZATION OF PORCINE ADIPOSE TISSUE-DERIVED STEM CELLS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Dissertation 
 
Submitted to the Graduate Faculty of the  
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the  
requirements for the degree of  
Doctor of Philosophy 
 
in 
 
The Interdepartmental Program in 
Animal and Dairy Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
by 
Kellie J. Williams 
M.S., University of Oklahoma Health Sciences Center, 2005 
August 2009 
 ii 
ACKNOWLEDGMENTS 
 
 It is with deep gratitude and appreciation that the author acknowledges the professional 
guidance of her major co-professors Drs. Robert A. Godke and Kenneth R. Bondioli from the 
School of Animal Sciences.  Both professors provided the environment conducive to the 
accomplishment of the presented work.  Their appreciated contributions included the provision 
of resources, equipment, financial support, patience, valued opinions and scholastic wisdoms.   
 The author would also like to extend her gratitude and appreciation to Dr. Jeffrey Gimble 
at Pennington Biomedical Research Center.  Dr. Gimble provided valuable advice and expertise 
in the field of adipose stem cell biology as well as a collaborative platform for the completion of 
several projects presented here.  In addition, the author would also like to thank the rest of her 
graduate committee including Dr. Patrick DiMario, Department of Biological Sciences, Dr. 
Zhimin Xu, Department of Food Science and Dr. Masami Yoshimura, Department of Veterinary 
Medicine for their valuable time and contribution to the integrity of the presented work.   
 The author would like to thank the Laboratory Director at the Reproductive Biology 
Center, Dr. Glen Gentry, for his active involvement in establishing and maintaining a functional, 
workable environment that directly affected her research.  Dr. Gentry provided level minded 
solutions to circumvent various obstacles as well as appreciated advice and guidance 
throughout the completion of this work.    
 The author would also like to take this opportunity to thank the participation of Drs. John 
Lynn, Sarah Lyle, Bruce Eilts, Dale Paccamonti and Jose Len in weekly research meetings at 
the Reproductive Biology Center.  The contribution of their expertise and involvement in 
producing an environment for the development of oral presentation skills is immeasurable and 
fully appreciated by the author.   
 The author owes a very special thanks to Dr. J. Kevin Thibodeaux at the Tulsa Fertility 
Center in Tulsa, Oklahoma.  Dr. Thibodeaux served as the author’s mentor throughout her 
entire undergraduate and graduate career.  The author dedicates this dissertation to Dr. 
 iii 
Thibodeaux for his professional guidance, expert suggestions, constant friendship and 
encouragement.  The efforts documented here and elsewhere could never have come to fruition 
without his involvement.  Dr. Thibodeaux is responsible for the author’s path of higher education 
and continues to contribute to the author’s development on both personal and professional 
levels.  The author is indebted to Dr. Thibodeaux and will use his example as an inspiration to 
pay his efforts forward to the development of future students.  
 The author would also like to thank Dr. Paul DeAngelis, her major professor during the 
completion of her master’s degree in biochemistry and molecular biology at the University of 
Oklahoma Health Sciences Center in Oklahoma City, Oklahoma.  Dr. DeAngelis taught the 
author invaluable lessons in pervading integrity and in the methods of conducting reproducible 
science.  It was also through his teachings and example that the author attained a quality of 
initiative and enthusiasm for the quest of knowledge in basic science. 
 When she made the commitment to pursue a higher level of education at Louisiana 
State University, the author was unaware of what her experience would entail.  Unexpectedly, 
the experience was not only an education on a scholastic level but also in life.  Louisiana is a 
world of its own and the author will hold this “lily among thorns” close to her heart.  The 
experience was an inimitable, indigenous carnival procession, which included three major 
hurricanes, Katrina, Rita and Gustav, a myriad of authentic, culinary indulgences and the 
establishment of life-long friendships.  Benny and Myra Crawford, Pam Trepagnier, Jeanne 
Glaser and many others were absolutely integral to the author’s adaptation 600 miles from 
home and success through this scholastic endeavor.  It is these special people that portrayed 
Louisiana in a convivial light.  They are “Louisiana True.”   
 Lastly, and most importantly, the author lovingly acknowledges her family in Oklahoma.  
The pursuit of this scholastic feat would have been absolutely impossible without the constant 
support, encouragement, advice and motivation provided by her mother, Karrie Jean Keller 
Williams, father, Ricky Gene Williams and younger brother Shane Randel Williams.  Cell 
 iv 
phones allowed constant contact and letters from the author’s grandmother, Jeanine Maxine 
Randel Keller, made the experience easier for the author to adjust in a home away from home.  
Sincere gratitude and love are owed to the author’s loving family.
 v 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS…………………………………………………………………………..……..ii 
LIST OF TABLES……………………………………………………………………………………..…vii 
LIST OF FIGURES……………………………………………………………………………..……….viii 
LIST OF ABBREVIATIONS……………………………………………………………………..……....x 
ABSTRACT……………………………………………………………………………………….……...xii 
CHAPTER 
I. INTRODUCTION………………………………………………………………………..1 
References……………………………………..……………………………….7 
 
II. LITERATURE REVIEW.........................................................................................9 
Clinical Applications of Stem Cell Biology..................................................9 
Stem Cell Definition..................................................................................10 
Stem Cell Potential...................................................................................11 
Embryonic Stem Cells..............................................................................11 
Somatic Stem Cells…………………………………………………………..12 
Embryonic Stem Cells vs. Somatic Stem Cells…………………………....13 
Mesenchymal Stem Cells……………………………………......................15 
   Adipose Tissue………………………………………………………………..26 
   Adipose-derived Stem Cells…………………………………………………27 
   ASCs as Donor Cells for Nuclear Transfer………………….....................30 
   Conclusions……………………………………………………......................36 
   References…………………………………………………………………….38 
 
III. ISOLATION AND CHARACTERIZATION OF PORCINE ADIPOSE TISSUE-
DERIVED ADULT STEM CELLS.........................................................................49 
Introduction…………………………………………………………………….49 
Materials and Methods……………………………………………………….50 
Results………………………………………………………………………….53 
Discussion……………………………………………………………………..59 
References…………………………………………………………………….61 
 
IV. CELL SURFACE CHARACTERIZATION AND KARYOTYPIC ANALYSIS OF 
PORCINE ADIPOSE-DERIVED STEM CELLS...................................................64 
Introduction…………………………………………………………………….64 
Materials and Methods……………………………………………………….66 
Results………………………………………………………………………….71 
Discussion………...…………………………………………………………...77 
References…………………………………………………………………….85 
 
V. EPIGENETIC MODIFICATIONS OF CULTURED PORCINE ADIPOSE TISSUE-
DERIVED STEM CELLS......................................................................................88 
Introduction…………………………………………………………………….88 
Materials and Methods……………………………………………………….92 
Results………………………………………………………………………..103 
 vi 
Discussion……………………………………………………………………116 
References…………………………………………………………………...120 
 
VI. SUMMARY AND CONCLUSIONS…………………………………………………124 
 
APPENDIX A:  PROTOCOLS………………………………………………………………………..129 
 
APPENDIX B: REAGENT FORMULATIONS………………………………………………………139 
 
APPENDIX C: LETTER OF PERMISSION…………………………………………………………144 
 
VITA……………………………………………………………………………………………………..146
 vii 
LIST OF TABLES 
2.1.  Immunophenotype of Passaged Human ASCs...............................................................29 
3.1.  Number of surviving porcine clones to passage 4 and differentiation.............................57 
4.1.  Positive Events for Early Population Doublings 0-10.......................................................73 
4.2.  Positive Events for Late Population Doublings 11-34......................................................74 
4.3.  Types of Aneuploidies in pASCs Derived By In Vitro Culture (PD 1-30).........................79 
4.4.  Chromosomal Stability of In Vitro Cultured pASC Population Through PD 30 ...............80 
5.1.  Oligonucleotide PCR primers for real time quantitative PCR..........................................97 
5.2.  Levels of Methylated DNA in FPFs and pASCs through in vitro culture........................104 
5.3.  Levels of Acetylated Histone H3 in FPFs and pASCs through in vitro culture...............105 
5.4.  Average Relative Transcription Levels of DNA methyltransferase 1 in FPFs and    
pASCs through in vitro culture.......................................................................................109 
5.5.  Average Relative Transcription Levels of DNA methyltransferase 3a in FPFs and  
pASCs through in vitro culture.......................................................................................110 
5.6.  Average Relative Transcription Levels of Histone Deacetylase 1 in FPFs and          
pASCs through in vitro culture.......................................................................................111 
5.7.  Average Relative Transcription Levels of Methyl CpG-Binding Protein-2 in FPFs          
and pASCs through in vitro culture................................................................................112 
5.8 Chromatin Immunoprecipitation for Bivalent Domain Epigenetic Modifications.............114 
 viii 
LIST OF FIGURES 
 
2.1  Epigenetic reprogramming of methylation/demethylation patterns in preimplantation 
embryos.  The paternal genome (blue line) is demethylated immediately following 
fertilization via active demethylation whereas the maternal genome (red line) is 
demethylated through passive mechanisms shortly after.  The event of demethylation in 
nuclear transfer embryos (black line) is not believed to undergo complete erasure 
compared to the levels achieved by maternal and paternal genomes.  (Modified from 
Reik et al., 2001)………………………………………………………………………………..32 
3.1.   Undifferentiated stromal cell morphology.  Discrete colonies demonstrating spindle-like 
fibroblastic morphology adhered to plastic within 24 hours of initial seeding.  Most cells 
displayed a characteristic elongated shape (black arrow), while others had a more 
rounded appearance (white arrow).  Magnified using a 20X objective…………………...54 
3.2.  Proliferative characteristics of undifferentiated stromal cells:  1 and 2 represent each cell 
line while A and B are replicates.  (A) Average cell cycle lengths were recorded 
throughout the duration of culture.  (B) Proliferative capacity indicates cells have not 
reached observed, replicative senescence………………………………………………….55 
3.3.  Differentiation of P4 clones.  Adipogenic differentiation stained positive with Nile Red; 
viewed with a FITC filter (A) and phase contrast (B). Undifferentiated stromal cells 
(control) demonstrated only slight Nile Red staining (Panel C-FITC filter and Panel D-
phase contrast).  Chondrogenic induction was detected by Safranin O in differentiated 
clones (E) and less intensely in undifferentiated cell populations (F).  Osteocyte 
differentiation was observed only in induced cells (G) and not in undifferentiated stromal 
cells (H). Images A-F and H were magnified using a 20X objective while image G was 
magnified using a 40 X objective……………………………………………………………..58 
4.1.  Immunophenotypic analysis of porcine ASC surface proteins. Representative dot plots 
for CD3 (A), CD8 (B), CD29 (C), CD44 (D), CD90 (E), CD117 (F), SSEA-4 (G) and Sca-
1 (H).  Dot plots represent pASCs cultured at early PDs 0-10.  Quadrants were set 
according to fluorescence signals generated from propidium iodide and Alexa-Fluor® 488 
and the percentage of live cells positive for each stem cell antigen is depicted in the 
lower right corner……………………………………………………………………………….72 
4.2.   Western blot analysis of human and porcine ASCs for CD44, CD90 and CD117.  Human 
CD44 and CD90 antibodies detected the protein in the human protein extraction (H) but 
not in the porcine protein extraction (P).  Porcine CD44 and CD117 antibodies did not 
detect the protein in either the human or the porcine protein extractions. ……………76 
4.3.   Metaphase spreads of pASCs.  Normal diploid porcine metaphase spread with 38 
chromosomes (left).  Aneuploid porcine metaphase spread with 52 chromosomes (right, 
magnification 100X oil immersion)……………………………………………………………78 
4.4.  Chromosomal stability of pASCs through in vitro culture.  For pASC 1, pASC 2 and 
pASC 3 cells lines, the proportion of aneuploid cells was significantly higher in later PD 
(PD 11-20 and PD 21-30) than the earlier PD 1-10.  Letters indicate significant 
differences between mean values of 46.6 + 1.5, 87.0 + 2.8 and 94.4 + 4.1 with a P < 
0.05………………………………………………………………………………………………81 
 ix 
5.1  Primer validation.  Representative melt curve (A), threshold cycle (Ct) values (B) and 
standard curve (C) derived from a 1:10 template dilution series for the validation of 
forward and reverse primers…………………………………………………………………..99 
5.2.   Porcine fibroblasts and pASCs stained with anti-5-methylcytidine and anti-acetyl-histone 
H3.  pASCs stained with anti-acetyl-histone H3 (A and E), counterstained with PI (B and 
F), anti-5-methylcytidine (C and G) and counterstained with PI (D and H).  FPFs stained 
with anti-acetyl-histone H3 (I), counterstained with PI (J), anti-5-methylcytidine (K) and 
counterstained with PI (L)……………………………………………………………………102 
5.3.  Global levels of methylated DNA and acetylated histone H3 in FPFs and pASCs at 
different passages.  Cells gated in G0/G1 cell cycle stage based on PI counterstaining 
were designated a software-generated mean value.  Each value was graphed for each 
of four cell lines and analyzed for FPF DNA methylation (A), FPF histone H3 acetylation 
(B), pASC DNA methylation (C) and pASC histone H3 acetylation (D)…………………106  
5.4.   Histograms of the mean transcript levels in FPFs and pASCs for DNA 
methyltransferase-1 (Dnmt1), DNA methyltransferase-3a (Dnmt3a), histone deacetylase-
1 (HDAC1) and methyl CpG binding protein-2 (MeCP2).  Means are reported as a fold 
change in expression of each gene relative to a calibrator from porcine muscle tissue.  
Relative differences are depicted for both FPFs and pASCs for expression of Dnmt1 (A), 
Dnmt3a (B), HDAC1 (C) and MeCP2 (D).  Bars are representative of the standard error 
of the mean…………………………………………………………………………………….113 
5.5 Proximal and Distal Promoter Regions of Oct-4 and Nanog.  Primers were designed for 
regions proximal and distal to the initiation of transcription (shown in green).  ChIP 
procedure was performed for immunoprecipitated chromatin containing the H3K4me3 
and H3K27me3 modifications and real-time PCR was performed to determine the 
presence of the modifications within the promoter regions of Oct-4 and Nanog.  
Transcripts were run on an electrophoresis gel for visualization...................................115 
 x 
LIST OF ABBREVIATIONS 
 
 
NT……………………………………………………………………………………..…Nuclear Transfer 
pASC…………………………………………………..….Porcine Adipose tissue-derived Stem Cells 
MSC…………………………………………………………………………...Mesenchymal Stem Cells 
DNA……………………………………………………………………………..…Deoxyribonucleic Acid 
FPF………………………………………………………………………………Fetal Porcine Fibroblast 
PD……………………………………………………………………………………Population Doubling 
LOS…………………………………………………………………………..Large Offspring Syndrome 
ECL…………………………………………………………………..…Enhanced Chemiluminescence 
mRNA…………………………………………………………………...…Messenger Ribonucleic Acid 
cDNA…………………………………………………………………………….…Complementary DNA 
PCR…………………………………………………………………………Polymerase Chain Reaction 
qPCR……………………………………………………………………………………Quantitative PCR 
ICM………………………………………………………………………………………..Inner Cell Mass 
POH……………………………………………………………...…Progressive Osseous Heteroplasia 
HSC……………………………………………………………………………Hematopoietic Stem Cell 
CFU-f…………………………………………………………………...Colony-forming Unit-fibroblastic 
LIF………………………………………………………………………….…Leukemia Inhibitory Factor 
Shh………………………………………………………………………………………Sonic Hedgehog 
EGF……………………………………………………………………………Epidermal Growth Factor 
FGF…………………………………………………………………………….Fibroblast Growth Factor 
TGF…………………………………………………………………………Transforming Growth Factor 
Dnmt…………………………………………………………………………..…DNA Methyltransferase 
HAT……………………………………………………………………………Histone Acetyltransferase 
HDAC………………………………………………………………………Histone Deacetyltransferase 
 xi 
H3…………………………………………………………………………………………………Histone 3 
miRNA……………………………………………………………………………………….…Micro RNA 
priRNA…………………………………………………………………………………….Primary miRNA 
BMP………………………………………………………………………….Bone Morphogenic Protein 
GDF…………………………………………………………………..Growth and Differentiating Factor 
MAPK…………………………………………………………………Mitogen-activated Protein Kinase 
PPAR!…………………………………………………….Peroxisome Proliferator-activated Receptor 
TNF……………………………………………………………………………….Tumor Necrosis Factor 
RXR………………………………………………………………………………….Retinoid X Receptor 
C/EBP…………………………………………………………….…CCAAT/Enhancer Binding Protein 
SCD……………………………………………………………………………Stearoyl CoA Desaturase 
GLUT……………………………………………………………………………..…Glucose Transporter 
PEPCK…………………………………………………………..Phosphoenolpyruvate Carboxykinase 
TIP……………………………………………………………………Tension-induced/inhibited Protein 
WAT……………………………………………………………………………..…White Adipose Tissue 
BAT………………………………………………………………………………..Brown Adipose Tissue 
POU…………………………………………………………………………………………….Pit/Oct/Unc 
HMG………………………………………………………………………………….High Mobility Group 
dPBS…………………………………………………………...Dulbecco’s Phosphate Buffered Saline 
P/S………………………………………………………………………………...Penicillin/Streptomycin 
DMEM…………………………………………………………...…Dulbecco’s Modified Eagle Medium 
FBS………………………………………………………………………………..…Fetal Bovine Serum 
BSA……………………………………………………………………………….Bovine Serum Albumin 
ChIP…………………………………………………………………….Chromatin Immunoprecipitation
 xii 
ABSTRACT 
 
Nuclear transfer (NT) results in relatively low success rates and research has reported 
substantial problems with the welfare of the cloned animals produced.  Evidence suggests that 
the use of a less differentiated donor cell, such as a stem cell, may lead to an increase in the 
efficiency of the NT procedure.  To this end, stem cell characteristics must be clearly defined in 
order to isolate, identify and optimally culture potential donor cells.  Stem cell characteristics 
such as self-renewal and differentiation have not been identified in stem cells from porcine 
adipose tissue, an easily attainable tissue resource.  At this time, the phenotypic profile of cell 
surface proteins and chromosomal stability of porcine adipose tissue-derived stem cells 
(pASCs) through in vitro culture have not been described.  In addition, research has not 
identified epigenetic modifications in adult somatic mesenchymal stem cells (MSCs) from 
porcine adipose tissue.  
The objective of Project 1 was to develop a protocol for the isolation and culture of 
pASCs and to determine stem cell-like characteristics.  The objective of Project 2 was to 
partially characterize the surface protein phenotype of undifferentiated porcine ASCs and to 
determine the chromosomal stability through in vitro culture.  Research has indicated that the 
inefficiency of NT may be attributed to changes in DNA methylation and histone acetylation as a 
result of the duration of somatic cell in vitro culture. The objective of Project 3 was to analyze 
pASCs and compare them to fetal porcine fibroblasts (FPF) for gene expression profiles of 
chromatin remodeling proteins, global methylation and acetylation patterns and methylated 
lysine residues within promoter regions of developmentally important transcription factors. 
Improved culture conditions and defined cellular characteristics of these pASCs have 
been identified.  pASCs can self-renew and differentiate into multiple tissue lineages.  Porcine 
ASCs do not express the stem cell surface markers analyzed at similar levels compared with 
those of human ASCs reported in the literature.  Also, in vitro-cultured porcine ASCs used as 
donor cells for NT should be chosen from early population doublings (PDs) due to increased 
 xiii 
levels of aneuploidy at later PDs. Further characterization of porcine ASCs in this manner could 
assist the isolation and purification of a population of MSCs from the easily obtainable tissue of 
adipose that can later be tested as donor cells in nuclear transfer.
 1 
CHAPTER I 
 
INTRODUCTION 
 
Currently, nuclear transfer (NT) results in relatively low success rates of approximately 
1-2% (Hiendleder et al., 2005) and research has reported substantial problems with the health 
and welfare of the cloned animals.  Developmental abnormalities observed following NT define 
Large Offspring Syndrome (LOS) and include low pregnancy rates, high percentages of loss 
during early and late pregnancy, stillbirths, early postnatal deaths, short life-span, obesity and 
malformations (Young et al., 2001).  LOS may be caused by several factors such as using an 
inappropriate donor cell and/or recipient oocyte, the inability to properly synchronize the cell 
cycle phase of the donor nucleus and the recipient cytoplasm and inadequate reprogramming of 
the donor genome.  Also, the inappropriate handling of oocytes, somatic cells and embryos 
during maturation with the subjection of these cells to the various necessary manipulations and 
cultural techniques could result in cellular stresses leading to LOS.   
Successful NT in combination with applicable genetic modifications must be conducted 
using normal diploid cells before they reach senescence (Denning et al., 2001).  Primary cells 
utilized to establish cell culture possess the capacity to survive only a finite number of 
population doublings (PDs) before cellular senescence is reached (Hayflick and Moorhead, 
1961).  As cells approach this limit, the rate of proliferation decreases (Cameron, 1972) and the 
probability of cells to undergo cytokinetic abnormalities and chromosomal alterations increases 
substantially (Giraldo et al., 2006; Oback and Wells, 2002). The current techniques employed 
today to establish and maintain primary in vitro cell cultures may also be responsible for the 
induction of these anomalies (Chu, 1962; Denning et al., 2001; Kasinathan et al., 2001; Oback 
and Wells, 2002; Rubin, 1997).  Spontaneous transformations, which will also influence the 
success of NT, have been described in human and murine adipose tissue-derived 
mesenchymal stem cells (MSCs) (Rubio et al., 2005) and have been reported to accumulate 
proportionally to the time in culture (Oback and Wells, 2002).  However, other studies indicate 
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that human bone marrow and adipose tissue-derived MSCs do not mutate and maintain 
chromosomal configuration through culture (Bernardo et al., 2007; Meza-Zepeda et al., 2008).   
Chromosomal aberrations and a limited proliferative capacity of somatic donor cells 
cultured in vitro dramatically influence the success of NT (Kasinathan et al., 2001).  The 
manifestation of genetic modifications in donor cells for NT requires a significant number of PDs 
and, unfortunately, these deleterious effects are impossible at this time to circumvent.  But the 
identification of a donor cell that is genetically stable for a long period of time in vitro may be the 
key to increasing the efficiency of NT.  
 Stem cell biology is one of the most active areas in biomedical research today.  
However, there is much controversy surrounding the use of human embryonic stem cells in 
research for medical applications.  This controversy has spurred the focus of research to the 
isolation of alternative stem cell sources.  Diligent efforts in current research are focusing on the 
isolation and characterization of adult stem cells.  Adult stem cells have been isolated from 
many different tissues including blood, fat, bone marrow, organs such as the liver and retina, 
and in cord blood.  Preliminary evidence suggests that these cells may be useful in clinical 
applications such as tissue engineering and cord blood transplants.   
MSCs are pluripotent precursors meaning that they can differentiate into any cell type 
except for a totipotent cell (which can differerentiate into all cell types).  MSCs can be found in 
adult tissues such as adipose tissue, bone marrow (BM), and cord blood (CB).  MSCs support 
differentiation into adipocyte, osteoblast and other mesodermal cell types.  Depending on the 
culture conditions, MSCs can be cultured in vitro as pluripotent cells or differentiated cells with a 
fibroblastic morphology.  Gene and protein expression profiles have been defined in some 
species specific MSCs showing the presence of cell surface markers such as CD34 and CD44.   
At this point, knowledge of the optimal culture conditions for pluripotent and 
differentiated MSCs from adipose, bone marrow and cord blood is limited.  Also, culture 
characteristics of these cells have not been clearly defined and studies generating gene and 
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protein expression profiles are underway but still remain inconclusive.  Currently, nuclear 
transfer utilizing a true MSC as the donor cell is unconvincing most likely due to inefficient 
isolation/purification protocols and characterization. Therefore, it is important that the true nature 
and potential of these cells be defined in order to best apply them to the medical field.  Also, in 
lieu of the controversy associated with embryonic stem cells, an animal model must be 
developed to maintain the progress of research in this area. 
The inherent ability of mesenchymal stem cells such as porcine adipose tissue-derived 
stem cells (pASCs) to proliferate in vitro and maintain their aptitude for pluripotency (Williams et 
al., 2008) makes them attractive candidates as donor cells for more efficient reprogramming 
during NT compared to somatic cells currently in use. Studies have however generated 
contradicting results for the success of stem cells in NT; for example, skin-derived stem cells 
increased NT efficiency (Hao et al., 2009; Zhu et al., 2004) while hematopoietic stem cells did 
not (Inoue et al., 2006; Sung et al., 2006).  Porcine ASCs have not been tested as donor cells 
for NT at this time.   
Multiple different research groups have characterized human ASCs by describing the 
surface phenotype, however, there are many subtle discrepancies represented throughout the 
literature.  The effects of these differences on the identity of these cells remain unknown.  
Various factors may play a role in producing these inconsistencies.  For example, porcine ASCs 
are isolated from fat depots likely different from human ASC liposuction aspirates.  Also, the age 
of the donor may be different and cause the results to disagree.  In addition, isolation 
procedures used, the specific cell seeding density, differences in culture media used, culture 
duration, the cell cycle, the passage numbers analyzed, whether the cells were cryopreserved 
prior to analysis and even the exposure to plastic all may cause incongruent results.  Therefore, 
it is important to characterize porcine ASCs on the cell surface level. 
NT results in relatively low success rates and research has reported substantial 
problems with the welfare of the cloned animals produced.  Evidence suggests that the use of a 
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less differentiated donor cell may lead to an increase in the efficiency of the NT procedure.  To 
this end, stem cell characteristics must be clearly defined in order to isolate, identify and 
optimally culture potential donor cells.  Stem cell characteristics such as self-renewal and 
differentiation have not been identified in stem cells from porcine adipose tissue, an easily 
attainable tissue source. At this time, the phenotypic profile of cell surface proteins and 
chromosomal stability of pASCs through in vitro culture has not been described.  In addition, 
research has not identified epigenetic modifications in adult somatic MSCs from porcine adipose 
tissue.  
The objective of Project 1 was to develop a protocol for the isolation and culture of 
pASCs and to determine stem cell-like characteristics.  Primary cultures were established and 
cell cultures were maintained.  Cloning capacity was determined using a ring cloning procedure.  
Primary cultures and clones were differentiated and stained for multiple differentiated 
phenotypes.  An average of 2,700,000 nucleated cells/ml was isolated, 26% were adherent, and 
cells completed a cell cycle approximately every 3.3 d.  Ring cloning identified 19 colonies.  
Primary cultures and clones were determined to differentiate along osteogenic, adipogenic and 
chondrogenic tissue lineages.  Improved culture conditions and defined cellular characteristics 
of self-renewal of these pASCs have been identified.  Porcine ASCs can self-renew, can 
differentiate into multiple tissue lineages and they express CD34.   
The objective of Project 2 was to partially characterize the surface protein phenotype of 
undifferentiated porcine ASCs and to determine the chromosomal stability through in vitro 
culture.  Cell surfaces were immunolabeled for stem cell surface proteins and analyzed by flow 
cytometric analysis as well as by western blot analysis paired with an enhanced 
chemiluminescence (ECL) kit.  Metaphase spreads were prepared for each cell line and 
counted to determine chromosomal stability through in vitro culture.  Cells at early and late PDs 
expressed CD29 and CD90.  All other markers analyzed were expressed at low levels, including 
CD3, CD8, CD44, CD117 (c-Kit), SSEA-4 and Sca-1.  Of 714 metaphases analyzed 71.3% 
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were aneuploid.  Cells cultured through early PDs (PD 1-10) had a significantly lower 
percentage of aneuploidy compared to cells at late PDs (PD 11-20 and PD 21-30).  Porcine 
ASCs do not express the stem cell surface markers analyzed at similar levels compared with 
those of human ASCs reported in the literature.  Also, in vitro cultured porcine ASCs used as 
donor cells for NT should be chosen from early PDs due to increased levels of aneuploidy at 
later PDs.  
Research has indicated that the inefficiency of NT may be attributed to changes in DNA 
methylation and histone acetylation as a result of the duration of somatic cell in vitro culture. 
The objective of Project 3 was to analyze pASCs alongside fetal porcine fibroblasts (FPF) for 
gene expression profiles of chromatin remodeling proteins and global methylation and 
acetylation patterns and to determine the presence of bivalent domains harboring both histone 
H3 lysine 4 and 27 tri-methylation within the promoter regions of developmentally important 
transcription factors.  Cells were immunolabeled with anti-5-methylcytidine and anti-acetyl 
histone H3 and analyzed by flow cytometric analysis.  Messenger RNA (mRNA) was isolated 
and reverse transcribed into complementary DNA (cDNA).  Quantitative PCR (qPCR) was 
performed and a mean fold change in transcript expression was determined.  Chromatin 
immunoprecipitation assay coupled with a qPCR was used to determine the presence of the 
bivalent domains.  pASCs demonstrated a consistently lower level of DNA methylation and 
histone acetylation through passages 2 through 7; whereas, the patterns for FPFs varied.  The 
expression levels of chromatin remodeling transcripts remained lower in pASCs throughout 
culture when compared to FPFs.  pASCs possess the bivalent chromatin structure within the 
promoter region of the developmentally important transcription factor OCT-4.  Further 
characterization of porcine ASCs in this manner could assist the isolation and purification of a 
population of MSCs from the easily obtainable tissue of adipose that can later be tested as 
donor cells in nuclear transfer. 
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Cutting edge methods for producing transgenic animals still need much improvement 
considering the inefficiency and expenses involved.  Researchers in industry are engineering 
bacteria or mammalian cells into bioreactors for producing recombinant proteins for therapeutic 
treatments.  However, these tiny bodies are incapable of producing the necessary mass 
quantity to adequately service the growing demand.  The current shortfall hinders such 
therapeutic products from entering the marketplace thereby preventing patient access to new 
therapies, which in turn denies revenue to pharmaceutical companies who have invested large 
sums of money in product development.   
By employing cells such as somatic stem cells or cells demonstrating stem-like 
characteristics as donor cells for nuclear transfer, resultant anomalies such as those which 
classify LOS may be averted and increase the success rates of nuclear transfer. An increase in 
the efficiency of transgenic animal production will provide a substitute factory for the 
manufacture of these recombinant proteins and offer a more cost effective mechanism for the 
production of large quantities (i.e., kilograms).  An increased efficiency will also shorten the time 
required to produce an adequate number of live transgenic offspring for pharmaceutical and 
other biomedical purposes and therefore decrease the ultimate cost of production.  In turn, this 
will eliminate economic barriers currently blocking the application of this technology from 
commercial large-scale production of transgenic animals and therefore make transgenic animals 
a more appealing method of producing recombinant proteins.  
Controversy associated with the use of human tissues necessitates the development of 
an animal model to continue research in this important area.  Many treatments have already 
resulted from the use of tissues generated through advancements made in the porcine animal 
model.  Therefore, the improvement of culture conditions and the definition of cellular 
characteristics for the efficient isolation and purification of a population of MSCs from porcine 
tissues to be used as donor cells in nuclear transfer will create an important animal model for 
additional future biomedical applications.   
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CHAPTER II 
 
LITERATURE REVIEW 
 
Clinical Applications of Stem Cell Biology  
The potential impact of the field of regenerative medicine has a multitude of applications 
through stem cell biology. The expansion of our basic knowledge of stem cell biology will greatly 
impact scientific areas including development, cancer, and aging as well as provide a 
foundation for the development of tissue engineering (Merok and Sherley, 2001).  An array of 
scientific disciplines have joined efforts to develop the techniques involved in tissue engineering 
for repairing, replacing, or regenerating diseased tissues and organs.  With the advancement of 
this biotechnology, for example, scaffold biomaterials can be combined with a variety of stem 
cells to treat disease through cell-based therapies.   Other cell therapeutic applications include 
bone marrow transplants, cartilage, tendon, ligament, and bone repair, treatment of vascular 
disease and even the production of transgenic animals (Merok and Sherley, 2001).   
Several applications involve the technique of cell transplantation.  Embryonic stem cells 
have the capability to form biologically functional cell populations suitable for integration, 
response and function within a diseased tissue.  Embryonic stem cells produce these cell 
populations in response to signaling pathways induced by factors such as cytokines, 
transcription factors and cell-to-cell interactions.  Multiple cell populations derived from 
embryonic stem cells, including cardiomyocytes (Klug et al., 1996), insulin-secreting cells (Soria 
et al., 2000) and neuronal precursor cells (Brustle et al., 1999; McDonald et al., 1999) have 
been successfully integrated within the host tissue and displayed the appropriate cell functions.  
For example, upon transplantation into the spinal cords of myelin-deficient rats, glial precursor 
cells derived from embryonic stem cells successfully differentiated into astrocytes and 
oligodendrocytes capable of forming myelin at the site of injection and in migration several 
millimeters away from the injection site (Brustle et al., 1999; Liu et al., 2000). 
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Candidate cells for such promising applications must meet several requirements to be 
eligible for classification as a stem cell population.  Cells must have the capacity for self-
renewal, must have long-term viability and must have the ability to give rise to differentiated cell 
types to be considered “stem cells.”  The isolation and culture of large numbers of cells that will 
uniformly differentiate to a functional state, such as those embryonic stem cell-derived glial 
precursors, is necessary to gain eligibility for application to cell therapies (Tsai et al., 2002).        
Stem Cell Definition 
 In 1855, Franz von Leydig postulated that life did not begin in a spontaneous fashion but 
rather from preexisting life.  In agreement with his hypothesis, Rudolf Virchow developed a 
theory called omnis cellula e cellula meaning that all cells within an organism arise from 
preexisting cells (Oberling and Woglom, 1944).  With these concepts, scientists began 
describing stem cells with the understanding that all cells are derived from the fertilized ova. For 
example, Edmund Beecher Wilson began describing mitotically quiescent primordial germ cells 
in 1896 (Wilson, 1896).  Collectively, these pioneering minds initiated the standing concept that 
a stem cell is the functional unit of life that gives rise to progeny cells that can differentiate into 
the cells of the various tissues that make up an organism. 
Stem cells are genetically identical to the stem cell from which it was derived, that is to 
say stem cells are clonogenic in nature.  Theoretically, a stem cell can undergo an infinite 
number of repeated cell divisions for many generations without differentiating into a specialized 
cell of a certain tissue or function.  During early embryonic development, cell division gives rise 
to two daughter cells each with a full chromosome complement and the capability of forming all 
differentiated cell types.  Division in this manner is referred to as symmetric division (Merok and 
Sherley, 2001).  Adult stem cells, or those stem cells derived from adult tissues, demonstrate 
asymmetric division which yields two daughter cells including one cell that remains a progenitor 
cell and one cell that begins the process of terminal determination or differentiation (Merok and 
Sherley, 2001). 
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Again, stem cell requirements include the capacity for self-renewal, long-term viability 
and the ability to give rise to differentiated cell types.  Differentiation of stem cells into 
specialized precursor cell types will commence as a result of inherent genetic characteristics 
and in response to multiple environmental cues.  Various cytokines, transcription factors, growth 
factors and cell-to-cell interactions dictate the fate of cell commitment.  In 1974, Friedenstein 
determined that exposing cells to increasing amounts of serum fibroblast growth factor-2 caused 
the cells to initiate cell cycle activity (Friedenstein et al., 1974).  In addition to growth factors, a 
lower seeding density can increase the expansion rate of cells in vitro as well as increase 
differentiation potential (Sekiya et al., 2002).  
Stem Cell Potential 
Stem cells with the capability of generating all tissue types of an organism, including 
cells of the placenta, are classified as totipotent cells.  Totipotent cells include the combined 
sperm and egg, or germ cells.  Totipotent cells give rise to pluripotent and multipotent stem 
cells.  Pluripotent cells can differentiate into cells that make up tissues of the three germ layers:  
endoderm, mesoderm and ectoderm.  On the other hand, multipotent cells can only differentiate 
into the cell types that make up the germ layer from which they came.  Friedenstein 
demonstrated that bone marrow cells can differentiate into osteocytes of bone tissue 
(Friedenstein et al., 1966).  However, recent reports suggest there are exceptions to these 
general classifications.  For example, mesenchymal stem cells (MSCs) from the mesoderm 
have been shown to differentiate into nerve cells that are derived from the ectoderm (Pittenger 
et al., 1999).  
Embryonic Stem Cells   
Fertilization of an ovum initiates a procession of cell divisions, also known as cleavage, 
which drive an embryo through the various developmental stages including the zygotic stage, 
the morula stage and the blastula stage.  The union of the haploid sperm and egg forms the 
diploid zygote before the onset of cell cleavage.  The zygotic cell undergoes multiple cell 
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divisions and a process known as compaction takes place in which cells begin to stick together 
through cell-surface adhesion glycoprotein interactions.  The inner most cells, or blastomeres, 
become the inner cell mass (ICM) and the outer cells form the trophoblast.  At this stage, the 
developing embryo is referred to as a blastocyst.  Blastocysts form at approximately 5 days post 
fertilization in the human and 7 days in the cow.  Preimplantation blastocysts consist of an ICM 
and a fluid-filled blastoceole, which are encapsulated in a layer of cells called the 
trophectoderm.  Cells of the ICM give rise to the three germ layers while the cells of the 
trophectoderm form the placental tissues.   
In 1981, Evans and Kaufman and Martin and coworkers independently established in 
vitro culture of embryonic stem cells derived from the ICM of the preimplantation mouse embryo 
(Evans and Kaufman, 1981; Martin, 1981).  Both groups utilized co-culture with fibroblast feeder 
layer cells that maintain embryonic stem cell pluripotency and prevent differentiation.  The cells 
in culture demonstrate chromosomal stability (Pera et al., 2000) and differentiation potential as 
embryoid bodies, which recapitulate embryonic development but do not form extraembryonic 
tissues (Evans and Kaufman, 1981).  Also, reports characterizing embryonic stem cells showed 
that they can integrate into the construction of all tissue types after injection into an early stage 
mouse embryo (Robertson et al., 1986; Thomas and Capecchi, 1987) and that they express a 
multitude of pluripotent stem cell surface markers (Rogers et al., 1991; Rosner et al., 1990).    
Somatic Stem Cells  
 Human patient pathologies for progressive osseous heteroplasia (POH) and fibrosis 
ossificans progressive (FOP) exhibit the formation of ectopic bone within subcutaneous adipose 
tissues, muscles, tendons and ligaments (Kaplan et al., 1994a; Kaplan et al., 1994b).  
Therefore, these afflicted tissues contain a mixture of cells, typically of mesenchymal origin, 
including osteoblasts (Kaplan et al., 1994a).  POH can be acquired in response to burns, 
infections, trauma, post-surgical complications, neoplasia and neurologic disease (Puzas et al., 
1989).  POH is also a rare autosomal dominant inheritable disease in which a mutation in the 
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GNAS1 gene prevents the coupling of hormone receptors to adenylate cyclase (Shore et al., 
2000).  The pathologic observations associated with POH indicate the presence of progenitor 
cells within adult tissues.   
 Pathological observations such as those in POH have spurred the exploration of other 
sources of progenitor cells or adult stem cells.  Sources of adult stem cells, also known as 
somatic stem cells, have been found in a multitude of tissues including bone marrow 
(Friedenstein et al., 1976), adipose (Rodbell, 1964; Zuk et al., 2001), cord blood (Broxmeyer et 
al., 1992) and skin (Toma et al., 2001).  Somatic stem cells are not totipotent, but may be 
considered pluripotent and definitely multipotent in that they can differentiate into tissue lineages 
of the germ layer from which they came.  At this time, hematopoietic stem cells (HSCs) are the 
best characterized of somatic stem cells and multiple studies have been performed to illustrate 
their plasticity or ability to give rise to progeny of different cell types.  Jahagirdar and Verfaillie 
demonstrated that not only could HSCs give rise to fat, bone, muscle and cartilage but also to 
gut, liver, lung and endothelial cells (Jahagirdar and Verfaillie, 2005).   Also in 2005, Mezey 
demonstrated that HSCs could differentiate into brain cells (Mezey, 2005).  These reports along 
with many others support the theory that somatic stem cells possess a more pluripotent capacity 
rather than the stricter multipotent characteristic as once thought.     
Embryonic Stem Cells vs. Somatic Stem Cells 
Under optimal in vitro culture conditions, somatic stem cells can demonstrate expansion 
rates of up to approximately 50 population doublings (PDs) (Friedenstein et al., 1974) similar to 
all other eukaryotic cell lines cultured in vitro as defined by the Hayflick limit (Hayflick and 
Moorhead, 1961).  However, embryonic stem cell populations are believed to possess a longer 
lifespan in vitro.  Human embryonic stem cells have maintained an undifferentiated state and a 
normal karyotype in vitro for up to 250 PDs (Amit et al., 2000).  These observations suggest that 
embryonic stem cells may in fact be more useful in their applications than somatic stem cells. 
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The longer lifespan of embryonic stem cells compared with somatic stem cells may be 
attributed to the length of telomeric DNA and telomerase activity.  In 1985, Carol Greider and 
Elizabeth Blackburn discovered the enzyme telomerase in the ciliate Tetrahymena (Greider and 
Blackburn, 1985).  Telomerase is responsible for adding TTAGGG specific sequence repeats to 
the 3’ end of DNA following each replication cycle (Greider and Blackburn, 1985).  The 
condensed repetitive DNA sequence, also known as the telomere, protects the chromosome 
ends from homologous recombination and non-homologous end joining.  The present 
understanding is that a decline in telomerase activity is associated with aging cells and that 
telomere length shortens as a result of incomplete replication (Counter et al., 1992; Harley et al., 
1992).  As telomere length shortens, the cell progresses closer to its replicative limit, 
accommodating Leonard Hayflick’s postulation of limited somatic cell division (Hayflick and 
Moorhead, 1961), therefore advancing into replicative cellular senescence (Counter et al., 1992; 
Harley et al., 1992).  Embryonic stem cells and malignant cells have been shown to have 
elevated levels of telomerase activity (Kim et al., 1994) lending to the virtual immortality of 
embryonic stem cells in vitro and the evasion of cancer cells from programmed destruction.  
However, somatic stem cells and somatic cells in general possess low levels of telomerase 
activity if any at all (Rubin, 2002; Wright and Shay, 2002).       
Although embryonic stem cells may prove to be more versatile in therapeutic 
applications, much controversy surrounds the use of stem cell sources derived from human 
embryos and fetuses for biomedical treatments.  The current media has illuminated stem cell 
research in a negative light by portraying all stem cells as those only from embryonic origin at 
the price of human embryo destruction.  Also, the inability to completely purify embryonic stem 
cell populations for use in clinical applications has maintained the potential for cancerous tumor 
formation.  The public belief has influenced the political circuit and as a result, the U. S. National 
Institutes of Health lists only 21 embryonic stem cell lines available for distribution for research 
nationwide in 2009.   
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Therefore, the controversy has spurred research of alternative stem cell sources.  The 
use of adult or somatic stem cells, found in adult tissues, escapes the controversy and also 
eludes immunological rejection and disease contraction (Merok and Sherley, 2001).  Diligent 
efforts of current research are now focusing on the isolation and characterization of adult or 
somatic stem cells.  Somatic stem cells can be found among differentiated tissues, however 
current research is focusing on more easily attainable sources with less patient discomfort.  
Ongoing research is also concentrating on the isolation and culture of large numbers of cells 
that will uniformly differentiate into a functional state to then become eligible for applications in 
cell therapies (Tsai et al., 2002).  
Mesenchymal Stem Cells   
To this date, many scientists are working vigorously to ascertain the true stem cell 
renewal capabilities of those cells referred to as mesenchymal stem cells or stromal cells or 
MSCs.  It remains to be determined whether they can demonstrate the ability to divide 
producing a daughter cell that remains a precursor cell as well as produce a daughter cell that 
will differentiate along a specific mesenchymal cell lineage.  For the purpose of terminology, 
MSCs are a type of somatic stem cell found in adult tissues such as adipose tissue, bone 
marrow and cord blood that are believed to be, for the most part, pluripotent precursors.  In 
1970, Friedenstein and colleagues first identified MSCs isolated from bone marrow as fibroblast 
precursors and referred to them as colony-forming unit-fibroblastic (CFU-f), which describes 
fibroblastic colony growth (Friedenstein et al., 1970).  Traditionally, MSCs have been isolated 
from various tissues based on their ability to adhere to plastic and their morphology similar to 
that of fibroblasts (Kassem et al., 1993; Luria et al., 1971; Rickard et al., 1996).  Depending on 
the culture conditions, MSCs can be cultured in vitro as pluripotent cells or as differentiated 
cells.  MSCs support differentiation into adipocyte, osteoblast and other mesodermal cell types 
(Gimble et al., 1990; Gimble et al., 1996; Nuttall and Gimble, 2000; Owen, 1988).   
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As previously stated, HSCs have been more extensively characterized than any other 
somatic stem cell type.  However, the niche or environment in which the HSC develops and 
functions is still very poorly understood.  Recent studies have revealed that cells derived from 
MSCs, such as osteoblasts and fibroblasts, interact directly with functioning HSCs.  MSCs have 
also been shown to play major roles in the regulation of hematopoiesis (Mitsiadis et al., 2007).  
Molecules produced by MSCs have a potent paracrine effect within the niche that ultimately 
regulates the proliferation rate of HSCs and their function (Orkin and Zon, 2008; Wilson and 
Trumpp, 2006).   
A multitude of reports describe the cell surface phenotypic profile of MSCs.  However, 
through the extensive exploration, conflicts in results have prevented the establishment of 
inimitable, identifiable cell markers for MSCs.  Haynesworth and coworkers demonstrated that 
SH2, SH3 and SH4 can be used to distinguish MSCs from contaminating HSC populations 
(Haynesworth et al., 1992).  In addition, STRO-1 antibodies have been employed to select for 
MSCs in bone marrow by magnetic activated cell sorting (Dennis et al., 2002; Gronthos et al., 
1994; Tamayo et al., 1994).  STRO-1 selected cells have been shown to be chondrogenic, 
adipogenic, and support hematopoiesis (Dennis et al., 2002) as well as osteogenic (Gronthos et 
al., 1994).  Gene and protein expression profiles in some species specific MSCs show the 
presence of cell surface markers, such as CD34, CD44 (Gronthos et al., 2001) and SSEA-4 
(Gang et al., 2007).  Yet, according to the Mesenchymal and Tissue Stem Cell Committee of the 
International Society for Cellular Therapy, a cell can only be classified a MSC if proved to be 
negative for CD11b, CD14, CD19, CD34, CD45, CD79a and HLA-DR and positive for CD73, 
CD90 and CD105 (Dominici et al., 2006).   
  MSCs in culture exhibit a high degree of plasticity as suggested above. The process of 
differentiation was traditionally thought to be an irreversible pathway to a committed cell lineage.  
However, differentiated MSCs possess the ability to dedifferentiate and transdifferentiate into 
other cells of mesenchymal origin such as adipocytes, chondrocytes and osteoblasts (Song and 
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Tuan, 2004).  Song and Tuan even rule out the potential for progenitor cell contamination within 
the originating stem cell pool and cell-to-cell fusion of progenitor cells and tissue-specific cells 
(Song and Tuan, 2004).  In addition, human articular chondrocytes have been shown to 
differentiate into osteogenic and adipogenic pathways and cultured adipocytes into the 
chondrogenic or osteogenic pathways (Sato et al., 2005; Tallheden et al., 2003).  In spite of 
these findings, research continues to explore the specific dedifferentiation and 
transdifferentiation capabilities of MSCs.      
MSCs have been applied in cell-based therapies for the treatment of such conditions as 
bone and cartilage defects, injuries to spinal cord and nervous system, lung diseases and 
cardiac disorders.  As mentioned above, MSCs exert paracrine effects by the secretion of 
bioactive molecules making them appealing for use in cell-based therapies.  MSCs have been 
injected following bone marrow transplants in order to speed up patient recovery (Le Blanc et 
al., 2004).  Also, tissue engineering using the combination of MSCs and scaffolds of a specified 
biomaterial and shape can be used in grafts (Kojima et al., 2004) with minimal host rejection (Le 
Blanc et al., 2004).  
MSC Cell Surface Phenotype 
In the field of stem cell biology it is important to be able to recognize, identify and 
distinguish one specific stem cell population from another.  Multiple techniques exist for the 
isolation of plastic-adherent multipotent cells from adult tissue sources, however, all render a 
heterogeneous population of cells with discrepant proliferation characteristics and differentiation 
potentials.  Identifiable stem cell populations are necessary in order for researchers to be able 
to describe localization, function and therefore mechanism of tissue repair.  The quest for a cell-
surface antigen profile for MSCs of all types is presently ongoing.  Consequently, the 
understanding as to what a MSC actually is requires better definition.   
The current method of physical phenotyping of MSCs populations relies on a 
combination of cell surface markers briefly described above.  There is a plethora of reported 
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positive cell surface markers for MSC identification in which different laboratories employ 
different combinations of markers.  Consequently, it is important to keep in mind that the lack of 
unique, standardized molecules leaves considerable room for generating discrepant results 
from varying research groups.  As mentioned above, SH2, SH3, SH4 and STRO-1 are among 
the most well known MSC surface markers.  SH3 and SH4 are monoclonal antibodies that were 
raised against CD73, a 5’ ecto nucleosidase, and were developed with specificity for MSCs 
(Haynesworth et al., 1992).  The specificity for CD73 of MSCs prevents the selection of HSCs, 
osteoblasts and other contaminating cell populations.  There are, however, discrepancies to 
consider when relying on STRO-1 alone in general MSC identification.  STRO-1 expression is 
unfortunately not limited to MSCs, and unlike CD73, STRO-1 expression is lost through 
expansion in culture (Gronthos et al., 2003).  The decline in STRO-1 expression restricts the 
use of STRO-1 as an identifiable marker to primary and early MSC cultures only (Gronthos et 
al., 2003).  It has been proposed that the use of STRO-1 is better exploited in combination with 
other MSC identifying cell surface markers (Gronthos et al., 2003). 
Vascular cell adhesion molecule-1 or CD106 has been identified as a cell surface 
marker that can be used in conjunction with other markers for positive MSC population 
identification.  Considering the caveats of utilizing STRO-1 alone, Gronthos and coworkers 
demonstrated that CD106 amplified the selection of multipotential, colony forming cells that 
coexpress STRO-1 with high telomerase activities (Gronthos et al., 2003).  Other positive MSC 
cell surface markers include CD10 (metalloproteinase; CALLA), CD13 (metalloproteinase; 
Aminopeptidase N), CD14, CD29 (integrin "1; fibronectin receptor), CD44 (adhsion receptor 
molecule; hyaluronate), CD49a, CD63, (HOP-26), CD71, CD73, CD90 (Thy-1), CD105 
(adhesion receptor molecule; Endoglin), CD120a, CD124, CD166 (SB-10), CD271 (NGFR), 
CD309 (Flk-1) and stem cell antigen-1 (Sca-1) (Gronthos et al., 1994; Koc et al., 2000; Mitchell 
et al., 2006; Pittenger et al., 1999; Stewart et al., 2003).  However, it is important to note that 
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other researchers have reported conflicting results concerning MSC expression of CD10, CD90, 
CD309, Sca-1 and others.    
Selection of a homogeneous population of MSCs might be accomplished with the use of 
both positive and negative cell surface markers.  Markers that have been reported not to be 
present upon the MSC surface include: CD11b, CD14, CD19, CD31, CD34, CD45, CD79a, 
CD117 and HLA-DR (Colter et al., 2001; da Silva Meirelles et al., 2006; Pittenger et al., 1999). 
MSC Self-renewal and Maintenance 
 A recent shift in MSC research has focused on unraveling the intricate machinery 
involved in stem cell self-renewal and maintenance.  The mechanisms of self-renewal function 
to preserve the undifferentiated state of the stem cell and are dictated by extrinsic signals and 
several intrinsic factors including epigenetic modifications and small RNA regulators.  Leukemia 
inhibitory factor (LIF), multiple growth factors and other soluble factors such as Wnt, Notch and 
Sonic hedgehog (Shh) have all been implicated in the mediation of stem cell self-renewal and 
maintenance.  The detailed mechanism of the LIF pathway is unknown, however it has been 
shown to maintain the undifferentiated state of MSCs (Jiang et al., 2002) as well as 
activate/repress bone cell activities (Heymann and Rousselle, 2000).   
Growth factors such as epidermal growth factor (EGF), fibroblast growth factor-2 (FGF-
2) and transforming growth factor-alpha (TGF-#) regulate stem cell replication via the 
extracellular environment (Reynolds et al., 1992; Reynolds and Weiss, 1992; Tsutsumi et al., 
2001; Zaragosi et al., 2006).  Apparently, EGF, FGF-2 and TGF-# play a role in the control of 
receptor tyrosine kinase signaling essentially preserving the stem state of MSCs and extending 
their viability in culture (Tsutsumi et al., 2001; Zaragosi et al., 2006).   
Wnts have been shown to be major players in the proliferation of adult human MSCs by 
initiating the cascade involving "-catenin and cyclin D1 (Boland et al., 2004; Willert and Nusse, 
1998).  Wnt3a specifically increased MSC proliferation while suppressing osteogenic 
differentiation (Boland et al., 2004).  Notch functions as a paracrine factor released from a 
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neighboring cell within the MSC niche, which transduces signals into the nucleus of the cell 
affecting gene expression for maintaining the undifferentiated state (Jarriault et al., 1995; Yoon 
and Gaiano, 2005).  Lastly, Shh is also considered an important component of enhancing 
proliferation capacity of MSCs.  Hepatic stellate cells increased Shh expression after coculture 
with MSCs, in which stellate cells then served in a paracrine fashion to elevate the proliferation 
and differentiation of the MSCs delivered through treatment of liver fibrosis (Lin et al., 2008). 
 Stem cell self-renewal and the maintenance of the undifferentiated state are also 
controlled by epigenetic modifications.  These modifications include histone acetylation, 
methylation, phosphorylation, ubiquitination, sumoylation, citrullination and ADP-ribosylation 
(Strahl and Allis, 2000).  The expression levels of the enzymes responsible for producing these 
modifications ordain epigenetic control.  For example, DNA methyltransferases (Dnmt) add 
covalent methyl groups (-CH3) to cytosine bases located within the promoter region of a gene 
(Geiman and Robertson, 2002).  The resultant methyl group is associated with transcriptional 
silencing as a result of the inability of transcription factors to bind to methylated DNA sequences 
(Hiendleder et al., 2004a).  Also, histone acetylation occurs through the histone acetylases or 
HATs and modifications are removed via histone deacetylases or HDACs.  The removal of 
histone acetylated groups primarily from histone H3 and H4 causes significant changes in the 
shape or configuration of the chromatin that then prevents the access of transcription factors to 
bind DNA sequences (Cezar, 2003).  Without access to the DNA, transcription cannot 
commence, therefore the cell remains in a stem state all on account of the specific interactions 
between the DNA and chromatin remodeling proteins.   
 The epigenetic landscape created by these modifying enzymes has been under close 
investigation recently.  Methylation modifications have been described on targeted genes just 
downstream to a variety of developmentally important transcription factors such as Oct4, 
Nanog, Sox2, c-Myc, and Klf4.  These particular transcription factors have been implicated in 
human development and are believed to be necessary for the maintenance of pluripotential and 
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the regulation of self-renewal pathways (Boyer et al., 2005).  Stem cell self-renewal under 
transcriptional control is associated with the degree of lysine methylation including mono-, di- or 
tri-methylated histones.   Dnmts and demethylases facilitate chromatin modifications to form a 
described “bivalent” conformation that consist of regions of histone 3 (H3) lysine 27 methylation 
harboring smaller regions of H3 lysine 4 methylation (Bernstein et al., 2006).  Studies show that 
methylation of lysine 4 positively mediates transcription by recruiting histone acetylases and 
other chromatin remodeling enzymes (Santos-Rosa et al., 2003) while lysine 27 negatively 
mediates transcription by preserving a closed chromatin conformation (Francis et al., 2004; 
Ringrose et al., 2004).  The methylation pattern functions to repress transcription while holding 
the chromatin in a potentially activate state.  Other transcriptionally repressive demarcations 
include H3 trimethyl lysine 9, H3 monomethyl lysine 20 and H3 lysine 27 methylation, and all 
can be found in neuronal stem cells (Shi et al., 2008; Wernig et al., 2007).   
 Small non-coding RNA regulators also control cell proliferation and other cellular 
processes involved in development (Wienholds et al., 2005).  Micro-RNAs (miRNA) are single-
stranded RNA fragments transcribed from DNA but not translated into proteins.  Primary miRNA 
transcripts (pri-miRNA) are processed within the nucleus into short stem-loop or hairpin-like 
structures called pre-miRNAs.  These pre-miRNAs translocate into the cytoplasm where they 
interact with the endonuclease Dicer that cleaves pre-miRNA into two complementary RNA 
molecules.  One of the complements created integrates into a RNA-induced silencing complex 
or RISC and guides the complex to complementary portions of messenger RNA.   The 
interaction represses translation thereby preventing differentiation either by a physical block or 
the cleavage of target mRNAs.  
MSC Differentiation 
 Following the successful isolation and identification of a cell population thought to be 
MSCs, further characterization must be performed to determine the ability of the population to 
differentiate.  The elucidation of specific signaling networks involved in the differentiation of 
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MCSs remains unclear.  However, several intrinsic as well as extrinsic factors from the cell’s 
environment, as mentioned above, influence cell and tissue differentiation.   
MSCs exist in their respective niche within varying tissues as quiescent cells arrested in 
the G0/G1 cell cycle stage until an extracellular cue from the cell’s environment induces 
proliferation and differentiation of that cell (Baksh et al., 2004).  MSCs are adult or somatic stem 
cells and, also as mentioned above, divide in an asymmetric manner where the tissue 
progenitor cells give rise to two daughter cells, one that remains a progenitor cell and one 
precursor cell that begins the process of terminal differentiation.  The resultant progenitor cell 
goes on to continue the asymmetric division pattern to replenish the MSC population within the 
tissue from which it came for future use in tissue repair or regeneration in the case of injury or 
disease.  The precursor cell formed can further divide to produce multipotent cells that can 
differentiate along specific cell lineages such as chondrocytes, osteoblasts, adipocytes and 
myocytes.  Cytokines, extracellular matrix proteins and other soluble factors are responsible for 
dictating this division process and the timing of their function is likely very important (Baksh et 
al., 2004).   
In order to facilitate the development of optimal culture conditions of MSCs for 
appropriate clinical applications, Baksh and coworkers investigated the presence of a myriad of 
transcripts before and after the induction of lineage differentiation including osteogenesis, 
chondrogenesis and adipogenesis.  They propose a model for the regulation of MSC 
differentiation suggesting that due to the presence of many common genes, osteogenesis, 
chondrogenesis and adipogenesis are likely governed by a single master control mechanism 
(Baksh et al., 2004). 
MSC Differentiation: Chondrogenesis 
 Molecular investigations have identified multiple instructive signaling molecules that 
induce the expression of specific chondrogenic genes.  The discovery of these molecules has 
led to their incorporation into culture medium allowing chondrogenic differentiation in vitro.  
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Kisiday et al. compared bone marrow and adipose tissue-derived MSCs for their ability to 
express benchmark chondrogenic genes after culture in media with and without transforming 
growth factor-"1 (TGF-"1) and found that TGF-"1 media did in fact upregulate the expression of 
collagen type II (Kisiday JD, 2007).  MSC-derived chondrocytes then positively express 
chondrogenic-associated markers including transcription factor Sox-9 (Sry-type high mobility 
group box containing gene 9) and extracellular matrix genes such as collagen II, collagen IX, 
aggrecan, decorin, glycan and cartilage oligomeric matrix protein (Baksh et al., 2004; Tuan et 
al., 2003).  Additional research indicates that chondrogenesis of MSCs can be induced by the 
presence and combination of other molecules including TGF-"3, bone morphogenetic protein-2 
(BMP-2), BMP-4, BMP-6 (Boskey et al., 2002; Gooch et al., 2002), BMP-12 (Gooch et al., 
2002), BMP-13 (Gooch et al., 2002; Nochi et al., 2004), growth and differentiation factor-5 
(GDF-5) (Tuan et al., 2003), ascorbic acid and dexamethasone (Awad et al., 2003; Erickson et 
al., 2002; Guilak et al., 2004; Zuk et al., 2001). 
Ongoing investigations are exploring the roles of TGF-"s and BMPs in MSC 
differentiation mechanism because they signal through mitogen-activated protein kinases 
(MAPKs) and R-Smad proteins.  The MAPK cascades phosphorylate HATs that then bind R-
Smad proteins (Abecassis et al., 2004).  Again, HATs modulate the addition of an acetyl group 
to histones thereby opening up chromatin conformation increasing the accessibility of 
transcription factors to bind DNA sequences and inducing chrondrogenesis in MSCs.  
MSC Differentiation: Osteogenesis 
 Recent data suggests that there is most likely a close relationship between the 
processes of adipogenesis, osteogenesis and chondrogenesis in MSCs supporting the 
presence of multiple common genes observed by Baksh et al. (Baksh et al., 2004).  However, it 
is proposed that adipogenesis and osteogenesis have more regulatory control genes and 
precursors in common than those involved in the chondrogenesis pathway (Baksh et al., 2004; 
Muraglia et al., 2000).  Regulating transcription factors have a completely opposite effect on the 
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control of osteogenesis (Beresford et al., 1992; Nuttall and Gimble, 2004).  The inverse 
communication between these committed cell lineages instigates the potential for exploitation of 
the phenomenon in therapeutic applications.  
Peroxisome proliferator-activated receptor ! (PPAR!) is an important regulator of both 
adipogenesis and osteogenesis.  While PPAR! promotes adipogenesis of MSCs it sequesters 
osteogenesis (Nuttall and Gimble, 2004).  Runx2 is a major regulating gene for the onset of 
osteogenesis.  Runx2 interferes with cyclin-dependant kinase inhibitors p21 and p27 lifting cell 
cycle arrest and allowing the cell to progress into the S phase (Lian et al., 2006).  PPAR! blocks 
DNA binding of transcription factor Runx2, therefore preserving the quiescent state of the cell 
and blocking the development of the osteogenic phenotype (Lian et al., 2006).  Also, histone 
deacetylases 4 and 5 remove acetyl groups from Runx2 allowing for its degradation by Smurf1, 
Smurf2 and E3 ubiquitin ligases (Jeon et al., 2006).  Tumor necrosis factor-# (TNF-#), a 
cytokine involved in systemic inflammation, also induces Runx2 degradation by stimulating 
increased expression of Smurf1 and Smurf2 (Kaneki et al., 2006).  On the other hand, BMP-2 
modulates the action of Runx2 by inducing p300 recruitment of histone acetylases, which in turn 
enhance osteogenic differentiation (Jeon et al., 2006).   
MSC Differentiation:  Adipogenesis 
 PPAR-! can be inhibited by many factors including those described above as well as by 
a variety of cytokines and growth factors.  Regardless, PPAR-! is the central regulatory unit for 
the promotion of MSC adipogenesis.  PPAR-! complexes with the retinoid X receptor (RXR) that 
together causes the activation of CCAAT/enhancer binding proteins (C/EBP) (Rosen and 
Spiegelman, 2000).  C/EBPs play a major role in the maturation of adipose tissue and without 
their expression adipogenesis is severely retarded as demonstrated in knockout mice (Tanaka 
et al., 1997).   
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Common components of adipogenic-inducing culture media include: 
methylisobutylxanthine, dexamethasone, insulin and fetal bovine serum, which by some 
unknown mechanism induce the action of C/EBP family members.  Specifically, C/EBP# 
activates multiple genes unique to mature differentiated adipocytes including stearoyl CoA 
desaturase (SCD1), insulin-responsive glucose transporter-4 (GLUT-4), phosphoenolpyruvate 
carboxykinase (PEPCK) and UCP genes that have functional binding sites within their promoter 
regions (Christy et al., 1989; Park et al., 1990; Yubero et al., 1994). 
The toggle between stretch and non-stretch induced pathways dictates tension-
induced/inhibited protein (TIP) activation.  TIPs are chromatin remodeling proteins with inherent 
HAT activity.  The mechanical force of tension or “stretch” inflicted upon the MSCs will affect the 
lineage of differentiation that the cell will pursue (Jakkaraju et al., 2005).  Under non-stretch 
conditions TIP-1 is activated and promotes the onset of adipogenesis (Jakkaraju et al., 2005).  
On the other hand, static stretch will activate the TIP-3 pathway leading to the induction of 
myogenesis (Jakkaraju et al., 2005).  On some occasions non-stretch conditions will induce TIP-
1 activation through RhoA mediation (McBeath et al., 2004).  Through this unique mechanism, 
cell shape alters the cytoskeletal structure, which in turn fires signals altering transcription and 
therefore differentiation potential of the MSC.  
MSC Differentiation:  Myogenesis and Tenogenesis 
 The induction of myogenesis for muscle generation and tenogenesis for tendon 
generation has also been studied.  Bone marrow MSCs have been shown to differentiate into 
muscle tissue for treatment following muscle degeneration when transfected with an active form 
of the single-pass transmembrane receptor Notch-1(Dezawa et al., 2005).  Further research has 
identified the ligand for the Notch-1 transmembrane receptor as Jagged 1, also known as 
CD339 (Li et al., 2006).  Li and coworkers cocultured MSCs with cardiomyocytes from neonatal 
rat ventricles producing an inductive environment for the differentiation of MSCs into 
cardiomyocytes (Li et al., 2006).  Soluble Jagged 1 was added to the culture media, which 
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enhanced myogenesis of the MSCs through the Notch-1 pathway (Li et al., 2006).  A 
mechanism involving R-Smad8 and BMP-2 has been shown to cause differentiation of MSCs 
into tenocytes (Hoffmann et al., 2006).  An active form of Smad8 was cotransfected with BMP-2 
into MSCs, which produced morphological changes and gene expression profiles similar to 
tenocytes (Hoffmann et al., 2006).  In vitro culture of induced myogenic and tenogenic cell 
populations will be very useful in the treatment of these tissues when damaged or diseased. 
Adipose Tissue 
Adipose tissue can be found throughout the entire human body.  There are two different 
types of adipose tissue that are physiologically unique from each other and have completely 
different functions:  white adipose tissue (WAT) and brown adipose tissue (BAT).  The cells 
comprising WAT often contain one large lipid filled vacuole that takes up the majority of the cell 
itself leaving just enough room for the nucleus.  WAT can be found subcutaneously and in 
visceral depots.  It functions primarily as an energy reservoir but also plays roles in lipid 
metabolism, insulation, mechanical cushioning, structural support, and regulating hematopoeisis 
and osteogenesis.  BAT cells contain many lipid filled vacuoles and multiple mitochondria that 
give the cells their brown color (Hull and Segall, 1966).  BAT is located in the interscapular 
region and around major organs such as the heart and lungs.  Energy is converted into heat 
within these cells to maintain body heat in early youth and hibernating animals.        
Over the past several decades, the prevalence of overweight and obese people has 
drastically increased.  The worldwide epidemic has drawn the attention of many research 
arenas.  A Pubmed search for “obesity” over the past 60 years brings up articles that have 
increased progressively with each decade.  With the infiltration of technology in our everyday 
lives and an abundant food supply, obesity in the United States has reached astronomical 
proportions and has become the number one concern in childhood health.  
Obesity results when a severe imbalance between energy intake and expenditure 
occurs.  Adipose tissue by nature serves as a reservoir for energy to be used during periods of 
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starvation.  As long as energy intake exceeds expenditure, adipocytes will accommodate the 
storage of energy by increasing in size and number until the balance is tipped and energy 
expenditure begins to deplete the supply.  However, in 1999, Roger Cone proposed a model for 
the regulation and maintenance of a certain volume of adipose tissue within an individual.  A 
drop in the overall volume of adipose tissue due to dieting, strenuous exercise or liposuction 
triggers a homeostasis modulator to return the total adipose tissue volume to its original level. 
Also, classic experiments performed in rats by Faust et al. demonstrate that the removal of 
inguinal fat pads stimulated regeneration within 7 months of surgery (Faust et al., 1977).  
Therefore, the processes involved in adipogenesis leading to obesity suggests the presence of 
a population of stem cells located in specific fat depots.         
Adipose-derived Stem Cells 
  MSCs have been isolated from a myriad of mammalian tissues including the placenta 
(Yen et al., 2005), nervous tissue (Baksh et al., 2004), brain, thymus, lung, kidney, liver, spleen 
(da Silva Meirelles et al., 2006), brain (Jiang et al., 2002) and pancreas (Hu et al., 2003).  
However, MSCs from bone marrow have been more thoroughly characterized than any other 
type of MSC most likely due to accessibility.  Obtaining this tissue requires a relatively 
uncomplicated yet painful procedure.  Adipose tissue, on the other hand, represents a tissue 
source that is extremely abundant (i.e., via discarded lipoaspirate tissue), readily accessible, 
results in minimal patient discomfort and yields high enough cell numbers to sufficiently and 
efficiently expand cell populations.   
Isolation Procedures 
 Martin Rodbell is accredited with the first description for the isolation of adipose tissue 
from rats in 1964 (Rodbell, 1964).  Briefly, the procedure involved the removal of tissue, fine 
mincing and exposure to, at the time, a commercially available crude preparation of collagenase 
(Type I). The digested tissue was then subjected to multiple centrifugation steps yielding the 
separation of floating cells, which were adipocytes, from the pelleted, heterogenous stromal-
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vascular fraction (Rodbell, 1964).  Several research groups since then, including Van and 
Roncari, Deslex et al. and Hauner et al., have shown that the isolated fraction of cells contains 
plastic-adhering adipocyte precursors (Deslex et al., 1987; Hauner et al., 1989; Van and 
Roncari, 1977).  Modified versions of this protocol have been adapted for the isolation of 
adipocyte precursors or adipose-derived stem cells (ASCs) from the rat, mouse, pig, horse and 
human.  Human adipose tissue has been obtained through processed liposuction aspirates, 
which are discarded in a typical procedure (Deslex et al., 1987; Hauner et al., 1989; Lalikos et 
al., 1997; Moore et al., 1995; Van and Roncari, 1977).  Obtaining ASCs from liposuction 
aspirates is beneficial in that it bypasses several steps in the original procedure.  
 ASC Characterization:  Immunophenotype 
 Due to the easy access to human adipose tissue described above, much of the research 
investigating the immunophenotype of ASCs has been performed in the human.  Previously 
stated, MSCs are positive for multiple cluster differentiation molecules such as CD73, CD105 
and CD90 and negative for CD11b, CD14, CD45 and HLA-DR.  The presence, or absence, of 
these markers was consistent for the human ASC cell surface.  Other positive antigens include 
CD9, CD29, CD44, CD49, CD166, osteopontin, osteonectin, vimentin, HLA-ABC and various 
others (Table 2.1) (Aust et al., 2004; Gimble et al., 2007; Gronthos et al., 2001; McIntosh et al., 
2006; Mitchell et al., 2006; Zuk et al., 2002).  Human ASCs produced additional negative results 
for CD16, CD18, CD31, CD50, CD56, CD62 and CD104 (Table 1)(Aust et al., 2004; Gimble et 
al., 2007; Gronthos et al., 2001; McIntosh et al., 2006; Mitchell et al., 2006; Zuk et al., 2002).    
ASC Characterization:  Differentiation 
 In addition to the determination of the phenotypic landscape, the differentiation capacity 
must be evaluated to further characterize ASCs.  Vidal et al. (2007) determined the 
multipotentiality of equine ASCs.  Following adipogenesis induction, accumulation of oil droplets 
by Oil-red-O staining along the periphery of preadipocytes was noted followed by the formation 
of fat globules by day 2 following induction (Vidal et al., 2007).  In addition to adipogenesis, the 
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Tabe 2.1. Immunophenotype of Passaged Human ASCs 
Antigen Category Surface-Positive Antigens Surface-Negative Antigens 
Adhesion molecules CD9 (tetraspan), CD29 (!1 integrin), CD49 days ("4 integrin), CD54 
(ICAM-1), CD105 (endoglin, CD166 (ALCAM) 
 
CD11b ("b integrin), CD18 (!2 integrin), CD50 (ICAM-3), 
CD56 (NCAM), CD62 (E-selectin), CD104 ("4integrin) 
 
Receptor molecules CD44 (hyaluronate), CD71 (transferrin) 
 
CD16 (Fc receptor) 
 
Enzymes CD10 (common acute lymphocytic leukemia antigen), CD13 
(aminopeptidase), CD73 (5’ ecto-nucleotidase), aldehyde 
dehydrogenase 
 
 
Extracellular Matrix 
molecules 
CD90 (Thy-1), CD146 (Muc18), collagen types I and III, 
osteopontin, osteonectin 
 
 
Cytoskeleton "-smooth muscle actin, vimentin  
Hematopoietic  CD14, CD31, CD45 
Complement cascade CD55 (decay-accelerating factor), CD59 (protectin) 
 
 
Histocompatibility 
Antigen 
HLA-ABC 
 
HLA-DR 
Stem Cell CD34, ABCG2 
 
 
Stromal CD29, CD44, CD73, CD90, CD166  
 (Gimble et al., 2007)
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osteogenic potential was demonstrated in these equine ASCs by the presence of calcium 
minerlization through alizarin red positive calcium phosphate nodule formation (Vidal et al., 
2007). Human ASCs have been more extensively characterized in terms of differentiation 
potential and have been shown to successfully respond to chondrogenic, osteogenic, myogenic, 
adipogenic and neurogenic conditions.  The presence of TGF-!, ascorbate and dexamethosone 
in the ASC culture environment will induce the expression of chondrogenic proteins including 
collagen Type II, Type IV and aggrecan (Awad et al., 2003; Erickson et al., 2002; Wickham et 
al., 2003).  Although culture components are similar to those in chondrogenic inducing 
conditions, osteogenesis marked by calcium phosphate mineralization within the extracellular 
matrix will ensue with the inclusion of ascorbate, dexamethasone, in addition to !-
glycerophosphate (Halvorsen et al., 2000; Halvorsen et al., 2001b).  Finally, an induction 
cocktail consisting of insulin, methylisobutylxanthine, dexamethasone and indomethacin will 
cause ASCs to form lipid-filled vacuoles that secrete leptin and lipoprotein lipase (Halvorsen et 
al., 2001a; Hauner et al., 1989; Zuk et al., 2001).  
ASCs as Donor Cells for Nuclear Transfer 
Currently, nuclear transfer results in relatively low success rates and research has 
reported substantial problems with the welfare of some of the cloned animals produced.  
Developmental abnormalities observed following nuclear transfer include low pregnancy rates, 
high percentages of loss during early and late pregnancy, stillbirths, early postnatal deaths, 
short life-span, obesity and malformations.  These abnormalities make up what is referred to as 
Large Offspring Syndrome or LOS and may be caused by several factors, such as using an 
inappropriate donor cell and/or recipient oocyte, the inability to properly synchronize the cell 
cycle phase of the donor nucleus and the recipient cytoplasm, inadequate reprogramming of the 
donor genome, inappropriate handling of oocytes, somatic cells and embryos during maturation, 
and/or subjection of these cells to the various necessary manipulations and cultural techniques 
which could result in cellular stresses (Young et al., 2001).   
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Epigenetic Modifications and Nuclear Transfer 
Much research has focused on the epigenetic modifications of DNA and their role in 
embryonic development.  In the production of a normal developing embryo, the oocyte (arrested 
at metaphase II) is united with a sperm where it completes meiosis and extrudes the second 
polar body.  The embryo contains a subset of cells that remain totipotent (can support 
differentiation into all cell types) for the first one to two cell divisions (Kono, 1997).  The following 
cleavage events undergo DNA modifications, which render them unable to form all tissue types 
and once initiated the series of events proceeds beyond the point of no return.  However, 
exposure of a donor cell’s chromatin to ooplasm as in nuclear transfer will redirect the 
programming of the donor nucleus to mimic that of a zygotic nucleus as in normal fertilization 
(Figure 2.1) (Kikyo and Wolffe, 2000).  The oocyte virtually erases the epigenetic modifications 
imposed on the genome during differentiation and reinstates totipotency (Kikyo and Wolffe, 
2000).  The reprogramming of the donor cell nucleus is essential to initiate and complete 
embryonic development.   
Fusion with embryonic stem cells provides an alternative method for inducing nuclear 
reprogramming of somatic nuclei.  Factors within the embryonic stem cell, much like in the 
unfertilized oocyte, render a resultant hybrid cell, which demonstrates pluripotent competence 
by differentiation into multiple cell lineages and expression of tissue-specific genes (Cowan et 
al., 2005; Tada et al., 2001).  Several somatic cell types have been successfully reprogrammed 
upon fusion with embryonic stem cells including thymocytes (Tada et al., 2001), human 
fibroblasts (Cowan et al., 2005) and human myeloid precursor cells (Yu et al., 2006).  Research 
indicates that the nuclear compartment of the embryonic stem cell houses the reprogramming 
capability because fusion of karyoplasts and not cytoplasts generate the reprogrammed hybrid 
(Do and Scholer, 2004). These reprogrammable epigenetics govern the regulation of repression 
of genes not necessary in cell types at specific developmental stages while preserving the DNA 
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Figure 2.1 Epigenetic reprogramming of methylation/demethylation patterns in preimplantation 
embryos.  The paternal genome (blue line) is demethylated immediately following fertilization via 
active demethylation whereas the maternal genome (red line) is demethylated through passive 
mechanisms shortly after.  The event of demethylation in nuclear transfer embryos (black line) is 
not believed to undergo complete erasure compared to the levels achieved by maternal and 
paternal genomes (Modified from Reik et al., 2001).
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sequence (Wolffe and Matzke, 1999).  Epigenetic modifications during the reprogramming 
process following nuclear transfer include DNA methylation and posttranslational acetylation, 
phosphorylation, and methylation of histone amino termini that function to modulate chromatin 
structure, which ultimately regulates transcriptional activation or repression of specific genes.  
Acetylatable lysine residues in the N termini of histone H3 (such as K9, K14, K18, and K23) and 
H4 (such as K5, K8, K12, and K16) and methylatable lysine residues in H3 (such as K4, 
K9,K27, K36, and K79) and H4 (K20) are the most relevant that have been identified (Kimura et 
al., 2004).  Histone acetyltransferases (HATs) are the enzymes responsible for the transfer of 
acetyl groups to lysine residues and histone deacetylases (HDACs) dictate their removal.  
Acetylation neutralizes the positive amino acid charge decreasing the affinity for DNA.  The 
termini displace from the nucleosome increasing accessibility of transcription factors, which 
leads to gene expression (Grunstein, 1997).   
Alternatively, cytosine methylation demarcates or “imprints” portions of DNA in order to 
distinguish between silenced and expressed genes of parental alleles (Cezar, 2003).  Generally, 
DNA methylation blocks transcription factors from binding methylated sequences and is 
associated with transcriptional silencing and imprinting (Hiendleder et al., 2004b).  For example, 
H19, insulin-like growth factor II, and the insulin-like growth factor II receptor all display 
alternative DNA methylation patterns based on the inheritance of the allele either from the 
sperm or the oocyte (Kono, 1997).  In nuclear transfer, genes normally expressed during 
embryogenesis are silent in somatic donor cells and must be turned back on.  Therefore, the 
DNA methylation patterns must be reorganized to resemble that of undifferentiated nuclei 
(Rideout et al., 2001) (Figure 2.1).  LOS and other phenotypic abnormalities may be a result of 
improper expression of imprinted genes as a result of reorganized DNA methylation (Kono, 
1997).   
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Epigenetic Regulation of Pluripotency 
The initial epigenetic landscape of the DNA sequence determines the pluripotent 
capabilities of the cell.  Embryonic stem cells possess transcriptionally active chromatin that is 
structured in an open configuration containing an abundance of acetylated lysine residues 
(Boyer et al., 2006).  However, as the cell commits to a differentiation pathway, acetylated 
histone modifications decrease, heterochromatin formation ensues, and pluripotential declines 
(Meshorer and Misteli, 2006; Meshorer et al., 2006).   
Regulators of development in undifferentiated cells are suggested to be silenced by the 
presence of a bivalent domain modification pattern in which a large region of histone H3 lysine 
27 trimethylation (H3K27me3) harbors smaller regions of histone 3 lysine 4 trimethylation 
(H3K4me3) (Bernstein et al., 2006).  Important to the maintenance and pluripotency of stem 
cells Polycomb-group proteins catalyze the H3K27me3 modification and Trithorax group 
proteins catalyze the H3K4me3 modification (Bernstein et al., 2006).  The dual marks contain 
both repressive (H3K27me3) and activating (H3K4me3) modifications, which work to silence 
developmental genes in embryonic stem cells while simultaneously keeping them poised for 
activation.  As the cell differentiates, the bivalent conformation resolves where H3K4me3 
activating marks permit early-replicating gene expression in lineage-committed cells and 
H3K27me3 repressing marks block late-replicating gene expression in lineage-committed cells 
(Boyer et al., 2006; Meshorer and Misteli, 2006).   
Also of note, these developmental regulators contain highly conserved non-coding 
elements, which contain a wealth of H3K27me3 and H3K4me3 containing bivalent domains 
(Bernstein et al., 2006).  These regions house genes responsible for encoding several 
transcription factors which function to maintain and regulate pluripotency and self-renewal in 
both early embryos and embryonic stem cells (Bernstein et al., 2006).  These factors include the 
POU (Pit/Oct/Unc) domain-containing protein Oct-4 (also known as Pou5fl) (Nichols et al., 1998; 
Niwa et al., 2000; Rosner et al., 1990; Scholer et al., 1990a; Scholer et al., 1990b), the high 
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mobility group (HMG)-box protein Sox-2 (Avilion et al., 2003), and the homeoprotein Nanog 
(Chambers et al., 2003; Mitsui et al., 2003).  These three transcription factors function through 
very distinct pathways that are thought to converge to dictate early cell fate decisions (Boyer et 
al., 2006).  Recently, the conservation of these proteins among mammalian species has 
become apparent and Oct-4, Sox-2 and Nanog are considered markers of cells that have 
pluripotent capabilities.  Also, their association with highly conserved non-coding elements 
suggests a conserved role for the bivalent chromatin domains mentioned above (Bernstein et 
al., 2006).         
At this time, research has not identified bivalent domains in adult somatic MSCs from 
porcine adipose tissue.  Analysis of these cells may reveal global methylation and/or acetylation 
patterns similar to their embryonic stem cell counterparts.  Further characterization of porcine 
ASCs in this manner could assist the isolation and purification of a population of MSCs from the 
easily obtainable tissue of adipose that can later be tested as donor cells in nuclear transfer.  
Somatic cells used as donor cells in nuclear transfer typically produce more blastocyst stage 
embryos compared to embryos derived from embryonic stem cells (Rideout et al., 2001).  About 
60% of embryonic stem cells are in S-phase when used as donor cells (Rideout et al., 2001).   
S-phase embryonic stem cells are exposed to high levels of maturation promoting factor, which 
induces premature nuclear envelope breakdown and chromosome condensation.  Cells likely 
undergo a second DNA replication cycle activating cell checkpoint mechanisms ultimately 
leading to inappropriate ploidy and cell cycle arrest.  However, more embryonic stem cell 
nuclear transfer embryos develop to term than somatic cell nuclear transfer embryos (Rideout  
et al., 2001).  Although nuclear transfer clones produced from either embryonic stem cells or 
somatic cells demonstrate similar phenotypic abnormalities, term embryonic stem cell nuclear 
transfer clones indicate that utilization of a less differentiated donor cell may be more 
acquiescent to appropriate reprogramming (Rideout et al., 2001).   
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Our laboratory has contributed to the characterization of porcine ASCs by:  (1) the 
development of an isolation and culture procedure for both undifferentiated and differentiated 
(adipocytes, osteocytes, and chondrocytes) ASCs, (2) the definition of ASC growth 
characteristics such as cell cycle length, population doublings, (3) the confirmation of cell 
surface gene expression in both differentiated and undifferentiated ASCs, (4) the analysis of 
clonal capacity followed by differentiation potential in ASCs, (5) the determination of 
chromosomal stability through in vitro culture, (6) the analysis of stem cell surface markers 
through in vitro culture, (7) the detection of methylated DNA and acetylated histone H3 through 
in vitro culture, (8) the determination of expression patterns of chromatin remodeling proteins, 
and (9) the presence/absence of bivalent chromatin structures.  Our overarching hypothesis is 
that low development rates observed following porcine nuclear transfer are a result of 
incomplete reprogramming of the donor cell nucleus and that somatic stem cells or those cells 
which demonstrate stem-like characteristics (i.e. ASCs) will be reprogrammed more completely. 
The new information will aid the efficiency of isolation and purification of a population of MSCs 
from the easily obtainable tissue of porcine adipose that can later be tested as donor cells in 
nuclear transfer.   
Conclusions 
Cutting edge methods for producing transgenic animals still need much improvement 
considering the inefficiency and expenses involved.  By employing cells such as somatic stem 
cells or cells demonstrating stem-like characteristics as donor cells for nuclear transfer, resultant 
anomalies such as those that classify Large Offspring Syndrome may be averted and increase 
the success rates of nuclear transfer.  Controversy associated with the use of human tissues 
necessitates the development of an animal model to continue research in this important area.  
Many treatments have already resulted from the use of tissues generated through 
advancements made in the porcine animal model.  Therefore, the definition of stem cellular 
characteristics will aid in the efficient identification and isolation of a population of MSCs from 
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porcine adipose tissue to be later used as donor cells in nuclear transfer creating an important 
animal model for additional future biomedical applications.   
Currently, nuclear transfer utilizing a true MSC as the donor cell is unconvincing most 
likely due to inefficient isolation/purification protocols and characterization.  Based on the 
success of our preliminary experiments, we further defined cellular characteristics of MSCs 
derived from adipose tissue of the porcine animal model.  Knowledge of the true nature and 
potential of MSCs will aid their contributions to medical treatments.  The use of a less 
differentiated donor cell may be more conducive to appropriate reprogramming (Rideout et al., 
2001) leading to an increased success rate in nuclear transfer which will ultimately lend to the 
enhancement of the number of live transgenic offspring produced.  An increased efficiency will 
also shorten the time required to produce an adequate number of live transgenic offspring for 
pharmaceutical and other biomedical purposes and therefore decrease the ultimate cost of 
production.  In turn, this will eliminate economic barriers currently blocking the application of this 
technology from commercial large-scale production of transgenic animals and therefore make 
transgenic animals a more appealing method of producing recombinant proteins.     
Researchers in industry are engineering bacteria or mammalian cells into bioreactors for 
producing recombinant proteins for therapeutic treatments.  However, these tiny bodies are 
incapable of producing the necessary mass quantity to adequately service the growing demand.  
The current shortfall hinders such therapeutic products from entering the marketplace thereby 
preventing patient access to new therapies, which in turn denies revenue to pharmaceutical 
companies who have invested large sums of money in product development.  An increase in the 
efficiency of transgenic animal production will provide a substitute factory for the manufacture of 
these recombinant proteins and offer a more cost effective mechanism for the production of 
large quantities (i.e., kilograms).        
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CHAPTER III 
 
ISOLATION AND CHARACTERIZATION OF PORCINE ADIPOSE TISSUE-DERIVED ADULT 
STEM CELLS 
 
Introduction 
 Stem cell applications for biomedical treatments continue to face many challenges 
concerning the originating source, expansion and culture, and differentiation.  The controversy 
surrounding the use of stem cells from embryos has encouraged research of alternative stem 
cell sources.  Numerous efforts have focused on the isolation and characterization of adult stem 
cells.  By definition, stem cells must be able to self-renew as well as differentiate into multiple 
tissue phenotypes.  Adult stem cells can be found among differentiated tissues.  Adult stem 
cells can renew themselves and when removed from their niche they are able to differentiate 
into the multiple cell types surrounding them in order to maintain and repair that tissue or organ.  
The development of an animal stem cell model will enhance important biomedical treatments, 
such as tissue engineering and cord blood stem cell transplants utilized in human patients. 
 Mesenchymal stem cells (MSCs) are adult stem cells and have been isolated from many 
different mesodermal tissues including bone marrow (Friedenstein et al., 1976), fat (Rodbell, 
1966; Rodbell and Jones, 1966) and cord blood (Broxmeyer et al., 1992). MSCs are pluripotent 
precursors that support hematopoiesis and formation of bone tissue, cartilage and adipose 
tissue (Friedenstein et al., 1976; Halvorsen et al., 2000; Gimble and Guilak, 2003). The inherent 
ability of MSCs to proliferate in vitro and maintain their pluripotency makes them attractive 
candidates for the development of an animal stem cell model. 
 MSCs have been isolated from various tissues based on their ability to adhere to plastic 
and their morphology similar to that of fibroblasts (Luria et al., 1971; Kassem et al., 1993; 
Rickard et al., 1996).  However, hematopoietic cells contaminate MSCs creating a 
heterogenous population of cells in culture.  Cell surface markers, such as CD9, CD10, CD13, 
CD29, CD34, CD44, CD49 d, CD49 e, CD54, CD55, CD59, CD105, CD106, CD146, CD166 
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(Gronthos et al., 2001), SSEA-4 (Gang et al., 2007) and a combination of others, have been 
utilized to identify and isolate MSCs from these contaminating hematopoietic cells as well as to 
further characterize MSCs.  Gene and protein expression profiles have been defined in some 
human bone marrow and adipose tissue-derived MSC populations showing the presence of 
these cell surface markers (Simmons and Torok-Storb 1991; Barry et al., 1999; Gronthos et al., 
2001).  In addition to cell surface markers, another important characteristic used to distinguish 
MSCs from hematopoietic cells is their ability to support differentiation into several different cell 
types depending on culture conditions. 
 Human adipose tissue-derived adult stem (ASCs) cells are self-renewing, can be 
differentiated into multiple tissue lineages and exhibit a high expression level of CD34, CD44 
and other stem cell markers (Gronthos et al., 2001; Guilak et al., 2006).  At this time, these stem 
cell characteristics have not been identified in porcine ASCs.  In the present study, a protocol 
has been developed for the isolation and culture of porcine ASCs.  Growth characteristics 
including population doublings, cell cycle length and proliferative capacities have been 
determined.  We also examined these stem cell-like cells for the capacity to self-renew and 
differentiate into cell lineages.   
Materials and Methods 
 All reagents were purchased from Sigma (St. Louis, Mo., USA) unless otherwise stated. 
Establishment of Primary Cultures 
 Subcutaneous fat (10 g per pig) was harvested from the dorsal abdominal area in 
mature female crossbred domestic pigs (n = 5) between the age of 6 months and 1 year of age 
at a local abattoir.  Samples were transported on ice in Dulbecco’s phosphate-buffered saline 
(dPBS; Gibco, Grand Island, N.Y., USA) containing 200 U/ml of penicillin and 200 !g/ml of 
streptomycin (Gibco) and 2.5 !g/ml of Fungizone (Gibco).  The tissue was finely minced and 
washed with dPBS containing P/S and Fungizone.  Each sample was digested with an equal 
volume of 0.1% collagenase Type I (240 IU/ml; Gibco) in dPBS with 1% bovine serum albumin 
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in a shaker incubator rotating at 200 rpm at 39° C for 2 hours.  The cell suspension was filtered 
through a dual filter system comprised of two nylon net filters (20 and 180 !m; Millipore, 
Bedford, MA, USA).  Adipocytes were separated from the stromal-vascular fraction by 
centrifugation at 1,200 rpm for 5 minutes.  Cells were then stained with Hoechst 33342 (2 !g/ml) 
to determine the number of nucleated cells in the suspension.  Cells were plated at 6,700 
nucleated cells/cm2 in 10 ml of expansion medium containing Dulbecco’s modified Eagle 
medium (DMEM; Hyclone, Logan, UT, USA) with high glucose supplemented with 10% fetal 
bovine serum (FBS; Hyclone), 100 U/ml of penicillin and 100 !g/ml of streptomycin and 2.5 
!g/ml of Fungizone in a 75-cm2 culture flask and incubated at 39°C in 5% CO2. 
Cell Culture Maintenance 
 Fresh medium was supplied every 3 to 4 days.  At 70 to 90% confluence, adipose cells 
were passaged by trypsinization, counted using a hemacytometer and re-seeded at an initial 
concentration of 6,700 cells/cm2. Population doublings were calculated at each passage using 
the following equation:  log (final concentration/initial concentration) x 3.33 (Arat et al., 2006).  
Also, cell cycle length was calculated based on the following equation:  number of days in 
culture/population doublings.  Cells were passaged until replicative senescence was observed.  
Replicative senescence was observed when the cells ceased to divide and was defined by a 
change in morphology from an elongated, spindle like to flattened, irregular shape with 
dispersed cytoplasm and the appearance of cytoplasmic vacuoles. 
Cloning Capacity Procedures 
 Cells were isolated according to the above procedure and plated from the initial culture 
(passage 0) at approximately 5 cells/cm2 in 10 ml of expansion medium in a 100-mm culture 
dish and incubated at 39°C in 5% CO2.  Adherent cells formed colonies after 10 days in culture 
and were selected for ring cloning (passage 0) based on the following criteria:  colonies 
contained at least 100 cells and colonies were located a minimum of one microscopic field from 
all other colonies.  Cells were passaged by trypsinization and re-seeded in a 1.9-cm2 culture 
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dish (passage 1) and at 70 to 90% confluence passaged into a 9.62-cm2 culture dish (passage 
2), a 25-cm2 culture flask (passage 3) and a 75-cm2 culture flask (passage 4). 
Differentiation of Primary Cultures and Clones 
 At 70 to 90% confluence (following passage 4 for clones), cells were passaged by 
trypsinization and cultured for 21 days in culture medium previously demonstrated to induce 
differentiation (Zuk et al., 2002; Gimble and Guilak, 2003).  Culture media were changed every 
3 to 4 days throughout the study.  For adipogenesis, cells were cultured on days 1 to 4 in 
differentiation medium containing DMEM supplemented with 3% FBS, 100 U/ml of penicillin and 
100 !g/ml of streptomycin, 2.5 !g/ml of Fungizone, 10 ng/ml of insulin, 10–9 M, dexamethasone, 
250 !M isobutyl methylxanthine and 0.2 mM indomethacin. Culture medium beyond day 4 
contained DMEM with 3% FBS, 100 U/ml of penicillin and 100 !g/ml of streptomycin, 2.5 !g/ml 
of Fungizone, 10 ng/ml of insulin and 10–9 M dexamethasone.  
 For chondrogenesis, cells were cultured for the duration of differentiation 
in medium containing DMEM with 10% FBS, 100 U/ml of penicillin and 100 !g/ml of 
streptomycin, 2.5 !g/ml of Fungizone, 6.25 !g/ml of insulin, 10 ng/ml of transforming growth 
factor-" and 10–9 M dexamethasone.  
 For osteogenesis, cells were cultured in differentiation medium containing DMEM with 
10% FBS, 100 U/ml of penicillin and 100 !g/ml of streptomycin, 2.5 !g/ml of Fungizone, 10 mM 
" -glycerophosphate, 50 ng/ml of ascorbic acid and 10–9 M dexamethasone.  
 Histological staining techniques were used to determine differentiation. Nile Red, a stain, 
which detects intracellular lipid accumulation, was used to determine adipocyte differentiation.  
Safranin O was utilized to identify glycosaminoglycans in the extracellular matrix of 
differentiated chondrocytes. After osteogenic induction, Alizarin Red S was employed to detect 
mineralized calcium deposition.  
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Experimental Design 
 Cell lines were defined as cells isolated from a single porcine donor Five cell lines were 
cultured and population doublings and cell cycle length were calculated at each passage 
(except for clones).  Cells were trypsinized and re-seeded at 30 to 40% confluence to avoid 
contact inhibition and possible differentiation.  Passaged lines were cultured until 70 to 90% 
confluence was reached.  Two replicates per cell line were performed for establishing growth 
characteristics and one replicate per cell line was performed for cloning procedures. 
Results 
Isolation of Cell Lines 
 Porcine adipose tissue-derived adult MSC lines were successfully established from 5 
female pigs.  The average number of mononuclear cells was 2.7 x 106/10 g for each fat tissue 
sample.  Of those mononuclear cells, an estimated 26% adhered to the plastic surface of the 
culture vesicle, while the rest were removed during the first medium change after the first 24 
hours of culture. Adherent cells began forming colonies beginning on day 1 after the primary 
culture was established.  Most cells in culture demonstrated an elongated, spindle-like 
fibroblastic morphology (Figure 3.1, black arrow), while others displayed a more rounded 
appearance (Figure 3.1, white arrow).  Cell cultures expanded rapidly to 70 to 90% confluence 
by days 8 to 10 after initial seeding. 
Growth Characteristics 
 Population doublings were calculated following the first passage according to the 
calculation described above.  From two cell lines, two replicates of each line were analyzed in 
parallel.  Cumulative population doublings were measured for each replicate with a mean of 29 
population doublings without reaching replicative senescence (Figure 3.2 A).  Average cell cycle 
lengths for adherent, undifferentiated cells were recorded throughout the duration of the culture 
interval.  Cells completed one cell cycle approximately every 3.3 days (Figure 3.2 B).  Cells did 
not reach replicative senescence by the end of this study (100 days). 
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Figure 3.1.  Undifferentiated stromal cell morphology.  Discrete colonies demonstrating spindle-
like fibroblastic morphology adhered to plastic within 24 hours of initial seeding.  Most cells 
displayed a characteristic elongated shape (black arrow), while others had a more rounded 
appearance (white arrow).  Magnified using a 20X objective.
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Figure 3.2. Proliferative characteristics of undifferentiated stromal cells:  1 and 2 represent each 
cell line while A and B are replicates.  (A) Average cell cycle lengths were recorded throughout 
the duration of culture.  (B) Proliferative capacity indicates cells have not reached observed, 
replicative senescence.
A. 
B 
B. 
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Clonal Analysis of Porcine ASCs 
 A total of 16 clones were selected for ring cloning from each of 2 donor pigs and 15 from 
the 3rd donor resulting in 47 attempted clones selected in all.  Of the 47 clone attempts, 8 did 
not produce a clone for passage 1 (17.0%) and replicative senescence was observed in 12 of 
47 clones (25.5%).  There were 7 (43.7%) surviving clones produced from the first donor that 
were successfully cultured to passage 4, the second donor produced 10 (62.5%) and there were 
14 (87.5%) from the third donor.  Cloned colonies expanded in a monolayer maintaining a 
fibroblastic morphology throughout the culture interval.  Of the 31 cloned colonies that survived 
to passage 4 without reaching replicative senescence or acquiring contamination, 19 colonies 
(62.0% of the total cloned population) were subjected to multiple cell lineage differentiation 
analysis (Table 3.1). 
Cell Lineage Differentiation of Cloned Porcine ASCs 
 Clonal cell cultures were exposed to differentiation conditions.  On day 21 of 
differentiation, stains specific for characteristics of differentiated adipocytes, osteocytes and 
chondrocytes were utilized. Nile red, a stain which detects intracellular lipid accumulation, was 
used to determine adipocyte differentiation.  After chondrogenic induction, safranin O was used 
to detect glycosaminoglycans in the extracellular matrix.  Alizarin red S identified mineralized 
calcium deposition in differentiated osteocytes.  After 21 days of culture in differentiation 
medium, a qualitative estimate was assigned to each differentiation condition based on multiple 
fields of view.  
Of the 19 cloned colonies subjected to differentiation conditions, 92% of colonies 
differentiated under adipogenic conditions stained positive for intracellular lipids (Figure 3.3 A) 
and the undifferentiated control cells displayed expression of these intracellular lipids, only less 
intensely (Figure 3.3 C). Chondrogenic induction was detected in 97% of cloned colonies by the 
presence of glycosaminoglycans in differentiated clones (Figure 3.3 E).  This was also noted in 
undifferentiated cell populations, but again less intensely (Figure 3.3 F).  Finally, osteocyte
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Table 3.1. Number of surviving porcine clones to passage 4 and differentiation 
Cell line Total # clones P1 P2 P3 P4* Diff culture †Adipogenesis †Chondrogenesis †Osteogenesis 
I 16 16 12 12 7 0 0 (0%) 0 (0%) 0 (0%) 
II 16 16 13 13 10 5 10/10 (100%) 10/10 (100%) 10/10 (100%) 
III 15 15 14 14 14 14 25/28 (89%) 27/28 (96%) 28/28 (100%) 
P  Passage; Diff = Differentiated. 
*Approximately 14 population doublings or 4-8 weeks in culture. 
†Two replicates. 
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Figure 3.3. Differentiation of P4 clones.  Adipogenic differentiation stained positive with Nile 
Red staining; viewed with a FITC filter (A) and phase contrast (B). Undifferentiated stromal cells 
(control) demonstrated only slight Nile Red staining (Panel C-FITC filter and Panel D-phase 
contrast).  Chondrogenic induction was detected by Safranin O in differentiated clones (E) and 
less intensely in undifferentiated cell populations (F).  Osteocyte differentiation was observed 
only in induced cells (G) and not in undifferentiated stromal cells (H). Images A-F and H were 
magnified using a 20X objective while image G was magnified using a 40 X objective. 
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differentiation was observed in 100% of cloned colonies.  Positive staining for calcium 
deposition was observed only in the induced cells (Figure 3.3 G) and not in the undifferentiated 
stromal cells (Figure 3.3 H). 
Discussion 
 Stem cell biology has applications in regenerative medicine for repairing, replacing or 
regenerating diseased tissues and organs.  Stem cells must have the capacity for self-renewal 
and must have the ability to give rise to differentiated cell types to be considered ‘stem cells’.  
The use of somatic or adult stem cells, found in adult tissues, escapes the controversy 
associated with the use of stem cells derived from embryos and fetal tissues.  Also, adult stem 
cells have the potential to elude immunological rejection and disease contraction when 
transplanted back into the donor (Merok et al, 2001).  The advancement of stem cell technology 
is already contributing to applications, such as gene therapies for disease and the development 
of research techniques, such as bone marrow transplants and transgenic mice (Merok et al., 
2001).  
The emerging concept of plasticity (also known as transdifferentiation) in stem cells 
suggests that somatic stem cells have the ability to dedifferentiate from their source cell type 
and then differentiate into new cell types (Guilak et al., 2004).  The improvement of culture 
conditions and the definition of cellular characteristics for the efficient isolation and purification 
of a population of MSCs from multiple species-specific tissues will likely create important animal 
models for additional biomedical applications. 
 At this time, knowledge of the optimal culture conditions for pluripotent and differentiated 
MSCs from adipose, bone marrow and cord blood is limited.  Also, culture characteristics of 
these cells have not been clearly defined and studies generating gene and protein expression 
profiles are underway, but remain inconclusive.  This study has developed a successful protocol 
for the isolation and culture of porcine ASCs.  We were able to establish primary MSC lines from 
5 female pigs isolating an average of 2.7 x 106 MSCs/10 g from each fat tissue sample.  Similar 
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quantities of cells have been isolated from adipose tissue of rhesus monkeys and humans 
(Izadpanah et al., 2006; Oedayrajsingh-Varma et al., 2006).  Of the cells isolated, an estimated 
26% adhered to the plastic surface of the culture vesicle.  Most cells in culture displayed an 
elongated, spindle-like fibroblastic morphology.  Cells were plated at a density of 
6,700 cells/cm2, while lower concentrations did not render rapid colony cultivation (data not 
shown), suggesting that the cells prefer to have neighboring cells within a closer range.  Growth 
characteristics of these MSCs indicate that a mean of 29 population doublings could be reached 
without replicative senescence.  These cells completed one cell cycle approximately every 3.3 
days and had not yet reached replicative senescence by the end of this study (100 days). 
 In comparison, Zuk et al. (2001) described human adipose tissue to harbor 
approximately 2–6 x 106 cells per 300 ml of processed lipoaspirate which can be maintained in 
culture through passage 13 (approximately population doubling 22) or 165 days.  Human ASCs 
isolated by resection or tumescent liposuction demonstrate a cell cycle length of approximately 
1.5–2.8 days (Zuk et al., 2001; Oedayrajsingh-Varma et al., 2006).  Also, human adipose tissue 
isolated using these techniques contained adherent cells representing 1.9 to 6.3% of the total 
cellular population (Oeday rajsingh-Varma et al., 2006).  Porcine bone marrow derived MSCs 
can be isolated with a yield of approximately 2.3 x 108 cells per 20 ml bone marrow aspirate 
(Bosch et al., 2006).  Plating 500 bone marrow-derived cells per cm2 renders approximately 
4,000 cells per cm2 after 3 to 4 days in culture (estimating a cell cycle length of 0.75 to1 day) 
(Zeng et al., 2006).  Also, these cells can be cultured for more than 100 population doublings 
(Zeng et al., 2006).  Based on these findings, growth characteristics of the porcine ASCs used 
in this study demonstrate similar results. 
 Clonal analysis indicates that these stem cell-like cells have the capacity to self-renew 
and differentiate into cell lineages much like human ASCs (Guilak et al., 2006).  We hypothesize 
that the observed replicative senescence in these cloned colonies is a result of the cellular 
cloning processes because primary cultures did not exhibit this phenomenon.  Colonies 
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subjected to adipogenic, chondrogenic and osteogenic differentiation conditions all stained 
positive.  While undifferentiated controls (approximately population doubling 30) stained positive 
for adipogenesis and chondrogenesis, it is evident that the colonies subjected to differentiation 
conditions stained much more intensely than colonies that were not subjected to differentiation 
conditions. 
 Improved culture conditions and defined cellular characteristics of these porcine ASCs 
have been identified.  The techniques used in this study will increase the efficiency of isolation 
and purification of a population, of stem cell like cells from easily obtainable tissues.  The 
isolation and characterization of a somatic stem cell population from a model animal, such as 
the pig, could prove valuable in tissue engineering research.  The availability of such an animal 
model will be very beneficial in determining the true efficacy of somatic stem cell tissue, 
regeneration versus the use of embryonic stem cells. 
* This is a reprint of an article published in Cells Tissues Organs, Williams KJ, Picou AA, Kish 
SL, Giraldo AM, Godke RA, Bondioli KR. Isolation and characterization of porcine adipose 
tissue-derived adult stem cells. 188(3):251-258, with permission from S Karger AG, Basel. 
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CHAPTER IV 
 
CELL SURFACE CHARACTERIZATION AND KARYOTYPIC ANALYSIS OF PORCINE 
ADIPOSE-DERIVED STEM CELLS 
 
Introduction 
 
Over the last twenty years, human bone marrow stromal cells have been shown to 
differentiate along adipocyte, osteocyte and other mesodermal pathways as well as support the 
proliferation of hematopoietic stem cells.  It has been shown that specific adhesion molecules 
expressed on the surface of bone marrow stromal cells mediate the cell-cell interactions 
supporting differentiation and proliferation (Kincade et al., 1988). The presence of these 
molecules may be utilized in isolation protocols to identify and enhance the purification of a 
population of cells within a heterogeneous population.  
Human adipose tissue is an alternative source of multipotent stromal cells, which is 
largely derived from processed liposuction aspirates.  Human and porcine adipose tissue–
derived adult stem cells (ASCs) are a self-renewing population of cells with a multilineage 
plasticity similar to bone marrow–derived mesenchymal stem cells (MSCs) and show promise 
for use in combination with various biomaterials for reconstructive tissue engineering (Halvorsen 
et al., 2001a; Hauner et al., 1989; Williams et al., 2008).  The phenotypic profile of human ASC 
surface proteins has been partially characterized for stem cell-associated cluster differentiation 
molecules including CD9, CD10, CD13, CD29, CD31, CD34, CD44, CD49a CD49d, CD49e, 
CD54, CD55, CD59, CD63, CD73, CD90, CD105, CD106, CD144, CD146, CD166 (Gronthos et 
al., 2001; Mitchell et al., 2006), and for SSEA-4 (Gang et al., 2007), ABCG2, ALDH, VEGFr-2 
(Mitchell et al., 2006) and a combination of other molecules.  However, the surface protein 
phenotype has not been described for porcine ASCs at this time.   
Multiple research groups have characterized human ASCs by describing the surface 
phenotype, however, there are many subtle discrepancies throughout the literature.  The effects 
of these differences on the identity of these cells remain unknown.  Various factors may play a 
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role in producing these inconsistencies.  For example, porcine ASCs are isolated from fat 
depots likely different from human ASC liposuction aspirates.  Also, the age of the donor may be 
different and cause the results to disagree.  In addition, different isolation procedures, the 
specific cell seeding density, differences in culture media, culture duration, the cell cycle, the 
passage numbers analyzed, whether the cells were cryopreserved prior to analysis and even 
the exposure to plastic (Planat-Benard et al., 2004; Rehman et al., 2004) all may cause 
incongruent results.  Therefore, it is important to characterize porcine ASCs on the cell surface 
level. 
The inherent ability of mesenchymal stem cells such as porcine ASCs to proliferate in 
vitro and maintain their aptitude for pluripotency (Williams et al., 2008) makes them attractive 
candidates as donor cells for more efficient reprogramming during nuclear transfer (NT) 
compared to somatic cells currently in use. Studies have however generated contradicting 
results for the success of stem cells in NT; for example, skin-derived stem cells increased NT 
efficiency (Hao et al., 2009; Zhu et al., 2004) while hematopoietic stem cells did not (Inoue et 
al., 2006; Sung et al., 2006).  Porcine ASCs have not been tested as donor cells for NT at this 
time.   
Successful NT in combination with applicable genetic modifications must be conducted 
using normal diploid cells before they reach senescence (Denning et al., 2001).  Primary cells 
utilized to establish culture possess the capacity to survive only a finite number of population 
doublings (PDs) before cellular senescence is reached (Hayflick and Moorhead, 1961).  As cells 
approach this limit, the rate of proliferation decreases (Cameron, 1972) and the probability of 
cells to undergo cytokinetic abnormalities and chromosomal alterations increases substantially 
(Giraldo et al., 2006; Oback and Wells, 2002). The current techniques employed today to 
establish and maintain primary in vitro cell cultures may also be responsible for the induction of 
these anomalies (Chu, 1962; Denning et al., 2001; Kasinathan et al., 2001; Oback and Wells, 
2002; Rubin, 1997).  Spontaneous transformations, which will also influence the success of NT, 
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have been described in human and murine adipose tissue-derived MSCs (Rubio et al., 2005) 
and have been reported to accumulate proportionally to the time in culture (Oback and Wells, 
2002).  However, other studies indicate that human bone marrow and adipose tissue-derived 
MSCs do not mutate and maintain chromosomal configuration through culture (Bernardo et al., 
2007; Meza-Zepeda et al., 2008).   
Porcine ASCs have not been characterized in terms of chromosomal stability through in 
vitro culture.  Chromosomal aberrations and a limited proliferative capacity of somatic donor 
cells cultured in vitro dramatically influence the success of NT (Kasinathan et al., 2001).  The 
manifestation of genetic modifications in donor cells for NT requires a significant number of PDs 
and, unfortunately, these deleterious effects are impossible at this time to circumvent.  But the 
identification of a donor cell that is genetically stable for a long period of time in vitro may be the 
key to increasing the efficiency of NT.  
  The current study partially characterized the surface protein phenotype of 
undifferentiated porcine ASCs in comparison with the immunophenotype of undifferentiated 
human ASCs as reported in the literature using flow cytometry and enhanced 
chemiluminescence Western blot analysis.  Also, the chromosomal stability of porcine ASCs 
was determined through in vitro culture in order to further characterize them as potential donor 
cells for NT.  With a more complete characterization of porcine ASC (i.e. stem cell surface 
markers, chromosomal stability) a donor cell population, which can be more efficiently 
reprogrammed following fusion with the oocyte, may be identified. 
Materials and Methods 
 
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless 
otherwise stated. 
Establishment of Primary Cultures and Cell Culture Maintenance 
Primary cultures were established following procedures previously documented 
(Williams et al., 2008).  Briefly, 10 g subcutaneous fat was harvested from the dorsal abdominal 
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area in mature female crossbred domestic pigs (n = 20) between the ages of 6 months and 1 
year of age at a local abattoir.  The tissue was finely minced and washed with Dulbecco’s 
phosphate-buffered saline (dPBS) containing 200 U/ml of penicillin and 200 "g/ml of 
streptomycin (P/S) and 2.5 "g/ml of Fungizone (Gibco).  Each sample was homogenized with 
an equal volume of 0.1% collagenase Type I (240 IU/ml; Gibco) in dPBS with 1% bovine serum 
albumin (BSA) in a shaker incubator rotating at 200 rpm at 39°C for 2 hours.   
The cell suspension was filtered through a dual filter system comprised of two nylon net 
filters (20 "m and 180 "m; Millipore, Bedford, MA, USA).  Cells were then stained with Hoechst 
33342 (2 "g/ml) to determine the number of nucleated cells in the suspension.  Cells were 
plated at 6,700 cells/cm2 in 10 ml of expansion medium containing Dulbecco’s Modified Eagle 
Medium (DMEM; Hyclone, Logan, UT) with high glucose supplemented with 10% fetal bovine 
serum (FBS; Hyclone), 100 U/ml of penicillin and 100 "g/ml of streptomycin and 2.5 "g/ml of 
Fungizone in a 150-cm2 culture flask and incubated at 39°C in 5% CO2.   
Fresh medium was supplied every 3 to 4 days.  When 70 to 90% confluence was 
achieved, the adipose cells were harvested by trypsinization, counted using a hemacytometer 
and re-seeded at an initial concentration of 6,700 cells/cm2.  Cells were passaged until 
replicative senescence was observed.   
Stem Cell Surface Protein Immunolabeling 
 Porcine ASCs were harvested by trypsinization, washed and resuspended in cold PBS 
containing 10% FBS and 1% sodium azide.  The cells were incubated for 1 hour at room 
temperature in primary antibodies (10 "g/ml) to h#-Microglobulin (human, BD Pharmningen, 
San Jose, CA, USA, Catalog # 555550), pCD3 (porcine, direct label, BD Pharmingen, San Jose, 
CA, USA, Catalog # 559582), pCD8 (direct label, BD Pharmingen, San Jose, CA, USA, Catalog 
# 551303), pCD29 (BD Pharmingen, San Jose, CA, USA, Catalog # 552369), pCD44 (Abcam, 
Cambridge, MA, USA, Catalog # ab19622), hCD90 (BD Pharmingen, San Jose, CA, USA, 
Catalog # 555593) pCD117 (AbD Serotec, Catalog # MCA2598), SSEA-4 (Developmental 
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Studies Hybridoma Bank, Iowa City, IA, USA, Raleigh, NC, USA, Catalog # MC-813-70) and 
mouse Sca-1 (Ly-6A/E, BD Pharmingen, San Jose, CA, USA, Catalog #557403).   
 For indirect labeling, cells were then incubated at room temperature for 30 minutes in 10 
"g/ml of the Alexa-Fluor® 488 (Invitrogen, Eugene, OR, USA) conjugated secondary antibody.  
Cells were counterstained with propidium iodide (50 "g/ml) for 15 minutes.  The cells were then 
washed and resuspended for flow cytometric analysis at a concentration of 1,000,000 cells/ml in 
cold PBS containing 10% FBS and 1% sodium azide.  
Flow Cytometric Analysis of Stem Cell Surface Proteins 
 Samples were analyzed for relative percent positive events for each stem cell surface 
proteins using the Accuri® C6 Flow Cytometer® (Accuri Cytometers, Ann Arbor, MI, USA).  
Labeled cells were excited with a 488 nm diode laser and a 488 nm diode laser was used to 
detect PI levels (FL3-channel).  The DNA content derived from the PI levels was used to 
distinguish live cells from dead cells in the FL3-channel.  Percent positive events for stem cell 
surface proteins were detected at >670 nm in the FL1-channel.  A gate was established to 
exclude non-specific binding as a whole based on secondary antibody only staining.  FL3 and 
FL1 dot plots were generated using the Accuri CFlow Plus® (Accuri Cytometers) software and 
quadrants were instated to distinguish dead from live cells and immunolabeled cells from 
unstained cells.  Approximately 30,000 to 100,000 events were recorded per sample at early 
and late population doublings.   
Western Blot Analysis of Stem Cell Surface Proteins 
 Early PD human (positive control) and porcine ASCs were lysed and proteins extracted 
using a solution containing the M-PER® Mammalian Protein Extraction Reagent (Thermo 
Scientific, Rockford, IL, USA), HaltTM Protease Inhibitor Single-use Cocktail (Thermo Scientific) 
and 10 "l/ml EDTA solution on a rotator for 10 minutes.  Cellular debris was removed by 
centrifugation at 14,000 x g for 15 minutes.  The protein extractions were analyzed by a typical 
western blot procedure.  Briefly, protein extractions were separated by SDS-polyacrylamide gel 
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electrophoresis on 10% Tris-HCl Ready Gels (Bio-Rad, Hercules, CA, USA).  Extractions were 
then transferred to an Immun-BlotTM polyvinylidene fluoride membrane (Bio-Rad) and hybridized 
using the following primary antibodies:  hCD44 (BD Pharmingen, San Jose, CA, USA, Catalog # 
550988), hCD90 (BD Pharmingen, San Jose, CA, USA, Catalog # 555593), pCD44 (Abcam, 
Cambridge, MA, USA, Catalog # ab19622), pCD117 (c-Kit; AbD Serotec, Raleigh, NC, USA, 
Catalog # MCA2598), and #-actin (Abcam, Cambridge, MA, USA, Catalog # ab8226) for a 
loading control.  The secondary antibody to each primary was conjugated with horse radish 
peroxidase (Bio-Rad) and an enhanced chemiluminescence (ECL) kit (Amersham,Little 
Chalfont, Buckinghamshire, UK) was used for detection via exposure to x-ray film.   
Karyotypic Analysis 
 At each passage analyzed (starting at passage 2), an additional 75 cm2 culture flask was 
seeded with approximately 6,700 ASCs/cm2.  Then 24 hours after plating, adherent cells were 
incubated in a 0.05 "g/ml KaryoMAX® Colcemid® solution (Gibco) at 37°C for approximately 30 
minutes.  Cells were exposed to this low dosage of Colcemid® for only 30 minutes to reduce the 
risk of the induction of aneuploidies.  The synchronized cells were harvested by enzymatic 
dissociation using trypsin and then resuspended and incubated in a 0.9% sodium citrate 
hypotonic solution for 5 minutes in a 37°C waterbath.  Swelled cells were then washed and 
stored in fixative containing a 1:3 ratio of acetic acid:methanol at -20°C.   
 For slide preparation, the cells were washed in fresh, cold fixative and several drops 
were placed on pre-cleaned glass slides (Gold Seal® Products, Portsmouth, NH, USA), which 
were allowed to dry at room temperature for 10 minutes.  The slides were then flooded with a 
fixative solution of 1:1 acetic acid:methanol and allowed to dry again at room temperature for 10 
minutes.  The chromosomes were stained in 0.4% Accustain® Geimsa Stain (Sigma) for 15 
minutes, rinsed with deionized water and air-dried at room temperature.   
 Metaphase spreads were observed using bright field microscopy under 100x oil 
immersion.  Spreads were selected only if chromosomes could be visibly distinguished from 
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each other and were observably derived from a single cell.  A digital image was captured for 
each metaphase spread using the QCapture Pro imaging software (QImaging, Surrey, BC, 
Canada).  To avoid double counting, a digital mark was placed on each chromosome in each 
picture using the Rincon™ (ImagingPlanet, Goleta, CA, USA) image analysis software.  For 
each cell line, 20 to 30 metaphase spreads were analyzed per passage.  A total of 714 
metaphase spreads were analyzed for this study. 
Experimental Design  
 For flow cytometric analysis, a total of fourteen primary cell lines were established and 
cultured until cells reached senescence.  At each passage analyzed, cells were trypsinized and 
re-seeded at 30 to 40% confluence to avoid possible contact inhibition and differentiation.  
Passaged lines were cultured until 70 to 90% confluence was reached.  A portion of cell lines 
were analyzed for selected stem cell surface markers at early passages (PD 1-10) and late 
passages (PD 11-34).  For western blot analysis, total protein was extracted from three early PD 
(<PD 3) cell lines.  ECL-western blot analysis was performed on all three protein samples; 
PVDF membranes were cut to separate and incubated accordingly for each stem cell surface 
protein.  The human protein extraction was derived from a PD 1 human ASC cell line and used 
as a positive control for the human antibodies (CD44 and CD90) and to test for antibody cross-
reactivity for the porcine antibodies (CD44 and CD117).  Representative exposed x-ray films are 
presented. 
For karyotype analysis, two ASC cultures were established from each of three primary 
cell lines and were cultured under the exact same conditions.  At each passage analyzed, one 
culture was used to prepare metaphase spreads and the other was used to subculture the cell 
line for continuous karyotype analysis at subsequent passages.  Percent aneuploidies were 
calculated at population doublings (PD) 1-10, PD 11-20 and PD 21-30. 
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Statistical Analysis 
 In this study, Chi-square analysis was employed to karyotypic data in order to determine 
statistical differences between cell lines (pASC 1, pASC 2 and pASC 3) and PD (PD 1-10, PD 
11-20 and PD 21-30).  For this test, a P < 0.05 was considered significant.  Data were analyzed 
using the SigmaStat Statistical Software Version 3.5 (Systat Software, Inc., San Jose, CA, 
USA). 
Results 
Flow Cytometric Analysis of Stem Cell Surface Proteins 
 Flow cytometric analysis was performed on multiple pASC cell lines at early population 
doublings (PD; PD 0-10) and at late PDs (PD 11-34) for the detection of the presence of various 
stem cell surface markers.  Results demonstrate that profiles are similar for some cell surface 
markers and not similar for other markers on the human ASC surface as reported in the 
literature (Gronthos et al., 2001; Katz et al., 2005; Lo Cicero et al., 2008).  Analyses of porcine 
ASCs at early PDs 0-10 demonstrated essentially no positive events for CD44 or the lectin 
embryonic stem cell surface marker SSEA-4 (Table 4.1; Figure 4.1), whereas these proteins 
were, in fact, found on the surface of human ASCs (Gronthos et al., 2001; Katz et al., 2005; Lo 
Cicero et al., 2008). In this study, we also did not detect the presence of CD3, CD8, CD117 (c-
Kit) or stem cell antigen-1 (Sca-1; Table 4.1; Figure 4.1).  The lack of CD8 and CD117 was 
consistent with the results for these proteins in human ASCs (Katz et al., 2005).  At this time, 
there is no literature to report the presence of CD3 or Sca-1 proteins on the human ASC 
surface.  However, the percentage of positive events for CD29 (4.74 + 2.37; range 0.1 – 10.5) 
and CD90 (12.94 + 7.06; range 0 – 38.6) expression was found to be elevated and more 
comparable to those values reported in the literature (Table 4.1; Figure 4.1).  The mean percent 
positive values generated for CD29 and CD90 are, however, lower than that reported for human 
ASCs.  It is important to note that the antibody used for CD90 was directed against a human 
antigen and cross reactivity between the pig and the human species may not have occurred. 
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Figure 4.1. Immunophenotypic analysis of porcine ASC surface proteins. Representative dot plots for CD3 (A), CD8 (B), CD29 (C), 
CD44 (D), CD90 (E), CD117 (F), SSEA-4 (G) and Sca-1 (H).  Dot plots represent porcine ASCs cultured at early PDs 0-10.  
Quadrants were set according to fluorescence signals generated from propidium iodide and Alexa-Fluor® 488 and the percentage of 
live cells positive for each stem cell antigen is depicted in the lower right corner.
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    Table 4.1. Positive Events for Early Population Doublings 0-10 
Surface 
Marker 
# Cell Lines  
Analyzed 
Mean % Positive + 
SEM 
Range (%) 
‡Human ASC % 
Positive 
pCD3 3 < 1 0.1 – 0.2 NP 
 
pCD8 3 
 
0 0 0†† 
pCD29 
 
5 70.58 + 13.25 33.9 – 92.8 98.1 + 1† 
pCD44 
 
6 6.98 + 1.73 4.4 – 10.2 60 + 15† 
hCD90 
 
5 86.14 + 5.66 69.5 – 96.5 25.96* 
pCD117 
 
5 1.00 + 0.66 0.1 – 3.6 0.2 + 0.4†† 
SSEA-4 
 
3 < 1 0.2 – 1.1 +** 
mSca-1 3 < 1 0.1 – 0.2 NP 
      p = Porcine, h = Human, m = Mouse, NP = Not Published. 
        ‡All human ASCs cells analyzed were early passages. 
      †Gronthos et al., J Cell Phys 2001; 189:54-63. 
      *Zuk et al., Mol Bio Cell 2002; 13:4279-4295. 
      ††Katz et al., Stem Cells 2005; 23:412-423. 
      **Lo Cicero et al., Cell Prolif 2008; 41:460-473.
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         Table 4.2. Positive Events for Late Population Doublings 11-34 
Surface 
Marker 
# Cell Lines  
Analyzed 
Mean % Positive + 
SEM 
Range (%) ‡Human ASC % Positive 
pCD3 
 
3 < 1 0 – 0.2 NP 
pCD8 
 
3 < 1 0 – 0.1 0†† 
pCD29 
 
3 95.57 + 1.36 92.9 – 97.4 98.1 + 1† 
pCD44 
 
3 5.35 4.5, 6.2 60 + 15† 
hCD90 
 
3 88.77 + 8.21 72.3 – 97.4 25.96* 
pCD117 
 
3 < 1 0.1 – 0.5 0.2 + 0.4†† 
SSEA-4 
 
3 1.7 0.2, 3.2 +** 
mSca-1 
 
3 < 1 0.2 – 0.3 NP 
      p = Porcine, h = Human, m = Mouse, NP = Not Published. 
        ‡All human ASCs cells analyzed were early passages. 
      †Gronthos et al., J Cell Phys 2001; 189:54-63. 
      *Zuk et al., Mol Bio Cell 2002; 13:4279-4295. 
      ††Katz et al., Stem Cells 2005; 23:412-423. 
      **Lo Cicero et al., Cell Prolif 2008; 41:460-473.
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Analysis of porcine ASCs at late PDs 10-34 also demonstrated that CD3, CD8, CD44, 
CD117, SSEA-4 and Sca-1 proteins tested were virtually non-existent on the surface of porcine 
ASCs (Table 4.2; Figure 4.1). However, CD29 expression remained elevated in the later PDs 
with a mean percent positive value of 7.80 + 0.78 and a range of 6.5 – 9.2 (Table 4.2; Figure 
4.1).  Additionally, the percentage of positive events for CD90 (7.77 + 3.83; range 0.3 – 13.0 
remained elevated in the later passages.  These values determined for CD29 and CD90 are 
more consistent with the values reported for the human ASCs, although it is important to note 
that the cells analyzed in these reports were early PDs and were not cultured as long as the 
cells in this study (Tables 4.1 and 4.2).  Gronthos et al. studied cells cultured through two 
passages and cryopreserved (Gronthos et al., 2001), Katz et al. utilized human ASCs passage 
2 or earlier (Katz et al., 2005) and Lo Cicero analyzed passage three cells (Lo Cicero et al., 
2008). Nevertheless, the values are a good reference and our results indicate that the 
expression levels did not elevate in response to the duration in culture. 
Western Blot Analysis of Stem Cell Surface Proteins 
 Immunoblot detection was paired with an ECL kit to confirm flow cytometric results of 
select stem cell surface markers analyzed.  For both the human and porcine protein extractions, 
!-actin was utilized as a loading control and confirmed the presence of protein extraction in 
each sample (Figure 4.2).  As expected, antibodies used against the human CD44 and CD90 
proteins revealed a positive expression in human ASCs as indicated by bands present at the 
expected sizes (85 kDa and 25-35 kDa, respectively).  However, the human antibodies did not 
detect expression for CD44 or CD90 in porcine ASCs by Western blot analysis (Figure 4.2).  In 
response to this result we utilized a porcine antibody to CD44, but did not detect the protein in 
either the porcine or the human protein extractions (Figure 4.2).  The porcine antibody to CD117 
also did not identify the protein in the porcine or human protein extractions (Figure 4.2).  The 
inability to detect any of the proteins analyzed by x-ray exposure verifies the findings derived by  
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Figure 4.2.  Western blot analysis of human and porcine ASCs for CD44, CD90 and CD117.  
Human CD44 and CD90 antibodies detected the protein in the human protein extraction (H) but 
not in the porcine protein extraction (P).  Porcine CD44 and CD117 antibodies did not detect the 
protein in either the human or the porcine protein extractions. 
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flow cytometric analysis except for CD90.  Again, we suspect that antibody cross reactivity did 
not occur between the pig in the human especially for the CD90 antigen. 
Chromosomal Stability of pASC Through In Vitro Culture 
 Metaphase spreads were observed and selected following the previously described 
criteria.  Digital images were captured for each metaphase spread and each chromosome was 
documented using a digital marking system.  A normal porcine metaphase spread consisted of 
38 chromosomes (2n = 38) (Figure 4.3 A) and an aneuploid cell contained chromosome 
numbers other than 38 (38 + X) (Figure 4.3 B).  For each cell line, 20 to 30 metaphase spreads 
were analyzed per passage.  Table 3 illustrates a total of 714 metaphase spreads analyzed for 
this study.  Of 714 metaphases analyzed, 509 (71.3%) were aneuploid and only 205 (28.7%) 
were normal diploid porcine cells (Table 4.3).  Hypoploid cells represented 66% (336) of 
aneuploid cells and the remaining 33.2% (169) (hyperploid and tetraploid combined) were 
hyperploid (Table 4.3).  There were 153 (45.5%) cells that contained 37 or 36 chromosomes, 
141 (42.0%) cells with a range of 35 to 32 chromosomes and 42 (12.5%) contained less than 32 
chromosomes (Table 4.3).      
 For each cell line, (pASC 1, pASC 2 and pASC 3) we found a remarkable percentage of 
aneuploidies (43.7, 48.9 and 47.3, respectively, with a 46.6 + 1.5 average) present immediately 
after the cultures were established (PD 1-10).  Chi-square analysis indicates that the percents of 
aneuploid cells during PD 1-10 were significantly lower than those for PD 11-20 and PD 21-30 
(Table 4.4) (Figure 4.4).  The statistical difference was observed individually within a cell line 
and as an average of the three cell lines between PD groups (PD 1-10, PD 11-20 and PD 21-
30) (Table 4.4; Figure 4.4). 
Discussion  
Previously, we determined that porcine ASCs expressed the classic characteristics of 
stem cells by demonstrating the ability to self-renew through ring cloning experiments and the 
ability to differentiate along multiple tissue lineages (Williams et al., 2008). Those findings were 
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Figure 4.3.  Metaphase spreads of porcine ASCs.  Normal diploid porcine metaphase spread 
with 38 chromosomes (left).  Aneuploid porcine metaphase spread with 52 chromosomes (right, 
magnification 100X oil immersion).
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      Table 4.3. Types of Aneuploidies in pASCs Derived By In Vitro Culture (PD 1-30)  
Total metaphases analyzed 
 
714 
Diploid cells (%) 
 
205 (28.7) 
Aneuploid cells (%) 
 
509 (71.3) 
Hypoploid cells = 38 – X (%) 
 
336 (66.0) 
37 – 36 chromosomes (%) 
 
153 (45.5) 
35 – 32 chromosomes (%) 
 
141 (42.0) 
< 32 chromosomes (%) 
 
42 (12.5) 
Hyperploid cells = 38 + X (%) 
 
169 (33.2) 
Tetraploid cells = 76 chromosomes (%) 4 (0.8) 
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    Table 4.4. Chromosomal Stability of In Vitro Cultured pASC Population  
                                 Through PD 30  
Aneuploid Cells (%) 
Cell Line  N 
PD 1 – 10 PD 11 – 20 PD 21 – 30 
pASC 1 243 43.7a 87.1b 96.8b 
pASC 2 220 48.9a 82.1b 100.0b 
pASC 3 251 47.3a 91.7b 86.3b 
Mean 714* 46.6 + 1.5a 87.0 + 2.8b 94.4 + 4.1b 
     n = number of metaphases analyzed per cell line. 
     *Total number of metaphases analyzed. 
     Standard error of the mean was calculated for the mean in each PD group. 
    Different letters within rows represent significant statistical differences  
between PD derived by Chi-square analysis (P < 0.05). 
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Figure 4.4. Chromosomal stability of porcine ASCs through in vitro culture.  For pASC 1, pASC 
2 and pASC 3 cells lines, the proportion of aneuploid cells was significantly higher in later PD 
(PD 11-20 and PD 21-30) than the earlier PD 1-10.  Letters indicate significant differences 
between mean values of 46.6 + 1.5, 87.0 + 2.8 and 94.4 + 4.1 with a P < 0.05.
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consistent with the characteristics determined in human ASCs (Halvorsen et al., 2001a; Hauner 
et al., 1989).  Human and porcine adipose tissues offer an alternative stem cell source, can 
beaccessed easily with little pain and are plentifully available.  ASCs show much promise for 
use in reconstructive tissue engineering and therapeutic cloning.  The present study is the first 
to describe the cell surface profile for stem cell associated surface markers comparing early and 
late passages of undifferentiated porcine ASCs as well as to determine the chromosomal 
stability through in vitro culture. The surface phenotype of porcine ASC is similar for some stem 
cell antigens and different for others when compared to human ASC cell surface as reported in 
the literature (Gronthos et al., 2001; Katz et al., 2005; Mitchell et al., 2006; Zuk et al., 2002). 
Unlike reported values for human ASCs, porcine ASCs did not demonstrate positive 
expression for CD44 or SSEA-4.  The absence of CD44 was confirmed by western blot 
analysis.  However, our previous study did reveal positive gene expression of CD44 though 
reverse transcriptase polymerase chain reaction (Williams et al., 2008).  Neither SSEA-4, found 
on bone marrow MSCs and human ASCs, nor Sca-1, also found on MSCs, was detected on the 
surface of porcine ASCs at early or late PDs.  Consistent with the literature, however, CD29 and 
CD90 expression was detected in early and late PDs while CD8 and CD117 antigens were not 
present at early or late PDs.  Our study is by no means a comprehensive investigation for stem 
cell markers potentially present on the surface of porcine ASCs.  Bone marrow-derived MSCs 
and human ASCs have been more fully characterized in the literature and many more of these 
antigens need to be explored in porcine ASCs.  Additional antigens for further investigation 
include CD13, CD49, CD51, CD61, CD63, CD73, CD105, CD106, CD138, CD140, CD146 and 
CD166 (Gronthos et al., 2001; Katz et al., 2005; Mitchell et al., 2006; Zuk et al., 2002).  Cell 
surface proteins were chosen in the current study based on their availability and their indication 
of “stemness” in human ASC populations.  At this time, the selection of antibodies commercially 
available is an obstacle for thoroughly investigating these characteristics in the porcine animal 
model.  Human CD90 and mouse Sca-1 antibodies were used in flow cytometric analysis, while 
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human CD44 antibody (along with porcine CD44) was employed in the Western blot analysis.  
Antibody cross reactivity between species most likely did not occur as results indicate in the 
western blot analysis.  However, all other antibodies were specific for porcine.   
The inconsistency between porcine and human ASC surface may be due to several 
factors effecting the in vitro culture environment.  It has been proposed that the expression 
pattern may not be reproducible because of cellular response to a hostile environment (Katz et 
al., 2005).  The exposure of cells to culture vessel plastic, the specific medium used, the 
duration of culture (i.e. passage number, cell cycle length), the seeding density or whether the 
cells have been cryopreserved prior to culture all could influence the phenotype of the cell as it 
adapts to this environment (Katz et al., 2005; Planat-Benard et al., 2004; Rehman et al., 2004).  
Another important factor is the tissue donor including the age of the donor and the physiological 
location of tissue collection.  Human ASCs are derived from processed liposuction aspirates 
where in this study porcine ASCs were harvested from subcutaneous biopsies.     
 The age of the donor dictates the life expectancy of the cells in culture (Cristofalo et al., 
1998).  This phenomenon is extremely important when selecting cells to be used as donor cells 
in NT.  The process of NT requires a donor cell with a normal diploid that has not yet reached 
senescence.  The establishment of an applicable genetically modified donor cell requires 
multiple PDs, which increases the probability that the cells will acquire cytokinetic abnormalities 
and chromosomal alterations. The use of an afflicted donor cell is most likely responsible for the 
production of abnormal embryos that do not survive and may be the culprit of extremely low 
success rates in NT. 
 Studies of chromosomal integrity through in vitro culture are quite limited at this time.  
Giraldo et al. in 2006 characterized the proliferative capacity and the chromosomal stability of 
bovine fetal fibroblasts.  The level of aneuploid cells was highly elevated with a mean value of 
47.9 + 5.5 immediately after the primary cultures were established (Giraldo et al., 2006).  As the 
cells progressed through culture the aneuploid levels dramatically increased (67.4 + 1.4 for 
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middle PDs and 85.0 + 4.3 for late PDs (Giraldo et al., 2006).  Our findings for porcine ASCs 
were very similar.  Porcine ASCs demonstrated an increased percentage of aneuploid cells 
directly from the initiation of culture with a mean value of 46.6 + 1.5.  The percentage of 
aneuploid cells significantly increased for middle PDs (87.0 + 2.8) and late PDs (94.4 + 4.1).  
We conclude that the assault to chromosomal stability clearly occurs after removing the cells 
from their in vivo environment, which is supported by such elevated levels of aneuploidy directly 
from the start in both bovine fetal fibroblasts and porcine ASCs.  The suboptimal culture 
conditions continue to corrode the genetic stability of the cells as they fight to survive in vitro 
culture through middle and late PDs as indicated by the significant increases in aneuploidy. 
 NT efficiency may significantly increase with the implementation of a method to select 
karyotypically normal diploid cells since approximately 50% of in vitro-cultured cells in early PDs 
are aneuploid.  However, the techniques available at this time for determining chromosomal 
content are terminally destructive to the cell.  Until new methodology can be discovered, it is 
advantageous to choose donor cells at younger PDs.  With this in mind, improving the methods 
for generating transfected cells for NT at younger PDs would also likely increase the efficiency 
of NT techniques.   
The availability of an animal model for somatic stem cells will aid in tissue regeneration, 
gene therapies and the development of other stem cell research techniques.  The differences 
found between porcine ASC and human ASC surface markers may be attributed to many 
factors including the location of the fat depot as well as the age of the donor.  Therefore care 
should be taken when interpreting results from animal models of somatic stem cells.   A 
selection procedure for younger NT donor cells will minimize chromosomal defects and increase 
reprogrammability necessary for healthy embryo production.  Continued research will be 
needed to identify a selection method as well as improve the manipulation of other cellular 
mechanisms involved in the process of NT. 
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CHAPTER V 
EPIGENETIC MODIFICATIONS OF CULTURED PORCINE ADIPOSE TISSUE-DERIVED 
STEM CELLS 
 
Introduction 
 
Currently, nuclear transfer results in relatively low success rates and investigators have 
reported substantial problems with the welfare of the cloned animals.  Developmental 
abnormalities observed following nuclear transfer define Large Offspring Syndrome or LOS and 
include low pregnancy rates, high percentages of loss during early and late pregnancy, 
stillbirths, early postnatal deaths, short life-span, obesity and malformations.  LOS may be 
caused by several factors such as using an inappropriate donor cell and/or recipient oocyte, the 
inability to properly synchronize the cell cycle phase of the donor nucleus and the recipient 
cytoplasm and inadequate reprogramming of the donor genome.  Also, the inappropriate 
handling of oocytes, somatic cells and embryos during maturation with the subjection of these 
cells to the various necessary manipulations and culture techniques could result in cellular 
stresses leading to LOS.   
A shift in research has focused on the epigenetic modifications of DNA and their role in 
embryonic development.  In the production of a normal developing embryo, the oocyte (arrested 
at metaphase II) is united with a sperm and completes meiosis and extrudes the second polar 
body.  The embryo contains a subset of cells that remain totipotent (can support differentiation 
into all cell types) for the first one to two cell divisions (Kono, 1997).  The following cleavage 
events undergo DNA modifications, which render them unable to form all tissue types and once 
initiated it is believed that the series of events proceeds beyond the point of no return.  
However, exposure of a donor cell’s chromatin to ooplasm as in nuclear transfer will redirect the 
programming of the donor nucleus to mimic that of a zygotic nucleus as in normal fertilization 
(Kikyo and Wolffe, 2000).  The oocyte virtually erases the epigenetic modifications imposed on 
the genome during differentiation and reinstates totipotency (Kikyo and Wolffe, 2000).  The 
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reprogramming of the donor cell nucleus is essential to initiate and complete embryonic 
development.   
Fusion with embryonic stem cells provides an alternative method for inducing nuclear 
reprogramming of somatic nuclei.  Factors within the embryonic stem cell, much like in the 
unfertilized oocyte, render a resultant hybrid cell, which demonstrates pluripotent competence 
by differentiation into multiple cell lineages and expression of tissue-specific genes (Cowan et 
al., 2005; Tada et al., 2001).  Several somatic cell types have been successfully reprogrammed 
upon fusion with embryonic stem cells including thymocytes (Tada et al., 2001), human 
fibroblasts (Cowan et al., 2005), and human myeloid precursor cells (Yu et al., 2006).  Research 
indicates that the nuclear compartment of the embryonic stem cell houses the reprogramming 
capability because fusion of karyoplasts and not cytoplasts generate the reprogrammed hybrid 
(Do and Scholer, 2004).         
    These reprogrammable epigenetics govern the regulation of repression of genes not 
necessary in cell types at specific developmental stages while preserving the DNA sequence 
(Wolffe and Matzke, 1999).  Epigenetic modifications during the reprogramming process 
following nuclear transfer include DNA methylation and posttranslational acetylation, 
phosphorylation and methylation of histone N termini that function to modulate chromatin 
structure, which ultimately regulates transcriptional activation or repression of specific genes. 
Acetylatable lysine residues in the N termini of histone H3 (such as K9, K14, K18, and K23) and 
H4 (such as K5, K8, K12, and K16) and methylatable lysine residues in H3 (such as K4, K9, 
K27, K36, and K79) and H4 (K20) are only a few that have been identified (Kimura et al., 2004).  
Histone acetyltransferases (HATs) are the enzymes responsible for the transfer of acetyl groups 
to lysine residues and histone deacetylases (HDACs) dictate their removal.  Acetylation 
neutralizes the positive amino acid charge decreasing the affinity for DNA.  The termini displace 
from the nucleosome increasing accessibility of transcription factors, which leads to gene 
expression (Grunstein, 1997).  Alternatively, DNA methyltransferases (Dnmts) coordinate 
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methyl group addition to DNA, which demarcates or “imprints” portions of DNA in order to 
distinguish between silenced and expressed genes of parental alleles (Cezar, 2003).   
H19, insulin-like growth factor II, and the insulin-like growth factor II receptor are 
examples of genes that display alternative DNA methylation patterns based on the inheritance 
of the allele either from the sperm or the oocyte (Kono, 1997). Generally, DNA methylation 
blocks transcription factors from binding the methylated sequences and is associated with 
transcriptional silencing and imprinting (Hiendleder et al., 2004b).  The transcription repressor 
protein, methyl CpG-binding protein-2 (MeCP2), binds methylated DNA which then as a 
complex recruits HDACs (Jones et al., 1998; Nan et al., 1998).  The removal of acetyl groups 
from histone tails increases histone affinity for DNA further preventing transcription factor 
accessibility (Cezar, 2003).   
In nuclear transfer, genes normally expressed during embryogenesis are silent in 
somatic donor cells and must be turned back on.  Therefore, the DNA methylation patterns must 
be reorganized to resemble that of undifferentiated nuclei (Rideout et al., 2001).  LOS and other 
phenotypic abnormalities may be a result of improper expression of imprinted genes as a result 
of reorganized DNA methylation (Kono, 1997).   
Regulators of development in undifferentiated cells are suggested to be silenced by the 
presence of a bivalent domain modification pattern in which a large region of histone 3 lysine 27 
trimethylation (H3K27me3) contains smaller regions of histone 3 lysine 4 trimethylation 
(H3K4me3) (Bernstein et al., 2006).  Important to the maintenance and pluripotency of stem 
cells, Polycomb-group proteins catalyze the H3K27me3 modification and Trithorax group 
proteins catalyze the H3K4me3 modification (Bernstein et al., 2006).  The dual marks contain 
both repressive (H3K27me3) and activating (H3K4me3) modifications, which work to silence 
developmental genes in embryonic stem cells while simultaneously keeping them receptive to 
activation.  As the cell differentiates, the bivalent conformation resolves where H3K4me3 
activating marks permit early-replicating gene expression and H3K27me3 repressing marks 
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block late-replicating gene expression in cells committed to a specific lineage (Boyer et al., 
2006; Meshorer and Misteli, 2006).   
Also of note, these developmental regulators contain highly conserved noncoding 
elements, which contain a wealth of H3K27me3 and H3K4me3 harboring bivalent domains 
(Bernstein et al., 2006).  These regions house genes responsible for encoding several 
transcription factors that function to maintain and regulate pluripotency and self-renewal in both 
early embryos and embryonic stem cells (Bernstein et al., 2006).  These factors include the 
POU (Pit/Oct/Unc) domain-containing protein Oct-4 (also known as Pou5fl) (Nichols et al., 1998; 
Niwa et al., 2000; Rosner et al., 1990; Scholer et al., 1990a; Scholer et al., 1990b), the high 
mobility group (HMG)-box protein Sox-2 (Avilion et al., 2003) and the homeoprotein Nanog 
(Chambers et al., 2003; Mitsui et al., 2003).  These three transcription factors function through 
very distinct pathways that are thought to converge to dictate early cell fate decisions (Boyer et 
al., 2006).  Recently, the conservation of these proteins among mammalian species has 
become apparent and Oct-4, Sox-2 and Nanog are considered markers of cells that have 
pluripotent capabilities.  Also, their association with highly conserved non-coding elements 
suggests a conserved role for the bivalent chromatin domains mentioned above (Bernstein et 
al., 2006).         
The initial epigenetic landscape of the DNA sequence determines the pluripotent 
capabilities of the cell.  Embryonic stem cells possess transcriptionally active chromatin that is 
structured in an open configuration containing an abundance of acetylated lysine residues 
(Boyer et al., 2006).  However, as the cell commits to a differentiation pathway, acetylated 
histone modifications decrease, heterochromatin formation ensues and pluripotential declines 
(Meshorer and Misteli, 2006; Meshorer et al., 2006).   
At this time, research has not identified epigenetic modifications in adult somatic MSCs 
from porcine adipose tissue.  Analysis of these cells may reveal global methylation and/or 
acetylation patterns similar to their embryonic stem cell counterparts.  Further characterization 
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of porcine ASCs in this manner could assist the isolation and purification of a population of 
MSCs from the easily obtainable tissue of adipose that can later be tested as donor cells in 
nuclear transfer.  Somatic cells used as donor cells in nuclear transfer typically produce more 
blastocyst stage embryos compared to embryos derived from embryonic stem cells (Rideout et 
al., 2001).  Approximately 60% of embryonic stem cells are in S-phase when used as donor 
cells (Rideout et al., 2001).  S-phase embryonic stem cells are exposed to high levels of 
maturation promoting factor, which induces premature nuclear envelope breakdown and 
chromosome condensation.  Cells likely undergo a second DNA replication cycle activating cell 
checkpoint mechanisms ultimately leading to inappropriate ploidy and cell cycle arrest.  
However, more embryonic stem cell nuclear transfer embryos develop to term than somatic cell 
nuclear transfer embryos (Rideout et al., 2001).  Although nuclear transfer clones produced 
from either embryonic stem cells or somatic cells demonstrate similar phenotypic abnormalities, 
term embryonic stem cell nuclear transfer clones indicate that utilization of a less differentiated 
donor cell may be more acquiescent to appropriate reprogramming (Rideout et al., 2001).   
Our overarching hypothesis is that low development rates observed following porcine 
nuclear transfer are a result of incomplete reprogramming of the donor cell nucleus and that 
somatic stem cells or those cells which demonstrate stem-like characteristics (i.e., ASCs) will be 
reprogrammed more completely.  New information concerning the nature of the epigenetic 
landscape will aid the efficiency of isolation and purification of a population of MSCs from the 
easily obtainable tissue of porcine adipose that can later be tested as donor cells in nuclear 
transfer.   
Materials and Methods 
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless 
otherwise stated. 
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Establishment of Primary Cultures and Cell Culture Maintenance 
Primary cultures were established following procedures previously documented 
(Williams et al., 2008).  Briefly, 10 g subcutaneous fat was harvested from the dorsal abdominal 
area in mature female cross-bred domestic pigs between the ages of 6 months to 1 year at a 
local abattoir.  The tissue was finely minced and washed with Dulbecco’s phosphate-buffered 
saline (dPBS) containing 200 U/ml of penicillin and 200 "g/ml of streptomycin and 2.5 "g/ml of 
Fungizone (Gibco).  Each sample was homogenized with an equal volume of 0.1% collagenase 
Type I (240 IU/ml; Gibco) in dPBS with 1% bovine serum albumin (BSA) in a shaker incubator 
rotating at 200 rpm at 39°C for 2 h.   
The cell suspension was filtered through a dual filter system comprised of two nylon net 
filters (20 "m and 180 "m) (Millipore, Bedford, MA, USA).  Cells were then stained with Hoechst 
33342 (2 "g/ml) to determine the number of nucleated cells in the suspension.  Cells were 
plated at 6,700 cells/cm2 in 10 ml of expansion medium containing Dulbecco’s Modified Eagle 
Medium (DMEM) (Hyclone, Logan, UT, USA) with high glucose supplemented with 10% fetal 
bovine serum (FBS) (Hyclone), 100 U/ml of penicillin and 100 "g/ml of streptomycin and 2.5 
"g/ml of Fungizone in a 150 cm2 culture flask and incubated at 39°C in 5% CO2.   
Fresh medium was supplied every 3 to 4 days.  When 70 to 90% confluence was 
achieved, the porcine adipose-derived stem cells (pASCs) were harvested by trypsinization, 
counted using a hemacytometer and re-seeded at an initial concentration of 6,700 cells/cm2.  
Cells were passaged until replicative senescence was noted.   
Differentiation of pASC Cultures 
 At 70 to 90% confluence (following passage 6), cells were passaged by trypsinization 
and cultured for 21 days in culture medium previously demonstrated to induce differentiation 
(Zuk et al., 2002; Gimble and Guilak, 2003).  Culture media were changed every 3 to 4 days 
throughout the study.  For adipogenesis, cells were cultured on days 1 to 4 in differentiation 
medium containing DMEM supplemented with 3% FBS, 100 U/ml of penicillin and 100 "g/ml of 
 94 
streptomycin, 2.5 "g/ml of Fungizone, 10 ng/ml of insulin, 10–9 M dexamethasone, 250 "M 
isobutyl methylxanthine and 0.2 mM indomethacin. Culture medium beyond day 4 contained 
DMEM with 3% FBS, 100 U/ml of penicillin and 100 "g/ml of streptomycin, 2.5 "g/ml of 
Fungizone, 10 ng/ml of insulin and 10–9 M dexamethasone.  For chondrogenesis, cells were 
cultured for the duration of differentiation in medium containing DMEM with 10% FBS, 100 U/ml 
of penicillin and 100 "g/ml of streptomycin, 2.5 "g/ml of Fungizone, 6.25 "g/ml of insulin, 10 
ng/ml of transforming growth factor-! and 10–9 M dexamethasone.  For osteogenesis, cells were 
cultured in differentiation medium containing DMEM with 10% FBS, 100 U/ml of penicillin and 
100 "g/ml of streptomycin, 2.5 "g/ml of Fungizone, 10 mM !-glycerophosphate, 50 ng/ml of 
ascorbic acid and 10–9 M dexamethasone.  
 Histological staining techniques were used to determine differentiation. Nile Red, a stain, 
which detects intracellular lipid accumulation, was used to determine adipocyte differentiation.  
Safranin O was utilized to identify glycosaminoglycans in the extracellular matrix of 
differentiated chondrocytes. After osteogenic induction, Alizarin Red S was employed to detect 
mineralized calcium deposition.  
Stem Cell Surface Immunolabeling for Methylated DNA and Acetylated Histone H3 
 Porcine ASCs were harvested by trypsinization, washed and resuspended in dPBS.  The 
protocol established by Habib et al. (1999) was used to fix and immunolabel cells.  Briefly, 
pASCs were permeated by 3 washes in a dPBS solution containing 1% BSA and 0.1% Tween-
20 (PBST-BSA).  pASCs were then fixed in a 0.25% paraformaldehyde solution for 10 min at 
37˚C and then stored in 90% cold methanol at  -20˚C at least overnight.  Following two washes 
in PBST-BSA, cells were treated with 2N HCl for 30 minutes at 37˚C.  A 0.1M boric acid buffer 
(pH 8.5) was used to neutralize the fixative for 5 minutes at room temperature.  pASCs were 
washed 3 times in a dPBS solution containing 1% BSA and incubated in the last wash for 30 
minutes at room temperature to block nonspecific binding sites.  For methylated DNA, pASCs 
were incubated first in dPBS with 5 "g/ml mouse anti-5-methylcytidine (AbDSerotec, Oxford, 
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UK; Catalog # MCA2201) for 30 min at room temperature followed by incubation in dPBS with 
20 "g/ml Alexa Flour® 488 goat anti-mouse IgG (H+L) (Carlsbad, CA, USA; Catalog # A11001) 
for 30 minutes at room temperature.   For acetylated histone H3, pASCs were incubated first in 
dPBS with 10 "g/ml anti-acetyl-Histone H3 (rabbit polyclonal IgG) (Millipore, Temecula, CA; 
Catalog # 06-599) for 30 minutes at room temperature followed by incubation in dPBS with 20 
"g/ml Alexa Flour® 488 goat anti-rabbit IgG (H+L) (Carlsbad, CA, USA; Catalog # A11008) for 
30 min at room temperature.   pASCs were then counterstained in a 0.112% sodium citrate 
solution containing 50 "g/ml propidium iodide and 10 "g/ml RNase for 30 min at room 
temperature.  pASCs were washed and resuspended in dPBS at a concentration of 
approximately 1 x 106 pASCs/ml for flow cytometric analysis.  A portion of cells was observed 
under 100x magnification to verify antibody specificity for nuclear localization (Figure 5.3). 
Flow Cytometric Analysis of Epigenetic Modifications 
 Samples were analyzed for relative levels of methylated DNA and acetylated histone H3 
using the AccuriTM C6 Flow Cytometer® (Accuri Cytometers, Ann Arbor, MI, USA).  At each 
passage (1, 2, 3, 4, 5, 7 and 9) for every line analyzed (FPF 1, 2, 3 and 4, and pASC 1, 2, 3 and 
4), at least 10,000 cumulative events were collected. Labeled cells were excited with a 488 nm 
diode laser and a >670 nm band pass filter was used to detect PI levels (FL3-channel).  The 
DNA content derived from the PI levels was used to gate cells in G0/G1 phase (FL3-channel).  
Total methylated DNA and acetylated histone H3 levels in G0/G1 cells were then detected in the 
FL1-channel at 530/30 nm.  Dot plots and histograms were derived using the Accuri CFlow 
Plus® (Accuri Cytometers, Ann Arbor, MI, USA) software.  Positive fluorescent events detected 
in the FL1-channel were designated a mean value generated by the software and recorded as 
arbitrary fluorescence units (AFU).        
RNA Extraction and RT-PCR for Chromatin Remodeling Proteins 
 Total pASC and fetal porcine fibroblast (FPF) messenger RNA was isolated from 
approximately 1 x 106 cells using the TRI-Reagent® RNA/DNA/Protein Isolation Reagent 
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(Molecular Research Center, Inc., Cincinnati, OH) according to the manufacturer’s instructions.  
Briefly, media was discarded from cultured pASCs and FPFs grown in a monolayer.  The TRI 
reagent was added to monolayers and allowed to incubate at room temperature for 5 minutes.  
Cell lysates were passed several times through a pipette and transferred to 15 ml phase lock 
tubes.  The BCP reagent (1-bromo-3 chloropropane) was then added to the lysates, shaken 
vigorously and incubated at room temperature for 1 hour.  Lysates were centrifuged at 12,000 x 
g for 15 minutes at 4°C to separate phases in which the upper transparent aqueous phase was 
transferred to a clean 15 ml centrifuge tube.  Isopropanol was added to the aqueous phase and 
shaken to extract the RNA.  Samples were stored at -20°C overnight and centrifuged at 12,000 
x g for 20 minutes at 4°C the following day.  The RNA pellet was then washed with 75% ethanol 
made with DEPC treated water, air dried and then resuspended in DEPC treated water.  
Extracted total RNA was stored in -20°C for approximately 3 months and then reverse 
transcribed using the iScript® cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA) according to the manufacturer’s instructions.  The iScript® reverse transcription (RT) 
reaction volume was carried out in 20 µl total and contained 4 µl of iScript® reaction mix, 15 µl of 
mRNA and 1 µl reverse transcriptase.  Reaction mixes were concocted for each sample and a 
no reverse transcriptase negative control.  Negative control reactions were analyzed by gel 
electrophoresis to verify the absence of contaminating genomic DNA (data not shown).         
Quantitative Real Time PCR for Chromatin Remodeling Proteins 
 PCR primers were designed using the Beacon Designer 4.0 (PREMIER Biosoft 
International, Palo Alto, CA, USA) software for the amplification of DNA methyltransferase 1 
(Dnmt1), Dnmt3a, histone deacetylase 1 (HDAC1), methyl CpG-binding protein-2 (MeCP2) and 
the reference gene polyadenylate polymerase (Poly A) from both porcine and bovine gene 
sequences (Table 5.1).  cDNA was amplified in a reaction mix with a total volume of 25 µl 
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Table 5.1. Oligonucleotide PCR primers for real time quantitative PCR 
Gene Forward/Reverse 
Accession  
Number 
Primer 
Amplicon  
length (bp) 
Gene Expression Analysis of Chromatin Remodeling Proteins 
pDnmt1 
 
F NM_001032355 CAGACAAGTGGTGAGGAC 186 
 R  TGTGAAATGAGATGTGATGG  
pDnmt3a 
 
F DQ785811 CCCGAAAGAGCACAACTG 119 
 R  GCACATTCCTCCGATGAAG  
pHDAC1 
 
F AK230658 CATCTGGCTTCTGTTACG 139 
 R  ACTCGGTCTGTGGTATAG  
bMeCP2 
 
F XM_588477 CCGCTGGGAAGTATGATGTG 191 
 R  GGGAGATTTGGGCTTCTTAGG  
pPolyA 
 
F AK233143 GACTGACTGCCTGCTTACAC 137 
 R  TTTCTCGTATCCACTCTTTGACC  
     
Chromatin Immunoprecipitation Analysis of Pluripotent Transcription Factors 
pOCT4 Proximal 
 
F NC_010449 CAGAGGTCAAGGCTAGTG 214 
 R  CCAGGTCCGAGGATCAAC  
pOCT4 Distal 
 
F NC_010449 GGTGTCCGATTGATTCCTC 200 
 R  GCCCAGCCTATTAGATTCC  
pNANOG Proximal* 
 
F EF522119 AATTCGCAAGGGTGTGTGTG 128 
 R  CAGGAGCTAACCACCCCAAT  
pNANOG Distal* 
 
F EF522119 AGCTCATGGCAACGCTAGAT 115 
 R  TGACAGGAGTTTCCATCGTG  
p = porcine; b = bovine; Dnmt = DNA methyltransferase; HDAC = histone deacetylase; MeCP = methyl CpG-binding 
protein; PolyA = polyadenylate polymerase. 
      *Miyamoto et al., (2009).
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containing 12.5 µl iQTMSYBR Green Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, USA), 
2 µl cDNA, 8.5 µl nuclease-free water and 1 µl each of sense and antisense primers (20 pmol) 
for each gene.  Reaction mixes were concocted for each sample, a calibrator (derived from 
porcine muscle tissue) and a no reverse transcriptase negative control.  Quantitative real time 
PCR (qPCR) was performed for all genes including the reference gene Poly A in the MyiQ 
Reverse Transcription PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA, USA) 
using the program consisting of a denaturing cycle of 3 minutes at 95°C, 40 cycles of PCR (10 
seconds at 95°C, 45 seconds at 55°C and 1 minute at 95°C), a melting curve for 1 minute at 
95°C followed by 1 minute at 55°C, a step cycle starting at 55°C for 10 seconds with a 
0.5°C/second transition rate, and a constant cooling cycle held at 4°C.   
 Livak and Schmittgen describe the comparative quantification cycle (Cq) method used to 
analyze qPCR data (Livak and Schmittgen, 2001).  The data is reported as an n-fold change in 
gene expression relative to the calibrator.  The Cq of the reference gene Poly A was used to 
normalize the target gene Cq in each sample.  The !Cq for the transcription of each gene was 
then calibrated against cells from porcine muscle tissue.  The mean fold change in expression 
of the target gene relative to the calibrator was calculated by 2-!!Cq and presented as fold 
change in target gene expression.     
All primers were validated for annealing temperature by performing an annealing 
temperature gradient and subsequent analysis by gel electrophoresis (data not shown).  Also, 
primers were validated for the amplification of a single product in a quantitative manner, 
efficiency level, correlation coefficient and melting curves of cDNA at five different dilutions 
using qPCR (Figure 5.1).  All target genes analyzed generated efficiencies between 95 to 113% 
and correlation coefficients between 0.99 to 1.00.          
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B.
  
     C. 
 
Figure 5.1 Primer validation.  Representative melt curve (A), threshold cycle (Ct) values (B) and 
standard curve (C) derived from a 1:10 template dilution series for the validation of forward and 
reverse primers.
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Chromatin Immunoprecipitation 
 Chromatin immunoprecipitation (ChIP) assays were carried out according to the protocol 
described by Dahl and Collas (Dahl and Collas, 2008) with a few modifications.  Cells were 
harvested by trypsinization as per standard protocol described above.  Cells were counted using 
a hemacytometer and approximately 2.5 x 106 cells were allocated to the ChIP assay.  The use 
of sodium butyrate in all solutions and buffers throughout the protocol was eliminated on the 
basis that the epigenetic modification under investigation was not histone acetylation.  Cells 
were resuspended in 500 µl PBS.  DNA-protein crosslinking was performed by 
paraformaldehyde (1% v/v), vortexed gently and incubated at room temperature for 8 minutes.  
The reaction was terminated with the addition of glycine (125 mM final concentration) and 
incubated at room temperature for 5 minutes.   
Sonication of chromatin was performed on a Branson Sonifier 250 Duty cycle 40% Level 
4 for 10 times 20 pulses on ice with a 1 minute pause in between each set of 20 pulses.  
Preparation of antibody-bead complexes was performed by incubating 11 !l well-suspended 
protein A bead stock from Millipore MagnaChIP kit (Millipore, Billerica, MA, USA, Catalog 
#MAGNA001) with 2.4 !g of antibody at 4°C for 2 hours at 40 rpm in a hybridization oven.  
Chromatin was immunoprecipitated by incubating 100 !l diluted chromatin with the antibody-
bead complexes at 4°C overnight at 40 rpm in a hybridization oven.  The DNA was eluted per 
Dahl and Collas protocol and isolated using the spin filter columns provided in the Millipore 
MagnaChIP kit following the manufacturer’s instructions.   
PCR primers were designed using the Beacon Designer 4.0 (PREMIER Biosoft 
International, Palo Alto, CA, USA) software for the amplification of a proximal and distal region 
from the initiation of transcription within the promoter regions of both Oct-4 and Nanog (Table 
5.1).  cDNA was amplified in a reaction mix with a total volume of 25 µl containing 12.5 µl 
iQTMSYBR Green Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, USA), 2 µl cDNA, 8.5 µl 
nuclease-free water and 1 µl each of sense and antisense primers (20 pmol) for each gene.  
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Reaction mixes were concocted for each sample, a calibrator (derived from porcine muscle 
tissue) and a no reverse transcriptase negative control.  Quantitative real time PCR (qPCR) was 
performed for all genes including the reference gene Poly A in the MyiQ Reverse Transcription 
PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using the program 
consisting of a denaturing cycle of 3 minutes at 95°C, 40 cycles of PCR (10 seconds at 95°C, 
45 seconds at 55°C and 1 minute at 95°C), a melting curve for 1 minute at 95°C followed by 1 
minute at 55°C, a step cycle starting at 55°C for 10 seconds with a 0.5°C/second transition rate, 
and a constant cooling cycle held at 4°C.   
We present the data as fold enrichment of precipitated DNA associated with either 
H3K4me3 or H3K27me3 relative to a 1/100 dilution of input chromatin representing the 
percentage of precipitate material relative to the amount in the input sample. 
Experimental Design  
 Four cell lines each were established for porcine ASCs and porcine FPFs.  Cells were 
cultured until senescence was reached.   At each passage analyzed, cells were trypsinized and 
re-seeded at 30 to 40% confluence to avoid possible contact inhibition and differentiation.  
Passaged lines were cultured until 70 to 90% confluence was reached.  Following passage 6, a 
portion of pASC cell lines were cultured under differentiation conditions to assess the stem cell 
characteristics following that duration through in vitro culture.  Relative levels of methylated DNA 
and acetylated histone H3 as well as levels of chromatin remodeling protein expression were 
analyzed for both porcine ASCs and porcine FPFs at each passage.  These data are reported 
for each passage analyzed, however, the population doublings at each passage for each 
respective cell type is different based on their growth characteristics (PD 3, 5, 7, 10, 12 and 16 
respectively for FPFs and PD 1, 3, 5, 7, 8, 10 and 11, respectively, for pASCs).  
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Figure 5.2. Porcine fibroblasts and pASCs stained with anti-5-methylcytidine and anti-acetyl-
histone H3.  pASCs stained with anti-acetyl-histone H3 (A and E), counterstained with PI (B and 
F), anti-5-methylcytidine (C and G) and counterstained with PI (D and H).  FPFs stained with 
anti-acetyl-histone H3 (I), counterstained with PI (J), anti-5-methylcytidine (K) and 
counterstained with PI (L).
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Statistical Analysis 
 In this study, chi-square analysis was employed to karyotypic data in order to determine 
statistical differences between cell lines (pASC 1, pASC 2 and pASC 3) and PD (PD 1-10, PD 
11-20 and PD 21-30).  For this test, a P < 0.05 was considered significant.  Data were analyzed 
using the SigmaStat Statistical Software Version 3.5 (Systat Software, Inc., San Jose, CA, 
USA).  For DNA methylation and histone acetylation, student’s t-test was used to determine 
statistical differences between cell types using a P value of < 0.05.  Also, Tukey’s test was used 
to determine statistical differences between passages using a P value of < 0.05.  For chromatin 
remodeling protein gene expression data, the Proc Mixed with repeated measures procedure 
was used in SAS statistical software to determine statistical differences between cell type and 
passages.   
Results 
Differentiation of pASCs 
 Following passage 6, a portion of pASCs was cultured in differentiation conditions for 
adipogenesis, chondrogenesis and osteogenesis.  All four pASC cell lines successfully 
differentiated under adipogenic, chondrogenic and osteogenic conditions (data not shown).  
Cells cultured under adipogenic conditions stained positive for intracellular lipids.  Chondrogenic 
induction generated cells that stained positive for the presence of glycosaminoglycans.  Lastly, 
osteogenic differentiation was detected by the presence of calcium deposition in cultured cells.    
Antibody Specificity for Methylated DNA and Acetylated Histone H3 
 Epifluorescence microscopy reveals the specificity of high intensity staining for anti-
acetyl-histone H3 and anti-5-methylcytidine to the nuclear compartment for pASCs (Figure 5.2 A 
and C, respectively).  Counterstaining with PI confirmed the site of the fluorescent staining by 
corresponding to DNA detected within the nucleus (Figure 5.2 B and D).  A degree of 
cytoplasmic fluorescence can be observed in both pASCs (Figure 5.2 A, C, E and G) and FPFs 
(Figure 5.2 I and K), which may contribute to background fluorescence.  
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Table 5.2. Levels of Methylated DNA in FFs and ASCs through in vitro culture 
Methylated DNA (AFU) + SEM 
Cell Line 
P1 P2 P3 P4 P5 P7 P9 
FPF 1 
 
3990 2700 3106 2480 3264 2744  
FPF 2 
 
6510 5782 3984 5214 5993 2972  
FPF 3 
 
6691 4724 3691 3350 3031 2946  
FPF 4 
 
7337 4360 4213 5100 5515 3241  
Mean 
 
6132  
    + 736a,1 
4391  
     + 639a,1,2 
3749  
      + 239a,1,2 
4036  
      + 671a,1,2 
4451  
      + 760a,1,2 
2976  
    + 102a,2 
 
pASC 1 
 
8856 1836 1110 1001 1834 1965 6187 
pASC 2 
 
5236 1864 1034 1044 1599 2506 9336 
pASC 3 
 
8941 1346 1692 1422 2069 1961 4003 
pASC 4 
 
4901 2210 1342 1152 1675 1551 101 
Mean 6984   
      + 1108a,1 
1814  
     +178b,1,2 
1294  
     + 148b,2 
1155  
   + 94b,2 
1794  
      + 104b,1,2 
1996  
      + 196b,1,2 
4907  
      + 19401,2 
AFU, arbitrary fluorescence units; SEM, standard error of the mean.  
Different letters (a and b) within columns indicate significant difference between cell types.  
Different numbers (1 and 2) within rows indicate significant difference between passages. 
Student’s t-test was used to determine statistical differences between cell types (P < 0.05). 
Tukey’s test was used to determine statistical differences between passages (P < 0.05).
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 Table 5.3. Levels of Acetylated Histone H3 in FFs and ASCs through in vitro culture 
Acetylated Histone H3 (AFU) + SEM 
Cell Line 
P1 P2 P3 P4 P5 P7 P9 
FPF 1 
 
7392 7809 8644 3369 4269 3261  
FPF 2 
 
7597 9232 7384 4142 4646 3955  
FPF 3 
 
8654 6654 7108 1372 4526 2931  
FPF 4 
 
9029 6489 6330 3419 4039 3099  
Mean 
 
8168  
    + 399a,1 
7546  
    + 634a,1 
7366  
    + 481a,1 
3076  
    + 595a,2 
4370  
    + 136a,2 
3312  
    + 225a,2 
 
pASC 1 
 
17145 11654 4321 3173 4516 3124 12090 
pASC 2 
 
10248 8997 5571 3063 3668 3061 13725 
pASC 3 
 
9811 7150 5377 2793 3558 3284 5883 
pASC 4 
 
8126 7536 5170 2621 3270 2108 5017 
Mean 11333  
      + 1991a,1,2 
8834  
      +1020a,1,2 
5109  
      + 275b,1,2,3 
2913  
    + 126a,3 
3753  
      + 268a,1,2,3 
2894  
      + 266a,2,3 
9179  
        + 21861,2,3 
AFU, arbitrary fluorescence units; SEM, standard error of the mean.  
Different letters (a and b) within columns indicate significant difference between cell types.  
Different numbers (1, 2 and 3) within rows indicate significant difference between passages. 
Student’s t-test was used to determine statistical differences between cell types (P < 0.05). 
Tukey’s test was used to determine statistical differences between passages (P < 0.05).
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Figure 5.3. Global levels of methylated DNA and acetylated histone H3 in FPFs and pASCs at different passages.  Cells gated in 
G0/G1 cell cycle stage based on PI counterstaining were designated a software-generated mean value.  Each value was graphed for 
each of four cell lines and analyzed for FPF DNA methylation (A), FPF histone H3 acetylation (B), pASC DNA methylation (C) and 
pASC histone H3 acetylation (D).   
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Levels of Methylated DNA and Acetylated Histones in Porcine ASCs 
 Methylated DNA levels significantly decreased within the first passage for fibroblast cell 
lines FPF 1, 2, 3 and 4 gated in G0/G1 cell cycle stage (Table 5.2; Figure 5.3 A).  However, the 
four lines appeared to diverge after passage 3 with methylated DNA levels remaining low for cell 
lines FPF 1 and 3 and increasing for cell lines FPF 2 and 4 before a decrease to lower levels at 
passage 7 (Figure 5.3 A).  Relative levels of DNA methylation for pASCs also decreased 
significantly between passage 1 and passage 3 and remained low through culture (Table 5.2; 
Figure 5.3 C).  As an average, pASC methylation levels were significantly lower than FPF levels 
from passage 2 through passage 7 (Table 5.2).   
 Levels of acetylated histone H3 for cells gated in G0/G1 cell cycle stage for FPF cell 
lines did not demonstrate a similar pattern between all four lines (FPF 1, 2, 3 and 4) through 
culture but all together did show a significant decrease in mean AFUs after passage 3 (Table 
5.3; Figure 5.3 B).  pASCs were hyperacetylated at passages 1 through 3 when mean relative 
levels significantly dropped at passage 4 (Table 5.2; Figure 5.3 D).  When compared to FPFs, 
mean levels of acetylated histone H3 were significantly lower for pASCs only at passage 3, 
where as at all other passages analyzed the means were similar. 
Analysis of Chromatin Remodeling Proteins Transcript Levels 
 mRNA levels for chromatin remodeling proteins Dnmt1, Dnmt3a, HDAC1 and MeCP2 
were analyzed through RT-PCR.  A mean fold change in gene expression relative to the 
calibrator and normalized with Poly A was determined for all four genes in FPFs and pASCs 
across passages 1, 2, 3, 4, 5, 7 and 9.  Dnmt1 expression in pASCs increases through passage 
3 and then tapers off during passage 3 through passage 9 (Table 5.4; Figure 5.4 A).  FPF 
expression levels of Dnmt1 do not appear to follow any specific pattern through culture.  The 
nature of passage 1 Dnmt1 expression level data is difficult to interpret and from passage 2 on 
the levels oscillate up and down (Table 5.4; Figure 5.4 A).  However, when comparing the pASC 
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Dnmt1 expression pattern through culture to that of FPF, the levels are generally lower (Table 
5.4; Figure 5.4 A).  
Dnmt3a expression in pASCs follows a similar pattern to the expression of Dnmt1.  
Through passage 3, Dnmt3a expression levels increase and then begin to decrease after 
passage 3 through passage 9 (Table 5.5; Figure 5.4 B).  Again, FPF expression levels of 
Dnmt3a, similar to Dnmt1, do not follow a noted trend through culture (Table 5.5; Figure 5.4 B).  
The Dnmt3a pattern of the FPFs is less consistent than the pASC pattern and again the pASC 
levels are relatively lower than FPF levels (Table 5.5; Figure 5.4B).  Also, for both cell types the 
expression level for Dnmt3a as a whole is lower than that of Dnmt1.   
 The transcript levels for HDAC1 remained generally low throughout culture for both 
pASCs and FPFs with the exception of passage 1 and 9 for FPFs (Table 5.6; Figure 5.4 C).   
MeCP2 expression levels in pASCs, as expected, follow a similar trend through in vitro culture 
as Dnmt1 and Dnmt3a.  Transcripts levels increase through passage 3 and are followed by 
subsequent decrease through passage 9 (Table 5.7; Figure 5.4 D).  The abundance of MeCP2, 
as a whole, is more comparable to that of Dnmt1 hovering around a 1-fold change relative to the 
calibrator, whereas Dnmt3a levels are all under a 0.5-fold change (Tables 5.4, 5.5, 5.7; Figure 
5.4).  FPF expression levels of MeCP2 again are less consistent and do not follow any sort of 
trend through culture (Table 5.7; Figure 5.4 D).  pASC expression levels of MeCP2 are lower 
when compared to the expression levels in FPF (Table 5.7; Figure 5.4 D).    
Chromatin Immunoprecipitation of H3K4me3 and H3K27me3 Promoter Regions 
 Bivalent domains within the promoter regions work to silence developmentally important 
transcription factors while simultaneously keeping them poised for activation.  We analyzed 
pASCs for the presence of the repressive H3K27me3 epigenetic modification and the activating 
H3K4me3 epigenetic modification within the promoter region of Oct-4 and Nanog.  Preliminary 
evidence suggests that pASCs do, in fact, possess this bivalent chromatin structure in the 
proximal promoter region of Oct-4 with a value of 27.97 + 13.56 for H3K4me3, as derived as a  
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Table 5.4. Average Relative Transcript Levels of DNA methyltransferase 1 in FPFs and pASCs through In Vitro Culture 
Fold Change in Dnmt1 Expression + SEM 
Cell Line 
P1 P2 P3 P4 P5 P7 P9 
FPF 1 
 
  39.79  
     + 31.80 
0.30  
   + 0.05 
1.83  
   + 0.24 
1.03  
   + 0.13 
1.76  
   + 0.35 
3.02  
   + 0.28 
0.80  
   + 0.08 
FPF 2 
 
          0.66  
   + 0.45 
0.18  
   + 0.02 
1.93  
   + 0.58 
1.30  
   + 0.37 
2.63  
   + 0.90 
1.26  
   + 0.35 
0.00  
   + 0.00 
FPF 3 
 
16.17  
    + 11.46 
0.20  
   + 0.03 
4.08  
   + 1.39 
0.87  
   + 0.11 
1.22  
   + 0.09 
1.30  
   + 0.27 
0.70  
   + 0.08 
FPF 4 
 
0.41  
  + 0.07 
0.12  
   + 0.01 
1.07  
   + 0.13 
1.12  
   + 0.12 
1.08  
   + 0.03 
1.17  
    + 0.04 
0.57  
   + 0.07 
Mean 
 
 14.26  
     + 9.281,a 
0.20  
      + 0.042,a 
 2.23  
      + 0.652,a 
1.08  
      + 0.092,a 
1.67  
      + 0.352,a 
1.69  
       + 0.452,a 
0.52  
   + 0.182 
pASC 1 
 
0.34  
   + 0.05 
0.23  
   + 0.03 
2.85  
   + 0.38 
0.46  
   + 0.03 
0.33  
   + 0.04 
0.36  
   + 0.03 
0.28  
   + 0.01 
pASC 2 
 
0.39  
   + 0.05 
0.30  
   + 0.03 
1.42  
   + 0.22 
0.69  
   + 0.05 
0.65  
   + 0.09 
0.72  
  + 0.04 
0.32  
   + 0.01 
pASC 3 
 
0.39  
   + 0.06 
0.56  
   + 0.07 
0.33  
   + 0.04 
0.84  
   + 0.06 
0.91    
   + 0.15 
0.43  
   + 0.05 
0.23  
   + 0.01 
pASC 4 
 
0.20  
   + 0.03 
0.36  
   + 0.02 
1.87  
   + 0.41 
0.52  
   + 0.52 
0.37  
   + 0.04 
0.36  
   + 0.05 
0.24  
   + 0.04 
Mean 0.33  
      + 0.041,a 
0.36  
      + 0.071,a 
1.62  
      + 0.521,a 
0.63  
      + 0.091,b 
0.57  
     + 0.141,b 
0.47  
      + 0.091,b 
0.27  
   + 0.021 
SEM, standard error of the mean.  
Different letters (a and b) within columns indicate significant difference between cell types.  
Different numbers (1 and 2) within rows indicate significant difference between passages. 
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Table 5.5. Average Relative Transcript Levels of DNA methyltransferase 3a in FPFs and pASCs through In Vitro Culture 
Fold Change in Dnmt3a Expression + SEM 
Cell Line 
P1 P2 P3 P4 P5 P7 P9 
FPF 1 
 
2.50  
   + 2.15 
0.17  
   + 0.06 
0.32  
   + 0.03 
0.25  
   + 0.08 
0.31  
   + 0.15 
1.73  
   + 0.58 
0.07  
   + 0.01 
FPF 2 
 
0.03  
   + 0.01 
0.08  
   + 0.03 
0.25  
   + 0.04 
0.29  
   + 0.02 
0.30  
   + 0.02 
0.33  
   + 0.10 
0.00  
   + 0.00 
FPF 3 
 
0.66 
   + 0.62 
0.19  
   + 0.09 
0.47  
   + 0.07 
0.16  
   + 0.06 
0.34  
   + 0.01 
0.19  
   + 0.05 
0.70  
   + 0.05 
FPF 4 
 
0.27 
   + 0.01 
0.12  
   + 0.08 
0.12  
   + 0.01 
0.15  
   + 0.03 
0.30  
   + 0.02 
0.17  
   + 0.03 
0.69  
   + 0.02 
Mean 
 
0.86 
      + 0.561,a 
0.14  
      + 0.032,a 
0.29  
      + 0.072,a 
0.21  
      + 0.032,a 
         0.31  
      + 0.012,a 
0.60  
      + 0.381,a 
0.36  
      + 0.191,a 
pASC 1 
 
0.09 
   + 0.02 
0.04  
   + 0.02 
0.54  
   + 0.37 
0.03  
   + 0.03 
0.02  
   + 0.01 
0.01  
   + 0.00 
0.04  
   + 0.02 
pASC 2 
 
0.07 
   + 0.01 
0.08  
   + 0.01 
0.21  
   + 0.04 
0.07  
   + 0.01 
0.08  
   + 0.01 
0.14  
   + 0.02 
0.07  
   + 0.02 
pASC 3 
 
0.07  
   + 0.02 
0.14  
   + 0.03 
0.11  
   + 0.01 
0.20  
   + 0.02 
0.12  
   + 0.02 
0.06  
   + 0.02 
0.04  
   + 0.01 
pASC 4 
 
0.04  
   + 0.01 
0.04  
   + 0.02 
0.41  
   + 0.41 
0.11  
   + 0.03 
0.06  
   + 0.01 
0.05  
   + 0.01 
0.05  
   + 0.01 
Mean 
 
0.07  
      + 0.011,a 
         0.07  
     + 0.021,a 
       0.32  
      + 0.101,a 
0.10   
      + 0.041,a 
0.07  
      + 0.021,b 
0.06  
      + 0.031,a 
0.05  
      + 0.011,a 
SEM, standard error of the mean.  
Different letters (a and b) within columns indicate significant difference between cell types.  
Different numbers (1 and 2) within rows indicate significant difference between passages. 
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Table 5.6. Average Relative Transcript Levels of Histone Deacetylase 1 in FPFs and pASCs through In Vitro Culture 
Fold Change in HDAC1 Expression + SEM 
Cell Line 
P1 P2 P3 P4 P5 P7 P9 
FPF 1 
 
 13.93  
     + 13.15 
0.12  
   + 0.01 
0.28  
   + 0.04 
0.19  
   + 0.03 
0.26  
   + 0.05 
0.54  
   + 0.05 
0.11  
   + 0.00 
FPF 2 
 
0.02  
   + 0.02 
0.15  
   + 0.03 
0.35  
   + 0.05 
0.23  
   + 0.05 
0.52  
   + 0.19 
0.24  
   + 0.06 
1.44  
   + 1.18 
FPF 3 
 
0.14  
   + 0.14 
0.13  
   + 0.03 
1.07  
   + 0.37 
0.17  
   + 0.01 
0.25  
   + 0.01 
0.23  
   + 0.03 
0.78  
   + 0.08 
FPF 4 
 
0.12  
   + 0.02 
0.06  
   + 0.00 
0.20  
   + 0.01 
0.26  
   + 0.02 
0.18  
   + 0.01 
0.25  
   + 0.02 
0.85  
   + 0.09 
Mean 
 
3.55  
      + 3.461,a 
0.11  
      + 0.022,a 
0.48  
      + 0.202,a 
0.21  
      + 0.022,a 
0.30  
      + 0.072,a 
0.32  
      + 0.082,a 
0.80  
      + 0.272,a 
pASC 1 
 
0.16  
   + 0.02 
0.12  
   + 0.01 
0.53  
   + 0.09 
0.15  
   + 0.01 
0.08  
   + 0.01 
0.13  
   + 0.01 
0.13  
   + 0.00 
pASC 2 
 
0.18  
   + 0.03 
0.13  
   + 0.01 
0.35  
   + 0.07 
0.17  
   + 0.01 
0.11  
   + 0.01 
0.35  
   + 0.02 
0.14  
   + 0.01 
pASC 3 
 
0.19  
   + 0.01 
0.21  
   + 0.01 
0.14  
   + 0.01 
0.23  
   + 0.01 
0.16  
   + 0.02 
0.13  
   + 0.01 
0.11  
   + 0.00 
pASC 4 
 
0.11  
   + 0.01 
0.32  
   + 0.01 
0.27  
   + 0.11 
0.14  
   + 0.03 
0.10  
   + 0.01 
0.14  
   + 0.02 
0.08  
   + 0.01 
Mean 
 
0.16  
      + 0.021,a 
0.20  
      + 0.041,a 
0.32  
      + 0.081,a 
0.17  
      + 0.021,a 
0.11  
      + 0.021,b 
0.19  
      + 0.051,a 
0.12  
      + 0.011,b 
SEM, standard error of the mean.  
Different letters (a and b) within columns indicate significant difference between cell types.  
Different numbers (1 and 2) within rows indicate significant difference between passages. 
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Table 5.7. Average Relative Transcript Levels of Methyl CpG-Binding Protein-2 in FPFs and pASCs through In Vitro Culture 
Fold Change in MeCP2 Expression + SEM Cell 
Line P1 P2 P3 P4 P5 P7 P9 
FPF 1 
 
  68.95  
     + 33.65 
0.75  
   + 0.12 
1.89  
   + 0.15 
1.28  
   + 0.07 
2.08  
   + 0.20 
8.03  
   + 1.73 
0.98  
   + 0.08 
FPF 2 
 
2.32  
   + 0.75 
0.38  
   + 0.05 
2.30  
   + 0.32 
1.43  
   + 0.30 
2.41  
   + 0.87 
3.58  
   + 1.00 
    260.66  
       + 169.19 
FPF 3 
 
    283.70  
       + 279.83 
0.46  
   + 0.08 
5.90  
   + 2.03 
1.11  
   + 0.11 
1.16  
   + 0.08 
2.39  
   + 0.13 
4.29  
   + 0.48 
FPF 4 
 
0.33  
   + 0.05 
0.15  
   + 0.01 
1.12  
   + 0.11 
1.24  
   + 0.09 
1.02  
   + 0.13 
2.11  
   + 0.15 
7.02  
   + 0.37 
Mean 
 
  88.83  
        + 66.891,a 
0.44  
      + 0.122,a 
2.80  
      + 1.062,a 
1.26  
      + 0.072,a 
1.67  
      + 0.342,a 
4.03  
      + 1.372,a 
  68.24  
        + 64.151,a 
pASC 1 
 
0.48  
   + 0.08 
0.57  
   + 0.04 
3.55  
   + 0.69 
0.53  
   + 0.09 
0.25  
   + 0.02 
0.36  
   + 0.01 
0.54  
   + 0.08 
pASC 2 
 
0.46  
   + 0.06 
0.50  
   + 0.03 
1.58  
   + 0.30 
0.82  
   + 0.03 
0.40  
   + 0.01 
0.96  
   + 0.32 
0.32  
   + 0.02 
pASC 3 
 
0.46  
   + 0.12 
0.68  
   + 0.05 
0.35  
   + 0.01 
0.95  
   + 0.11 
0.50  
   + 0.07 
0.29  
   + 0.03 
0.24  
   + 0.03 
pASC 4 
 
0.30  
   + 0.10 
0.62  
   + 0.05 
1.27  
   + 0.84 
0.86  
   + 0.21 
0.29  
   + 0.04 
0.33  
   + 0.07 
0.27  
   + 0.02 
Mean 
 
0.43  
      + 0.041,a 
0.59  
      + 0.041,a 
1.69  
      + 0.671,a 
0.79  
      + 0.091,b 
0.36  
      + 0.061,b 
0.49  
      + 0.161,a 
0.34  
      + 0.071,a 
SEM, standard error of the mean.    
Different letters (a and b) within columns indicate significant difference between cell types.  
Different numbers (1 and 2) within rows indicate significant difference between passages. 
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).  
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Figure 5.4.  Histograms of the mean transcript levels in FPFs and pASCs for DNA methyltransferase-1 (Dnmt1), DNA 
methyltransferase-3a (Dnmt3a), histone deacetylase-1 (HDAC1) and methyl CpG binding protein-2 (MeCP2).  Means are reported as 
a fold change in expression of each gene relative to a calibrator from porcine muscle tissue.  Relative differences are depicted for 
both FPFs and pASCs for expression of Dnmt1 (A), Dnmt3a (B), HDAC1 (C) and MeCP2 (D).  Bars are representative of the 
standard error of the mean.     
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Table 5.8 Chromatin Immunoprecipitation for Bivalent Domain            
Epigenetic Modifications 
Percent + SEM 
Gene Promoter 
Lysine 4 Lysine 27 
pOCT4 Proximal 27.97 + 13.56 31.81 + 6.13 
pOCT4 Distal 3.21 + 0.99 7.34 + 2.01 
pNanog Proximal 1.40 + 0.77 0.86 + 0.84 
pNanog Distal 0.26 + 0.18 0.06 + 0.03 
             p = Porcine.
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Figure 5.5  Proximal and Distal Promoter Regions of Oct-4 and Nanog.  Primers were designed 
for regions proximal and distal to the initiation of transcription (shown in green).  ChIP procedure 
was performed for immunoprecipitated chromatin containing the H3K4me3 and H3K27me3 
modifications and real-time PCR was performed to determine the presence of the modifications 
within the promoter regions of Oct-4 and Nanog.  Transcripts were run on an electrophoresis gel 
for visualization.
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proportion of the input chromatin, and 31.81 + 6.13 for the H3K27me3 epigenetic mark. The 
Oct-4 distal promoter region generated lower values of 3.21 + 0.99 for lysine 4 and 7.34 + 2.01 
for lysine 27.  Nanog proximal (1.40 + 0.77 and 0.86 + 0.84) and distal (0.26 + 0.18 and 0.06 + 
0.03) promoters generated low values for each modification lysine 4 and lysine 27, respectively. 
Discussion 
Over a decade after the successful production of the first viable cloned sheep offspring 
named Dolly (Wilmut et al., 1997), the efficiency of NT remains remarkably low resulting in 
approximately 1 to 2% live births (Hiendleder et al., 2005).  Research initially focused on factors 
surrounding crucial synchronization of the cell cycle phase of the donor nucleus and the 
recipient cytoplasm, but has shifted to investigate the mechanisms involved in adequate 
reprogramming of the donor genome. 
During normal mammalian development, periods of genome-wide reprogramming of 
epigenetic patterns are believed to occur.  The events following fertilization of the oocyte 
generate many different types of cells that make up the developing organism.  A distinguishing 
pattern of epigenetic mechanisms summons differential subsets of gene activities without 
altering the DNA sequence.  Resultant epigenetic modifications, including histone modifications 
and DNA methylation, direct the cells produced from the fertilized oocyte to differentiate into a 
specialized cell type or tissue.  The sophisticated genetic coordination regulates proper 
temporal and spatial expression of these genes throughout development (Lieb et al., 2006; 
Shiota, 2004).   
The procession of these events must be preceded by the removal of acquired epigenetic 
modifications instated by genetic predisposition or environment in germ cells for normal 
development and donor cells for NT (Allen et al., 1990; Engler et al., 1991; Reik et al., 1993; 
Sapienza et al., 1989).  The failure of NT embryos to develop normally may be attributed to 
inherited epigenetic information from the somatic donor cell by the embryo as a result of 
incomplete erasure of the donor genome (Santos and Dean, 2004).  Therefore, the use of a cell 
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such as a stem cell with low or absent levels of chromatin remodeling proteins such as Dnmt1, 
Dnmt3a, HDAC1 and MeCP2 may correlate to low levels of DNA methylation translating into 
more complete reprogramming in NT embryos.  In this study, the gene expression profiles of 
epigenetic factors and their resultant modifications in differentiated fetal porcine fibroblasts 
(FPF) and undifferentiated porcine adipose tissue-derived stem cells (pASCs) at multiple 
passages through in vitro culture. 
The current techniques employed today to establish and maintain primary in vitro cell 
cultures may be responsible for the induction of cytokinetic abnormalities and chromosomal 
alterations (Chu, 1962; Denning et al., 2001; Kasinathan et al., 2001; Oback and Wells, 2002; 
Rubin, 1997).  We observed marked changes in the levels of mRNA for the chromatin 
remodeling proteins analyzed through culture in both FPFs and pASCs.  However, the variation 
was much more substantial in the FPF cell lines when compared to the pASC cell lines.  None 
of the cell lines analyzed were frozen at any point in the study; therefore neither the effects of 
cryoprotectants nor the freezing procedure itself can be responsible for the observed changes in 
transcript expression.  However, the cellular stresses induced during the initial establishment of 
the cell cultures especially in FPFs most likely attributed to the variation of mRNA expression 
levels as well as the high levels of both DNA methylation and histone acetylation in the analysis 
of passage 1 cell lines.  Spontaneous transformations reported to accumulate proportionally to 
the time in culture (Oback and Wells, 2002) may also contribute to the noted changes over time 
in in vitro culture. 
 Dnmt1 directly interacts with MeCP2 to recognize hemi-methylated DNA while HDAC1 
works with both Dnmt1 and MeCP2 to deacetylate histones (Nan et al., 1998).  As a unit these 
proteins function to maintain DNA methylation over multiple generations in culture (Kimura and 
Shiota, 2003) forming a synergism between histone acetylation and DNA methylation.  In 
addition, Dnmt3a will also function as a maintenance enzyme since a knockout demonstrates a 
decreased level of DNA methylation over time in culture (Chen et al., 2003).  Therefore, DNA 
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methylation would be expected to increase in response to an increase in the prevalence of 
these three proteins.   
In this study, the messenger RNA pattern detected in pASCs for Dnmt1, Dnmt3a, 
HDAC1 and MeCP2 all followed the same pattern through culture with a noted increase in 
expression at passage 3 followed by a subsequent decrease through passage 9.  A possible 
explanation of the increase in the expression levels of these proteins at passage 3 may be that 
the during the first two passages the cells are battling the initial stress of establishing the culture 
and that by passage 3 the cells have reinstated normal cellular processes.  Nevertheless, 
expression levels of these proteins through in vitro culture remain low and correlate to the 
expected low level of methylated DNA during passages 2 through 7.  Interestingly, the low level 
of DNA methylation for pASCs remained consistently low over passages 2 through 7, which was 
not observed to be true for FPF cell lines similar to those currently employed for NT.  This 
finding suggests that pASCs may serve as more efficient donor cells for NT because a lower 
level of DNA methylation may be more easily reprogrammed following fusion with the 
enucleated oocyte.   
The expression levels of HDAC1 in pASCs and FPFs were also observed at relatively 
low levels throughout culture.  The low abundance parallels the lower levels found for the other 
three chromatin remodeling proteins.  In relation to the expression levels of the HDAC1 
transcript, histone H3 acetylation patterns in pASCs were relatively low from passage 3 through 
passage 7.  This trend roughly correlates to the observed low levels of DNA methylation at 
passages 2 through 7.  
Primary cells utilized to establish culture possess the capacity to survive only a finite 
number of population doublings before cellular senescence is reached (Hayflick and Moorhead, 
1961).  As cells approach this limit, the rate of proliferation decreases (Cameron, 1972) and the 
probability of cells to undergo cytokinetic abnormalities and chromosomal alterations increases 
substantially (Giraldo et al., 2006; Oback and Wells, 2002).  We observed an altered display of 
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DNA methylation and histone H3 acetylation in the initial cultures as well as the late passage 9 
in pASCs.  The variation at these time points in culture may be attributed to the establishment of 
the cell culture in vitro for the first few passages and the accumulation of chromosomal 
abnormalities for the late passage 9 cell populations.  FPF cell lines also exhibited a high 
degree of variation in DNA methylation and histone H3 acetylation through culture.  These 
findings are consistent with the pattern of epigenetic modifications detected in bovine fetal 
fibroblasts (Giraldo et al., 2007).  The presence of a heterogenous cell population, a greater 
susceptibility to spontaneous transformation or characteristics exclusive to the particular cell line 
may be potential culprits of the variation. 
The inconsistent patterns of DNA methylation and histone acetylation found in FPF cell 
lines are probably more likely than pASCs to induce higher methylation levels found in cloned 
embryos.  A study using bovine fibroblasts showed that although bovine fibroblast nuclei initially 
lost some methylation following fusion with the oocyte, further demethylation was not observed 
and instead de novo methyltrasnferases prematurely reinstated levels back to resemble that in 
differentiated nuclei (Dean et al., 2001).  Somatic cell-like methylation patterns found in cloned 
embryos such as these may be a result of the introduction of the somatic version of Dnmt1 upon 
fusion with the recipient oocyte, which functions to maintain methylation patterns characteristic 
to the cell type in which it was derived (Reik et al., 2001).  Thus a requirement for successful NT 
is the sufficient erasure of inherited epigenetic information from the differentiated donor cell 
nuclei.   
In conclusion, in vitro cultured cells demonstrated altered mRNA transcript levels of 
chromatin remodeling proteins, which were consistently lower in pASCs than in FPFs.  Also, 
FPF cell lines displayed greater variability in DNA methylation and histone H3 acetylation 
patterns than pASCs.  We suggest that cultured pASCs, which display a consistently lower DNA 
methylation pattern as we described, may be more conducive to proper reprogramming 
necessary for improved efficiency of NT.  Also, preliminary evidence suggests the presence of a 
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stem cell-associated bivalent chromatin structure harboring both H3K4me3 and H3K27me3 
epigenetic modifications within the promoter region of Oct-4, providing further evidence that 
these cells possess this stem cell characteristic.  Subsequent employment of these cells in NT 
procedures will elucidate the true efficacy of pASCs as donor cells for NT. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Although considerable amounts of research have focused on the intricacies involved in 
the process of NT, the efficiency of the procedure remains low with a 1 to 2% success rate.  In 
addition to the low efficiency, anomalies resulting from suboptimal NT ultimately jeopardize the 
health and welfare of any produced cloned offspring generating problems such as those 
symptoms associated with Large Offspring Syndrome.  Research has previously focused on 
factors such as the improper synchrony of the cell cycle phase of the donor cell nucleus with the 
recipient ooplasm and more recently has shifted to investigating adequate reprogramming of the 
donor genome.   
The failure of NT embryos to develop normally may be attributed to inherited epigenetic 
information from the somatic donor cell by the embryo as a result of incomplete erasure of the 
donor genome. Therefore, the use of a cell such as a stem cell with low or absent levels of the 
enzymes responsible for creating the epigenetic landscape such as Dnmt1, Dnmt3a, HDAC1 
and MeCP2 may correlate to a lower incidence of inherited epigenetic marks carried over from 
the cell type in which the donor cell was derived.  The incorporation of a donor cell with low 
levels of DNA methylation initially may ultimately translate into more complete reprogramming in 
NT embryos.  
Research in stem cell biology has exploded over the last two decades.  However, the 
basic biology of in vitro culture continues to be elucidated.  The improvement of culture 
conditions and the definition of cellular characteristics will aid the efficient isolation and 
purification of stem cell populations from multiple species-specific tissues creating important 
animal models for biomedical applications.  Specific to this project, current knowledge of the 
optimal culture conditions for pluripotent and differentiated MSCs from adipose tissue, an easily 
attainable tissue source have not been defined.  Also, culture characteristics of these cells have 
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not been clearly defined and studies generating gene and protein expression profiles are 
underway, but remain inconclusive.   
Stem cell characteristics must be clearly defined in order to isolate, identify and optimally 
culture potential donor cells for NT.  Stem cell characteristics such as self-renewal and 
differentiation have not been identified until now in stem cells from porcine adipose tissue.  In 
addition, the phenotypic profile of cell surface proteins and chromosomal stability of porcine 
adipose tissue-derived stem cells (pASCs) through in vitro culture has not been described.  At 
this time, research has not identified epigenetic modifications in adult somatic MSCs from 
porcine adipose tissue.  
In Project 1 we developed a successful protocol for the isolation and culture of pASCs 
and determined stem cell-like characteristics.  Initial culture of pASCs generated similar 
quantities of cells to those of other species-specific fat depots reported in the literature.  pASC 
cell cultures preferred a higher seeding density in order for rapid colony cultivation to ensue.  
The duration of culture pASCs can undergo without reaching replicative senescence was 
comparable to those published for human adipose tissue and porcine bone marrow aspirates 
and the cell cycle lengths although a little longer for pASCs were also very similar to other 
species-specific tissues.  
The cloning capacity of pASCs was determined using a ring cloning procedure.  Multiple 
colonies were identified establishing the ability of pASCs to self-renew.  The colonies were then 
subjected to differentiation conditions and found to differentiate successfully into osteogenic, 
adipogenic and chondrogenic tissue lineages.   
Continuing our investigation of the basic biology of pASCs in Project 2, we described the 
cell surface profile for stem cell associated surface markers comparing early and late passages 
of undifferentiated porcine ASCs. The surface phenotype of porcine ASCs is similar for some 
stem cell antigens and different for others when compared with human ASCs cell surface, as 
reported in the literature.  Different from reported values for human ASCs, porcine ASCs did not 
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demonstrate positive expression for CD44 or SSEA-4.  We confirmed the absence of CD44 by 
western blot analysis. It is important to note that Project 1 was extracted from our publication 
that included a study, which did, in fact, reveal positive gene expression of CD44 though 
reverse transcriptase polymerase chain reaction. SSEA-4, found on bone marrow MSCs and 
human ASCs, and Sca-1, also found on MSCs, were not detected on the surface of porcine 
ASCs at early or late PDs.  We did find consistent with the literature, however, CD29 and CD90 
expression detected in early and late PDs while CD8 and CD117 antigens were not present at 
early or late PDs.  Our study is by no means a comprehensive investigation for stem cell 
markers potentially present on the surface of porcine ASCs and many others will need to be 
analyzed as antibodies become available. 
The chromosomal stability of pASCs through in vitro culture was found to be similar to 
bovine fetal fibroblasts as published in the literature.  pASCs demonstrated an increased 
percentage of aneuploid cells directly from the initiation of culture with almost a 50% decrease 
in the incidence of normal diploid cells.  The percentage of aneuploid cells significantly 
increased for middle PDs and late PDs. The assault to chromosomal stability clearly occurs 
after removing the cells from their in vivo environment, which is supported by such elevated 
levels of aneuploidy directly from the start in both bovine fetal fibroblasts and porcine ASCs.  
The sub-optimal culture conditions continue to corrode the genetic stability of the cells as they 
fight to survive in vitro culture through middle and late PDs as indicated by the significant 
increases in aneuploidy. 
In Project 3, we analyzed the gene expression profiles of epigenetic factors and their 
resultant modifications, DNA methylation and histone H3 acetylation, in differentiated FPF and 
undifferentiated pASCs at multiple passages through in vitro culture.  We observed marked 
changes in the levels of mRNA for the chromatin remodeling proteins analyzed through culture 
in both FPFs and pASCs.  However, the variation was much more substantial in the FPF cell 
lines when compared with the pASC cell lines. The messenger RNA pattern detected in pASCs 
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for Dnmt1, Dnmt3a, HDAC1 and MeCP2 all followed the same pattern through culture and 
remained low, which correlates with the expected low level of methylated DNA observed during 
passages 2 through 7.  Interestingly, the observed low level of DNA methylation for pASCs 
remained consistently low over passages 2 through 7, which was not true for FPF cell lines 
similar to those currently employed for NT. In relation to the expression levels of HDAC1, 
histone H3 acetylation patterns in pASCs were relatively low from passage 3 through passage 
7.  This trend roughly correlates to the observed low levels of DNA methylation at passages 2 
through 7.  Also, we observed an altered display of DNA methylation and histone H3 acetylation 
in the initial cultures as well as the late passage 9 in pASCs.  FPF cell lines also exhibited a 
high degree of variation in DNA methylation and histone H3 acetylation through culture. 
We consider the possibilities of cellular stresses induced during the initial establishment 
of the cell cultures especially in FPFs and spontaneous transformations reported to accumulate 
proportionally to the time in culture as culprits to the variation of mRNA expression levels as well 
as the high levels of both DNA methylation and histone acetylation in the analysis of passage 1 
cell lines.  Also, the variation at initial culture and later in passage may be attributed to the initial 
events necessary to establishment cell culture and the accumulation of chromosomal 
abnormalities in later passages.  The presence of a heterogeneous cell population, a greater 
susceptibility to spontaneous transformation or unique characteristics to the cell line under 
investiation may also be attributed with the variation noted in our results.  
In conclusion, improved culture conditions and defined cellular characteristics of self-
renewal of these pASCs have been identified.  pASCs can self-renew and differentiate into 
multiple tissue lineages.  The phenotypic landscape of pASCs is similar for some cell surface 
markers reported in human ASCs and different for others.  In vitro cultured porcine ASCs used 
as donor cells for NT should be chosen from early PDs due to increased levels of aneuploidy at 
later PDs.  pASCs may serve as more efficient donor cells for NT because a lower level of DNA 
methylation may be more easily reprogrammed following fusion with the enucleated oocyte.  It is 
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suggested that cultured pASCs which display a consistently lower DNA methylation pattern as 
we described may be more conducive to proper reprogramming necessary for improved 
efficiency of NT.  Subsequent employment of these cells in NT procedures will elucidate the true 
efficacy of pASCs as donor cells for NT.
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APPENDIX A:  PROTOCOLS 
WESTERN BLOTTING PROTOCOL 
1. Place 2-10% gels in running buffer. 
 
2. Load Gels: 
a. Load using 1:1 ratio of loading buffer:sample 
b. 10 !l MW stds –heat in water bath 
c. Heat samples at 95°C for 5-10 minutes 
 
3. Run gels at 100 V until standards reach the bottom of the gel (~1 " hour-3 hours). 
 
4. Wash gel for coomassie stain in MQ Water 3 X for 5 minutes. 
 
5. Stain gel in Coomassie Blue (Bio-Rad Catalog # 161-0786). 
 
6. Equilibrate gel by transferring into cold transfer (Towbin’s) buffer (> 15 min).  
 
7. Prepare membrane 30 seconds in 100% Methanol. 
 
8. Transfer membrane into cold Towbin’s buffer 2-3 minutes. 
 
9. Soak pads and filter paper in cold transfer buffer. 
 
10. Prepare transfer sandwich (load on black side of gel holder cassette in order): 
a. Pad 
b. Filter paper 
c. Gel 
d. Membrane 
e. Filter paper 
f. Pad 
 
11. Place red and black mini trans-blot module into gel tank with the black side in the center 
and banana plugs in middle. 
 
12. Place the frozen ice block (frozen in -80ºC) into gel tank. 
 
13. Slide cassette into the red and black mini trans-blot module as follows: 
a. Black side of the sandwich facing the black side of the mini trans-blot module 
(middle) and clear side facing the red (outside). 
 
14. Fill tank with cold Towbin’s buffer and a stir bar and place in ice bucket.   
 
15. Place ice bucket on stir plate and pack ice around the transfer apparatus.   
 
16. Run transfer at 90 volts for about 90 minutes (make sure bubbles appear between trans-
blot module and ice block). 
 
17. Remove cassette, disassemble, and place membrane in blocking buffer 2 to 3 hours 
(poke holes to denote where to cut membrane if probing with different antibodies). 
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18. Pour off blocking buffer and incubate with 1° Antibody according to predetermined 
dilution (1:2000) overnite at 4ºC: 
a. 20 ml of Blocking buffer 
b. 10 !l primary antibody 
 
19. Perform 5 X 10 minute washes in TBST. 
 
20. Incubate with 2° Antibody according to predetermined dilution (1:3000) for 1 hour at 
room temperature: 
a. 20 ml of Blocking buffer 
b. 6.7 !l secondary antibody 
 
21. Perform 5 X 10 minute washes in TBST. 
 
22. Incubate in color reagents for 30 minutes or when color appears: 
a. 1 x HRP = 20 ml 
b. Bio-Rad Reagent A = 2 ml 
c. Bio-Rad Reagent B = 120 !l 
 
     Alternatively, 
 
23. a.  Mix ECL reagents 1:1 and allow to warm to room temperature.  
b. Blot off wash buffer onto a paper towel by capillary action. 
c. Place membrane on a piece of saran wrap. 
d. Apply ECL reagents to top of membrane allowing surface tension to hold volume. 
e. Incubate for 1 minute. 
f. Again blot off ECL reagents onto a paper towel by capillary action. 
g. Place protein side down onto another piece of saran wrap and fold into a pocket. 
h. Tape into film cassette and expose to xray film 2 minutes, 5 minutes, 20 to 30 
minutes, overnite. 
 
i.   Develop film in dark room.  
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CHROMATIN IMMUNOPRECIPITATION PROTOCOL 
DNA-protein Cross-linking, Cell Lysis and Chromatin Fragmentation: 
 
1. Harvest cells by trypsinization per standard protocol. 
2. Count cells and allocate 2.5 x 106 cells to ChIP. 
3. Centrifuge cells 300 x g for 5 minutes and remove supernatant. 
4. Resuspend cells in 515 µl PBS (without calcium). 
5. Add 34 µl of 16% paraformaldehyde (gives 1% v/v) and vortex lightly. 
6. Incubate at room temperature 8 minutes. 
7. Add 62 µl room temperature 10X glycine (final concentration 125 mM). 
8. Incubate at room temperature 5 minutes. 
9. Centrifuge cells 300 x g for 10 minutes at 4°C and remove supernatant. 
10. Wash in 500 µl PBS. 
11. Centrifuge cells 300 x g for 10 minutes at 4°C and remove supernatant. 
12. Repeat wash (steps 10 and 11) or alternatively flash freeze pellet in LN2 and store at -
80°C. 
 
13. Resuspend in 500 µl Lysis Buffer and vortex lightly. 
14. Incubate on ice for 5 minutes. 
15. Transport cells to sonicate. 
16. Sonicate each sample on Branson Sonifier 250 Duty cycle 40% Level 4 for 10 x 20 
pulses on ice with 1 minute pause in between each set of 20 pulses. 
 
17. Centrifuge at 12,000 x g for 10 minutes at 4°C. 
18. Remove supernatant and put in new tube. 
19. Can store at -80°C or move on to next procedure. 
Preparation of Antibody-Bead Complexes: 
 
1. For each sample to be analyzed, remove 11 µl well-suspended bead stock solution 
(Millipore MagnaChIP Kit, Catalog #MAGNA001). 
 
2. Place single tube in magnet to capture beads and remove storage buffer. 
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3. Remove tube from magnet and resuspend beads in 500 µl RIPa buffer. 
4. Mix lightly and replace into magnet to capture beads and remove RIPA buffer. 
5. Repeat wash (steps 2-4). 
6. Resuspend beads in 10.5 µl RIPA buffer for each sample (i.e., 10.5 x # samples gives 
total volume to resuspend with). 
 
7.  Add 90 µl RIPA buffer to 0.2 ml PCR tube (1 per sample).   
8. Add 10 µl pre-washed beads to each PCR tube and 2.4 µg of antibody. 
9. Incubate at 4°C for 2 hours at 40 rpm on VWR Hybridization Oven. 
Immunoprecipitation: 
 
1. Dilute chromatin to 3 ml with RIPA buffer supplemented with 30 µl HALT protease 
inhibitor (approximately 100,000 cells in 100 µl). 
 
2. Make 100 µl aliquots and store in -20°C. 
3. Touch-spin PCR tubes containing antibody-bead complexes to remove contents from lid. 
4. Place into ice-cold magnet to capture beads and remove RIPA buffer. 
5. Remove tubes from magnet and resuspend in 100 µl of aliquoted chromatin. 
6. Incubate at 4°C overnight at 40 rpm on VWR Hybridization Oven. 
7. Touch-spin PCR tubes, place in ice-cold magnet and remove RIPA buffer. 
8. Remove tubes from magnet and resuspend in 100 µl RIPA buffer. 
9. Incubate at 4°C for 4 minutes at 40 rpm on VWR Hybridization Oven. 
10. Repeat wash 2 times (steps 7-9).   
11. Touch-spin PCR tubes, place in ice-cold magnet and remove RIPA buffer. 
12. Resuspend beads in 100 µl TE buffer. 
13. Incubate at 4°C for 4 minutes at 40 rpm on VWR Hybridization Oven. 
14. Touch-spin PCR tubes and transfer contents to new PCR tube. 
15. Place on magnet to capture beads and remove TE buffer. 
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DNA Elution, Cross-link reversal and Proteinase K Digestion: 
 
1. Add 150 µl Elution buffer and add SDS to 1% and proteinase K to 50 µg/ml. 
2. Add 200 µl Elution buffer to another 100 µl aliquot of diluted chromatin and add 
proteinase K to 50 µg/ml. 
 
3. Incubate at 68°C for 2 hours at 40 rpm on VWR Hybridization Oven. 
4. Touch-spin tubes and place on magnet to capture beads. 
5. Collect supernatant and transfer to new 1.5 ml tube. 
6. Add 150 µl Elution buffer/SDS/proteinase K and resuspend beads. 
7. Incubate at 68°C for 5 minutes at 40 rpm on VWR Hybridization Oven. 
8. Touch-spin tuves and place on magnet to capture beads. 
9. Collect supernatant and add to 1.5 ml tube. 
DNA Isolation: 
 
1. Add 500 µl Bind Reagent A (Millipore Kit) to each sample and vortex. 
2. Transfer sample/Bind Reagent A to Spin filter in collection tube. 
3. Centrifuge for 30 seconds at 12,500 x g. 
4. Remove spin filter from collection tube and save collection tube while discarding liquid. 
5. Replace spin filter into collection tube and add 500 µl Wash Reagent B. 
6.  Centrifuge for 30 seconds at 12,500 x g. 
7. Remove spin filter from collection tube and save collection tube while discarding liquid. 
8. Replace spin filter into collection tube. 
9. Centrifuge for 30 seconds at 12,500 x g. 
10. Discard collection tube containing residual liquid. 
11. Place spin filter into new collection tube. 
12. Add 130 µl Elution Buffer C directly onto center of white spin filter membrane. 
13. Centrifuge for 30 seconds at 12,500 x g. 
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14. Remove spin filter and discard. 
15. Analyze purified DNA by qPCR or store at -20°C. 
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TRI REAGENT® RNA ISOLATION PROTOCOL 
1. Turn on centrifuge and let cool to 4° C.  
2. Prep phase lock tubes by spinning at 3500 x g for 10 minutes. 
3. Pour off medium from flasks. 
4. For T75 add 8 ml Trizol reagent to each T75 flask and pass cell lysate through pipette 
several times.  Incubate at room temperature 5 min knock on counter top to dissociate. 
 
5. Use the scrapper to remove cells and transfer lysate to phase lock tube. 
6. Incubate at room temperature 5 minutes to permit the complete dissociation of 
nucleoprotein complexes. 
 
7. Add 0.8 ml BCP in hood. 
8. Cap tubes and shake vigorously by hand for 15 to 30 seconds. 
9. Incubate tubes at room temperature for 30 minutes to 1 hour.   
10. Centrifuge at 12,000 g for 15 minutes at 4° C. 
11. Transfer aqueous supernatant into a fresh tube.  
12. Precipitate RNA by mixing with 4 ml isopropyl alcohol (for T75).  Shake well. 
13. Hold at -20° C overnite for optimal recovery. 
14. Centrifuge at 12,000 g for 20 minutes at 4° C putting number side up. RNA will form a 
gel-like or white pellet on the side and bottom of the tube.  
 
15. Pour off supernatant away from pellet. 
16. Respin pellet at 12,000 g for 2 minutes at 4° C. 
17. Wash the RNA pellet in 75% EtOH (prepared in DECP water) using at least 1 ml of 
EtOH per 1 ml of Trizol reagent (8 ml for T75—make 40 ml for 4 samples). 
18. Vortex tube until pellet is floating.  Can use pipette tip to push off sides. 
19. Centrifuge at 15,000 g for 10 minutes. 
20. Transfer pellet in 1 ml ethanol (left from previous step) and respin for 15 minutes in 1.5 
ml tube.  
 
21. Carefully remove ethanol supernatant with a pipette followed by a disposable pipette 
then a thirsty stick.  
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22. Briefly dry the RNA pellet with top off at 37° C for about 7 minutes. 
23. Dissolve the RNA pellet in DEPC water about 25 ul and incubate in 55 to 60° C 
waterbath about 10 minutes if needed.
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KARYOTYPING PROTOCOL 
1. Thaw or passage cells 24 hours prior to cell synchronization. 
2. Add 0.05 µg/ml of KaryoMax® to directly to cell culture. 
3. Incubate 30 minutes to 3 h at 37°C. 
4. Remove media and put to side. 
5. Harvest cells by trypsinization. 
6. Add harvested cells to medium from step 4. 
7. Centrifuge at 1200 x g for 5 minutes. 
8. Remove supernatant and SLOWLY resuspend cells in 3 ml pre-warmed hypotonic 
solution in 0.5 ml increments. 
 
9. Incubate in 37°C water bath 5 minutes. 
10. Centrifuge at 1200 x g for 5 minutes. 
11. Remove supernatant. 
12. SLOWLY add fixative (3:1) in 0.5 ml increments. 
13. Incubate in 4°C for 10 minutes. 
14. Centrifuge at 1200 x g for 5 minutes. 
15. Remove supernatant.  
16. Resuspend in 0.5 ml fresh fixative. 
17. Store in -20°C at least overnight and up to 2 months. 
18. Hold clean slide at an angle and place 3 to 5 10 µl drops of cell suspension and 
allow drops to spread down slide. 
 
19. Allow slides to dry at least 10 minutes. 
20. Flood slide with 4 x 1 ml of 1:1 fixative. 
21. Allow slides to dry at least 10 minutes. 
22. Drop slides into Giemsa stain for 15 minutes. 
23. Remove slides from stain and gently rinse with deionized water. 
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24. Allow slides to dry completely. 
25. Visualize under 100 X oil immersion. 
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APPENDIX B:  REAGENT FORMULATIONS 
 
WESTERN RUNNING BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
10X Tris/Glycine/SDS  BIO-RAD 161-0732 100 ml 
    
MQ Water   900 ml 
    
Prepare on day of use. 
 
 
 
WESTERN LOADING BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Laemmli buffer BIO-RAD 161-0737 950 !l 
    
beta-mercaptoethanol Sigma M-7522   50 !l 
    
Prepare on day of use. 
 
 
 
WESTERN TOWBIN’S BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Trizma-Base Sigma T-1503 3.03 g (25 mM) 
    
Glycine Sigma G-8898 14.4 g (192 M) 
    
Methanol Sigma M-1775 200 ml (20 %) 
    
MQ Water   Bring up to 1 L 
Prepare on day of use. 
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WESTERN TBST BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
10X TBS BIO-RAD 170-6435 100 ml 
    
10% Tween 20 BIO-RAD 161-0781     5 ml 
    
MQ Water   Bring up to 1 L 
Prepare on day of use. 
 
 
WESTERN BLOCKING BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Non-fat Dry Milk BIO-RAD 170-6404     10 g 
    
TBST   200 ml 
Prepare on day of use. 
 
 
ChIP LYSIS BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Trizma-HCl Fluka 93313 5 ml (50 mM) 
    
EDTA Sigma E7889 2 ml (10 mM) 
    
10% SDS Gibco 15553-035    10 ml (1 %) 
    
HALT Proteases Inhibitor Thermo-Scientific 1860932 100 µl 
    
PMSF Sigma  5 µl (1 mM) 
Store at 4°C several months.
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ChP RIPA BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Trizma-HCl Fluka 93313 1 ml (10 mM) 
    
EDTA Sigma E7889 200 µl (1 mM) 
    
EGTA Sigma E3889 50 ml (0.5 mM) 
    
Triton X-100 Sigma X-100 1 ml 
    
10% SDS Gibco 15553-035 1 ml (0.1 %) 
    
Sodium deoxycholate Sigma D6750 0.1 g 
    
NaCl Sigma S5886 0.818 g 
    
MQ Water   Bring to 100 ml 
Store at 4°C several months. 
 
ChIP TE BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Trizma-HCl Fluka 93313 250 µl (10 mM) 
    
EDTA Sigma E7889 500 µl (10 mM) 
Store at room temperature several months. 
 
ChIP Elution BUFFER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Trizma-HCl Fluka 93313 500 µl (20 mM) 
    
EDTA Sigma E7889 250 µl (5 mM) 
    
NaCl Sigma S5886 0.073 g 
    
MQ Water   Bring up to 25 ml 
Store at room temperature several months.
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DEPC WATER 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
DEPC Sigma D5758 100 µl 
    
MQ Water   100 ml 
Incubate at 37°C 1 hr, autoclave 15 min. 
Store at room temperature several months. 
 
 
 
 
 
 
 
HYPOTONIC SOLUTION 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Sodium Citrate Sigma S4641    0.9 g 
    
MQ Water   100 ml 
Filter and store at room temperature indefinitely. 
 
 
 
 
 
 
 
 
3:1 FIXATIVE SOLUTION 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Methanol Sigma M1775 15 ml 
    
Acetic Acid Sigma A6283   5 ml 
Prepare fresh on day of use.
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1:1 FIXATIVE SOLUTION 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Methanol Sigma M1775 10 ml 
    
Acetic Acid Sigma A6283 10 ml 
Prepare fresh on day of use.  
 
 
 
 
 
 
 
GIEMSA STAINING SOLUTION 
REAGENT COMPANY 
CATALOG 
NUMBER 
AMOUNT 
    
Giemsa Stain Sigma GS-500   2 ml 
    
MQ Water   28 ml 
Prepare fresh on day of use. 
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APPENDIX C:  LETTER OF PERMISSION 
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